|
G
|
Akr1b1
|
aldo-keto reductase family 1 member B1
|
increases oxidation
|
ISO
|
AKR1B1 protein results in increased oxidation of Benzyl Alcohol
|
CTD |
PMID:17194029 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:63,899,222...63,913,315
|
|
G
|
Akr1b15
|
aldo-keto reductase family 1 member B15
|
multiple interactions
|
EXP
|
[AKR1B8 protein co-treated with NADP] affects the oxidation of Benzyl Alcohol
|
CTD |
PMID:18845131 |
|
NCBI chr 4:62,997,241...63,009,815
Ensembl chr 4:63,960,880...63,978,349
|
|
G
|
Il1a
|
interleukin 1 alpha
|
increases expression
|
ISO
|
Benzyl Alcohol results in increased expression of IL1A protein
|
CTD |
PMID:19878710 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
G
|
Lif
|
LIF, interleukin 6 family cytokine
|
increases expression
|
ISO
|
Benzyl Alcohol results in increased expression of LIF protein
|
CTD |
PMID:19878710 |
|
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053
|
|
G
|
Sult1a1
|
sulfotransferase family 1A member 1
|
increases sulfation
|
ISO
|
SULT1A1 protein results in increased sulfation of Benzyl Alcohol
|
CTD |
PMID:26663444 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:190,702,592...190,706,131
|
|
G
|
Sult1b1
|
sulfotransferase family 1B member 1
|
increases sulfation
|
ISO
|
SULT1B1 protein results in increased sulfation of Benzyl Alcohol
|
CTD |
PMID:26663444 |
|
NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,771,868...20,785,549
|
|
G
|
Ugt2b1
|
UDP glucuronosyltransferase 2 family, polypeptide B1
|
increases glucuronidation
|
EXP
|
UGT2B1 protein results in increased glucuronidation of Benzyl Alcohol
|
CTD |
PMID:8302279 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,378,853...21,392,331
|
|
|
G
|
Enpp2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
increases expression
|
ISO
|
benzyl acetate results in increased expression of ENPP2 mRNA; benzyl acetate results in increased expression of ENPP2 protein
|
CTD |
PMID:22952646 |
|
NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957
|
|
G
|
Mmp9
|
matrix metallopeptidase 9
|
increases expression
|
ISO
|
benzyl acetate results in increased expression of MMP9 mRNA; benzyl acetate results in increased expression of MMP9 protein
|
CTD |
PMID:22952646 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
G
|
Ppp3ca
|
protein phosphatase 3 catalytic subunit alpha
|
multiple interactions
|
ISO
|
benzyl acetate results in increased cleavage of and results in increased activity of PPP3CA protein
|
CTD |
PMID:22952646 |
|
NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:227,839,062...228,113,554
|
|
|
G
|
Atf3
|
activating transcription factor 3
|
increases expression
|
ISO
|
benzyl benzoate results in increased expression of ATF3 mRNA
|
CTD |
PMID:27965148 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:105,282,440...105,295,750
|
|
G
|
Cd86
|
CD86 molecule
|
increases expression
|
ISO
|
benzyl benzoate results in increased expression of CD86 protein
|
CTD |
PMID:29540657 |
|
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
|
|
G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
benzyl benzoate inhibits the reaction [Estradiol binds to ESR1 protein]
|
CTD |
PMID:19338011 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
G
|
Esr2
|
estrogen receptor 2
|
multiple interactions
|
ISO
|
benzyl benzoate inhibits the reaction [Estradiol binds to ESR2 protein]
|
CTD |
PMID:19338011 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
G
|
Maoa
|
monoamine oxidase A
|
decreases activity
|
ISO
|
benzyl benzoate results in decreased activity of MAOA protein
|
CTD |
PMID:27270453 |
|
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
|
|
G
|
Maob
|
monoamine oxidase B
|
decreases activity
|
ISO
|
benzyl benzoate results in decreased activity of MAOB protein
|
CTD |
PMID:27270453 |
|
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:8,490,344...8,594,375
|
|
G
|
Nefh
|
neurofilament heavy chain
|
affects expression
|
EXP
|
benzyl benzoate affects the expression of NEFH mRNA
|
CTD |
PMID:22954530 |
|
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:84,044,023...84,054,417
|
|
G
|
Tff1
|
trefoil factor 1
|
increases expression
|
ISO
|
benzyl benzoate results in increased expression of TFF1 mRNA
|
CTD |
PMID:19338011 |
|
NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,237,095...9,240,956
|
|
|
G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
increases expression
|
ISO
|
benzylparaben results in increased expression of ADIPOQ mRNA
|
CTD |
PMID:22956630 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:91,226,180...91,240,169
|
|
G
|
Afp
|
alpha-fetoprotein
|
affects binding
|
EXP
|
benzylparaben binds to AFP protein
|
CTD |
PMID:23013281 PMID:25349334 |
|
NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649
|
|
G
|
Ar
|
androgen receptor
|
decreases activity
|
ISO
|
[benzylparaben results in decreased activity of HSD17B6 protein] which results in decreased activity of AR protein
|
CTD |
PMID:39532263 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
G
|
Cebpa
|
CCAAT/enhancer binding protein alpha
|
increases expression
|
ISO
|
benzylparaben results in increased expression of CEBPA mRNA
|
CTD |
PMID:22956630 PMID:27659731 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:96,896,171...96,899,309
|
|
G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
benzylparaben binds to and results in increased activity of ESR1 protein
|
CTD |
PMID:23220609 PMID:23567241 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
G
|
Esr2
|
estrogen receptor 2
|
multiple interactions
|
ISO
|
benzylparaben binds to and results in increased activity of ESR2 protein
|
CTD |
PMID:23567241 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
G
|
Esrrg
|
estrogen-related receptor gamma
|
multiple interactions
|
ISO
|
benzylparaben inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]
|
CTD |
PMID:23583298 |
|
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:101,889,706...102,316,877
|
|
G
|
Faah
|
fatty acid amide hydrolase
|
decreases activity
|
ISO EXP
|
benzylparaben results in decreased activity of FAAH protein
|
CTD |
PMID:27659731 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:134,716,545...134,735,396
|
|
G
|
Fabp4
|
fatty acid binding protein 4
|
increases expression
|
ISO
|
benzylparaben results in increased expression of FABP4 mRNA
|
CTD |
PMID:22956630 PMID:27659731 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:93,488,271...93,492,972
|
|
G
|
Fasn
|
fatty acid synthase
|
increases expression
|
ISO
|
benzylparaben results in increased expression of FASN mRNA
|
CTD |
PMID:22956630 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
G
|
Hsd17b6
|
hydroxysteroid (17-beta) dehydrogenase 6
|
decreases activity
|
ISO
|
[benzylparaben results in decreased activity of HSD17B6 protein] which results in decreased activity of AR protein; benzylparaben results in decreased activity of HSD17B6 protein
|
CTD |
PMID:39532263 |
|
NCBI chr 7:422,466...442,008
Ensembl chr 7:831,421...850,873
|
|
G
|
Lep
|
leptin
|
decreases expression increases expression
|
ISO
|
benzylparaben results in decreased expression of LEP mRNA benzylparaben results in increased expression of LEP mRNA
|
CTD |
PMID:22956630 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
G
|
Ncoa2
|
nuclear receptor coactivator 2
|
multiple interactions
|
ISO
|
benzylparaben inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]
|
CTD |
PMID:23583298 |
|
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:10,618,722...10,852,776
|
|
G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
increases expression
|
ISO
|
benzylparaben results in increased expression of NR1I2 mRNA
|
CTD |
PMID:31472229 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:75,965,632...76,002,380
|
|
G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
increases activity
|
ISO
|
benzylparaben results in increased activity of NR1I3 protein
|
CTD |
PMID:28927721 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:86,165,349...86,170,370
|
|
G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
increases expression
|
EXP
|
benzylparaben results in increased expression of PPARA mRNA
|
CTD |
PMID:31472229 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
increases expression increases activity
|
ISO
|
benzylparaben results in increased expression of PPARG mRNA benzylparaben results in increased activity of PPARG protein
|
CTD |
PMID:22956630 PMID:27659731 PMID:28527915 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
G
|
Shbg
|
sex hormone binding globulin
|
affects binding
|
ISO
|
benzylparaben binds to SHBG protein
|
CTD |
PMID:25349334 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,831,718...54,838,760
|
|
|
G
|
A4galt
|
alpha 1,4-galactosyltransferase
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of A4GALT mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 7:116,248,571...116,272,917
Ensembl chr 7:116,247,880...116,273,171
|
|
G
|
Abca1
|
ATP binding cassette subfamily A member 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ABCA1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
|
|
G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of ABCB1 protein
|
CTD |
PMID:33965509 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
increases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in increased expression of ABCC2 mRNA [dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of ABCC2 mRNA
|
CTD |
PMID:35739735 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
|
|
G
|
Abcc3
|
ATP binding cassette subfamily C member 3
|
increases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in increased expression of ABCC3 mRNA [dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of ABCC3 mRNA
|
CTD |
PMID:26519955 PMID:35739735 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
|
|
G
|
Abcc4
|
ATP binding cassette subfamily C member 4
|
multiple interactions increases expression
|
ISO
|
[dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of ABCC4 mRNA butylbenzyl phthalate results in increased expression of ABCC4 mRNA
|
CTD |
PMID:35739735 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
|
|
G
|
Abcg1
|
ATP binding cassette subfamily G member 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ABCG1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,127,803...9,186,563
|
|
G
|
Abcg2
|
ATP binding cassette subfamily G member 2
|
multiple interactions increases expression
|
EXP ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ABCG2 mRNA [dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of ABCG2 mRNA butylbenzyl phthalate results in increased expression of ABCG2 mRNA
|
CTD |
PMID:31199487 PMID:35739735 |
|
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
|
|
G
|
Abcg5
|
ATP binding cassette subfamily G member 5
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ABCG5 mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376
|
|
G
|
Acaa2
|
acetyl-CoA acyltransferase 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACAA2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420
|
|
G
|
Acaca
|
acetyl-CoA carboxylase alpha
|
multiple interactions
|
ISO
|
[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of ACACA protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACACA mRNA; [butylbenzyl phthalate co-treated with Dietary Fats] results in increased expression of ACACA mRNA
|
CTD |
PMID:26820058 PMID:32905190 PMID:35739755 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,511,857...69,773,888
|
|
G
|
Acly
|
ATP citrate lyase
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,912,402...85,963,631
|
|
G
|
Acot1
|
acyl-CoA thioesterase 1
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of ACOT1 mRNA
|
CTD |
PMID:26519955 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:109,367,268...109,380,749
|
|
G
|
Acot2
|
acyl-CoA thioesterase 2
|
multiple interactions
|
ISO
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ACOT2 protein
|
CTD |
PMID:38995844 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:109,342,646...109,350,502
|
|
G
|
Acox1
|
acyl-CoA oxidase 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of ACOX1 mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,905,083...101,930,136
|
|
G
|
Acsbg1
|
acyl-CoA synthetase bubblegum family member 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSBG1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 8:54,991,294...55,047,276
Ensembl chr 8:63,887,435...63,984,178
|
|
G
|
Acsf2
|
acyl-CoA synthetase family member 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSF2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:79,504,510...79,546,714
Ensembl chr10:80,001,389...80,045,050
|
|
G
|
Acss1
|
acyl-CoA synthetase short-chain family member 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSS1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:159,910,809...159,960,748
|
|
G
|
Acta2
|
actin alpha 2, smooth muscle
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACTA2 mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACTA2 protein
|
CTD |
PMID:35739755 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
G
|
Adam12
|
ADAM metallopeptidase domain 12
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of ADAM12 mRNA
|
CTD |
PMID:39921026 |
|
NCBI chr 1:188,686,984...189,014,206
Ensembl chr 1:198,116,975...198,447,552
|
|
G
|
Adamts1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of ADAMTS1 mRNA] [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein affects the expression of ADAMTS1 mRNA]
|
CTD |
PMID:33316053 PMID:37552060 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:38,418,101...38,427,390
|
|
G
|
Adamts2
|
ADAM metallopeptidase with thrombospondin type 1 motif, 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ADAMTS2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:34,920,992...35,126,465
Ensembl chr10:35,422,030...35,627,483
|
|
G
|
Adgrl1
|
adhesion G protein-coupled receptor L1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ADGRL1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr19:24,202,405...24,244,137
Ensembl chr19:41,109,117...41,148,896
|
|
G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
multiple interactions
|
ISO
|
[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of ADIPOQ mRNA; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of ADIPOQ protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of ADIPOQ mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of ADIPOQ protein; butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]; Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]] butylbenzyl phthalate promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; butylbenzyl phthalate promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; butylbenzyl phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]
|
CTD |
PMID:26820058 PMID:28595985 PMID:31016361 PMID:32407875 PMID:34864131 PMID:37021957 PMID:38954831 More...
|
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:91,226,180...91,240,169
|
|
G
|
Adrb3
|
adrenoceptor beta 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of ADRB3 mRNA
|
CTD |
PMID:37021957 |
|
NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420
|
|
G
|
Ahr
|
aryl hydrocarbon receptor
|
affects localization multiple interactions increases expression affects activity
|
ISO
|
butylbenzyl phthalate affects the localization of AHR protein 3',4'-dimethoxyflavone inhibits the reaction [butylbenzyl phthalate results in increased expression of AHR mRNA]; 3',4'-dimethoxyflavone inhibits the reaction [butylbenzyl phthalate results in increased expression of AHR protein]; AHR mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of ARNT mRNA]; AHR mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of ARNT protein]; AHR mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of CYP1B1 mRNA]; AHR mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of CYP1B1 protein]; butylbenzyl phthalate binds to and results in increased activity of AHR protein; butylbenzyl phthalate promotes the reaction [AHR protein binds to ARNT protein]; butylbenzyl phthalate promotes the reaction [AHR protein binds to CYP1B1 promoter] butylbenzyl phthalate results in increased expression of AHR mRNA; butylbenzyl phthalate results in increased expression of AHR protein butylbenzyl phthalate affects the activity of AHR protein
|
CTD |
PMID:18294747 PMID:22138065 PMID:23220035 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
G
|
Ahsg
|
alpha-2-HS-glycoprotein
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of AHSG mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr11:91,625,975...91,632,583
Ensembl chr11:91,625,975...91,634,039
|
|
G
|
Ak5
|
adenylate kinase 5
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of AK5 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:244,057,240...244,241,366
|
|
G
|
Akap1
|
A-kinase anchoring protein 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of AKAP1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:74,118,232...74,151,366
Ensembl chr10:74,119,124...74,138,190
|
|
G
|
Akr1b15
|
aldo-keto reductase family 1 member B15
|
increases expression
|
EXP
|
butylbenzyl phthalate results in increased expression of AKR1B8 mRNA
|
CTD |
PMID:19560483 |
|
NCBI chr 4:62,997,241...63,009,815
Ensembl chr 4:63,960,880...63,978,349
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
increases phosphorylation multiple interactions affects phosphorylation decreases phosphorylation
|
ISO EXP
|
butylbenzyl phthalate results in increased phosphorylation of AKT1 protein HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate results in increased phosphorylation of AKT1 protein] butylbenzyl phthalate affects the phosphorylation of AKT1 protein butylbenzyl phthalate results in decreased phosphorylation of AKT1 protein [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased phosphorylation of AKT1 protein
|
CTD |
PMID:22552774 PMID:29864457 PMID:31319113 PMID:33395283 PMID:35739755 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
G
|
Akt2
|
AKT serine/threonine kinase 2
|
increases phosphorylation multiple interactions
|
EXP ISO
|
butylbenzyl phthalate results in increased phosphorylation of AKT2 protein [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased phosphorylation of AKT2 protein
|
CTD |
PMID:31319113 PMID:35739755 |
|
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420
|
|
G
|
Akt3
|
AKT serine/threonine kinase 3
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased phosphorylation of AKT3 protein
|
CTD |
PMID:35739755 |
|
NCBI chr13:91,475,839...91,758,060
Ensembl chr13:91,475,839...91,748,020
|
|
G
|
Aldh1a1
|
aldehyde dehydrogenase 1 family, member A1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDH1A1 mRNA
|
CTD |
PMID:30768133 |
|
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
|
|
G
|
Aldh1a2
|
aldehyde dehydrogenase 1 family, member A2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ALDH1A2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883
|
|
G
|
Aldoc
|
aldolase, fructose-bisphosphate C
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDOC protein
|
CTD |
PMID:31199487 PMID:37690569 |
|
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,715,489...63,719,133
|
|
G
|
Alox15
|
arachidonate 15-lipoxygenase
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of ALOX15 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723
|
|
G
|
Alpl
|
alkaline phosphatase, biomineralization associated
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ALPL protein
|
CTD |
PMID:35739755 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:155,234,775...155,254,167
|
|
G
|
Amh
|
anti-Mullerian hormone
|
multiple interactions increases expression
|
EXP
|
[butylbenzyl phthalate co-treated with 4-vinyl-1-cyclohexene dioxide] results in decreased expression of AMH mRNA; [butylbenzyl phthalate co-treated with Dibutyl Phthalate] results in decreased expression of AMH mRNA; butylbenzyl phthalate promotes the reaction [4-vinyl-1-cyclohexene dioxide results in decreased expression of AMH protein] butylbenzyl phthalate results in increased expression of AMH mRNA; butylbenzyl phthalate results in increased expression of AMH protein
|
CTD |
PMID:29969652 PMID:31319113 |
|
NCBI chr 7:8,906,776...8,909,192
Ensembl chr 7:9,557,451...9,559,867
|
|
G
|
Ampd3
|
adenosine monophosphate deaminase 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of AMPD3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:174,294,867...174,364,608
|
|
G
|
Angpt2
|
angiopoietin 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of ANGPT2 protein
|
CTD |
PMID:38954831 |
|
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:77,790,563...77,841,239
|
|
G
|
Angptl3
|
angiopoietin-like 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of ANGPTL3 protein
|
CTD |
PMID:38954831 |
|
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:118,818,499...118,826,444
|
|
G
|
Angptl4
|
angiopoietin-like 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ANGPTL4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:15,252,473...15,258,681
|
|
G
|
Ankrd50
|
ankyrin repeat domain containing 50
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ANKRD50 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:121,466,275...121,500,758
Ensembl chr 2:123,396,606...123,427,340
|
|
G
|
Anpep
|
alanyl aminopeptidase, membrane
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ANPEP mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:143,176,645...143,195,101
|
|
G
|
Antxr1
|
ANTXR cell adhesion molecule 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ANTXR1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:121,148,103...121,336,892
|
|
G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of APAF1 mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
G
|
Apc2
|
APC regulator of WNT signaling pathway 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of APC2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:10,043,010...10,065,037
Ensembl chr 7:10,043,010...10,065,210
|
|
G
|
Aplp1
|
amyloid beta precursor like protein 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of APLP1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:94,824,330...94,834,705
Ensembl chr 1:94,824,072...94,834,610
|
|
G
|
Aplp2
|
amyloid beta precursor like protein 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of APLP2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:37,857,407...37,920,031
|
|
G
|
Apoe
|
apolipoprotein E
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of APOE mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
G
|
Aqp1
|
aquaporin 1
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of AQP1 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504
|
|
G
|
Aqp7
|
aquaporin 7
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of AQP7 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618
|
|
G
|
Ar
|
androgen receptor
|
multiple interactions decreases activity affects activity affects binding
|
ISO EXP
|
butylbenzyl phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; butylbenzyl phthalate inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; butylbenzyl phthalate inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; butylbenzyl phthalate inhibits the reaction [Stanozolol binds to and results in increased activity of AR protein] butylbenzyl phthalate results in decreased activity of AR protein butylbenzyl phthalate affects the activity of AR protein butylbenzyl phthalate binds to AR protein
|
CTD |
PMID:9846162 PMID:14565775 PMID:15840436 PMID:18294747 PMID:20943248 PMID:28571686 PMID:29162470 PMID:33049310 More...
|
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
G
|
Arhgap18
|
Rho GTPase activating protein 18
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:20,222,948...20,456,827
Ensembl chr 1:20,222,954...20,456,670
|
|
G
|
Arhgap6
|
Rho GTPase activating protein 6
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP6 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr X:28,525,912...29,062,344
Ensembl chr X:28,525,917...29,061,244
|
|
G
|
Arhgef2
|
Rho/Rac guanine nucleotide exchange factor 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646
|
|
G
|
Arnt
|
aryl hydrocarbon receptor nuclear translocator
|
multiple interactions increases expression
|
ISO
|
3',4'-dimethoxyflavone inhibits the reaction [butylbenzyl phthalate results in increased expression of ARNT mRNA]; 3',4'-dimethoxyflavone inhibits the reaction [butylbenzyl phthalate results in increased expression of ARNT protein]; AHR mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of ARNT mRNA]; AHR mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of ARNT protein]; butylbenzyl phthalate promotes the reaction [AHR protein binds to ARNT protein] butylbenzyl phthalate results in increased expression of ARNT mRNA; butylbenzyl phthalate results in increased expression of ARNT protein
|
CTD |
PMID:22138065 |
|
NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546
|
|
G
|
Arnt2
|
aryl hydrocarbon receptor nuclear translocator 2
|
multiple interactions decreases expression
|
ISO EXP
|
1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [butylbenzyl phthalate results in decreased expression of ARNT2 mRNA] [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ARNT2 mRNA
|
CTD |
PMID:21771643 PMID:31199487 |
|
NCBI chr 1:138,236,235...138,392,868
Ensembl chr 1:147,599,058...147,801,997
|
|
G
|
Arrdc3
|
arrestin domain containing 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARRDC3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:12,873,202...12,885,875
|
|
G
|
Arrdc4
|
arrestin domain containing 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARRDC4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:131,779,437...131,793,565
|
|
G
|
Asip
|
agouti signaling protein
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:143,473,584...143,561,170
Ensembl chr 3:164,015,903...164,021,378
|
|
G
|
Asns
|
asparagine synthetase (glutamine-hydrolyzing)
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of ASNS mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:36,751,802...36,776,050
|
|
G
|
Astn1
|
astrotactin 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr13:70,537,423...70,855,440
Ensembl chr13:73,071,267...73,388,895
|
|
G
|
Astn2
|
astrotactin 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 5:78,758,142...79,744,021
Ensembl chr 5:83,773,633...84,759,485
|
|
G
|
Atf3
|
activating transcription factor 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ATF3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:105,282,440...105,295,750
|
|
G
|
Atf4
|
activating transcription factor 4
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ATF4 mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:113,684,681...113,686,739
|
|
G
|
Atm
|
ATM serine/threonine kinase
|
increases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in increased expression of ATM protein ATM protein affects the reaction [butylbenzyl phthalate results in increased expression of ZEB1 protein]
|
CTD |
PMID:31212022 |
|
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
|
|
G
|
Atp10d
|
ATPase phospholipid transporting 10D (putative)
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ATP10D mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr14:35,911,728...36,012,549
Ensembl chr14:36,265,696...36,366,460
|
|
G
|
Atp1a1
|
ATPase Na+/K+ transporting subunit alpha 1
|
increases expression
|
EXP
|
butylbenzyl phthalate results in increased expression of ATP1A1 mRNA
|
CTD |
PMID:19560483 |
|
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425
|
|
G
|
Atp1a3
|
ATPase Na+/K+ transporting subunit alpha 3
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ATP1A3 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:89,700,645...89,729,782
Ensembl chr 1:89,700,649...89,729,825
|
|
G
|
Atp6v1c2
|
ATPase H+ transporting V1 subunit C2
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of ATP6V1C2 mRNA
|
CTD |
PMID:36756972 |
|
NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:45,809,271...45,848,747
|
|
G
|
B3glct
|
beta 3-glucosyltransferase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of B3GLCT mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr12:5,255,521...5,346,807
Ensembl chr12:10,291,910...10,426,357
|
|
G
|
Bad
|
BCL2-associated agonist of cell death
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of BAD mRNA
|
CTD |
PMID:39947446 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
G
|
Bak1
|
BCL2-antagonist/killer 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAK1 mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of BAX protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAX protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BAX mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BAX mRNA
|
CTD |
PMID:28013214 PMID:35739755 PMID:37021957 PMID:37364641 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcam
|
basal cell adhesion molecule (Lutheran blood group)
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BCAM mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:79,415,016...79,429,403
Ensembl chr 1:88,542,972...88,557,888
|
|
G
|
Bcat1
|
branched chain amino acid transaminase 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BCAT1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:179,695,662...179,777,288
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions decreases methylation increases expression
|
ISO EXP
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of BCL2 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of BCL2 protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA butylbenzyl phthalate results in decreased methylation of BCL2 promoter butylbenzyl phthalate results in increased expression of BCL2 mRNA
|
CTD |
PMID:28013214 PMID:31016752 PMID:35487445 PMID:35739755 PMID:35762964 PMID:37021957 PMID:37364641 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Bcl2l10
|
Bcl2-like 10
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2L10 mRNA
|
CTD |
PMID:37021957 |
|
NCBI chr 8:84,987,833...84,993,878
Ensembl chr 8:84,987,833...84,993,872
|
|
G
|
Bcl6
|
BCL6, transcription repressor
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BCL6 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047
|
|
G
|
Bdnf
|
brain-derived neurotrophic factor
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BDNF mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
G
|
Bend6
|
BEN domain containing 6
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BEND6 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 9:36,081,033...36,135,309
Ensembl chr 9:43,576,982...43,631,194
|
|
G
|
Bex1
|
brain expressed X-linked 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BEX2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr X:99,219,014...99,220,518
Ensembl chr X:104,010,371...104,011,236
|
|
G
|
Bhlhe40
|
basic helix-loop-helix family, member e40
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BHLHE40 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783
|
|
G
|
Bhlhe41
|
basic helix-loop-helix family, member e41
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BHLHE41 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:180,565,003...180,569,355
|
|
G
|
Bhmt
|
betaine-homocysteine S-methyltransferase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BHMT mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:26,594,854...26,614,715
|
|
G
|
Bid
|
BH3 interacting domain death agonist
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BID mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
G
|
Bmp6
|
bone morphogenetic protein 6
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of BMP6 mRNA
|
CTD |
PMID:19560483 |
|
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,523,704...26,675,261
|
|
G
|
Bnip3
|
BCL2 interacting protein 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BNIP3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
G
|
Bok
|
BCL2 family apoptosis regulator BOK
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of BOK mRNA
|
CTD |
PMID:39947446 |
|
NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:101,670,625...101,681,833
|
|
G
|
Bpgm
|
bisphosphoglycerate mutase
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BPGM mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:64,106,804...64,135,627
|
|
G
|
Brsk1
|
BR serine/threonine kinase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BRSK1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:69,134,166...69,159,947
Ensembl chr 1:78,163,341...78,188,922
|
|
G
|
Btg2
|
BTG anti-proliferation factor 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BTG2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690
|
|
G
|
Bzw1
|
basic leucine zipper and W2 domains 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BZW1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:59,930,672...59,944,468
Ensembl chr 9:67,424,866...67,439,684
|
|
G
|
C11h21orf91
|
similar to human chromosome 21 open reading frame 91
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of D16ERTD472E mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr11:30,716,034...30,749,292
Ensembl chr11:30,716,034...30,749,415
|
|
G
|
C4bpa
|
complement component 4 binding protein, alpha
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of C4BPA mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr13:42,075,715...42,111,205
Ensembl chr13:44,627,982...44,663,471
|
|
G
|
C5
|
complement C5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of C5 protein
|
CTD |
PMID:38954831 |
|
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468
|
|
G
|
Ca1
|
carbonic anhydrase 1
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of CAR1 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 2:88,550,681...88,593,454
Ensembl chr 2:88,495,475...88,593,454
|
|
G
|
Ca9
|
carbonic anhydrase 9
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CA9 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr 5:62,559,024...62,565,626
Ensembl chr 5:62,558,823...62,565,626
|
|
G
|
Cacng7
|
calcium voltage-gated channel auxiliary subunit gamma 7
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CACNG7 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:65,800,059...65,831,246
Ensembl chr 1:74,715,483...74,746,669
|
|
G
|
Cadm3
|
cell adhesion molecule 3
|
multiple interactions
|
EXP ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CADM3 mRNA [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CADM3 mRNA
|
CTD |
PMID:31199487 PMID:32949613 |
|
NCBI chr13:85,784,785...85,817,412
Ensembl chr13:88,317,124...88,350,114
|
|
G
|
Cadps
|
calcium dependent secretion activator
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CADPS mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr15:12,289,803...12,742,786
Ensembl chr15:14,720,726...15,173,211
|
|
G
|
Camk4
|
calcium/calmodulin-dependent protein kinase IV
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CAMK4 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,857,146...25,077,193
|
|
G
|
Camkk1
|
calcium/calmodulin-dependent protein kinase kinase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CAMKK1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:57,637,335...57,660,498
Ensembl chr10:58,135,915...58,159,010
|
|
G
|
Cand2
|
cullin-associated and neddylation-dissociated 2 (putative)
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CAND2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:148,835,050...148,864,039
Ensembl chr 4:150,507,657...150,541,293
|
|
G
|
Car2
|
carbonic anhydrase 2
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of CAR2 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064
|
|
G
|
Casp14
|
caspase 14
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CASP14 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr 7:10,929,759...10,932,591
Ensembl chr 7:11,580,339...11,583,171
|
|
G
|
Casp2
|
caspase 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP2 mRNA
|
CTD |
PMID:37021957 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:72,116,246...72,134,022
|
|
G
|
Casp3
|
caspase 3
|
increases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in increased expression of CASP3 protein alternative form [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP3 protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CASP3 mRNA; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CASP3 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of and results in increased activity of CASP3 protein; butylbenzyl phthalate results in increased expression of and results in increased activity of CASP3 protein
|
CTD |
PMID:23220035 PMID:29029336 PMID:35739755 PMID:37839492 PMID:39947446 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp8
|
caspase 8
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP8 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of CASP8 protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CASP8 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CASP8 mRNA
|
CTD |
PMID:28013214 PMID:35739755 PMID:37364641 PMID:39947446 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:67,758,033...67,806,699
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP9 protein
|
CTD |
PMID:35739755 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Cat
|
catalase
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of CAT mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CAT mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CAT mRNA
|
CTD |
PMID:28013214 PMID:37364641 PMID:39150890 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Cbs
|
cystathionine beta synthase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CBS mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,709,395...9,734,066
|
|
G
|
Ccdc3
|
coiled-coil domain containing 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CCDC3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr17:73,031,891...73,135,173
Ensembl chr17:77,944,977...78,044,470
|
|
G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL2 mRNA
|
CTD |
PMID:37021957 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
G
|
Ccl20
|
C-C motif chemokine ligand 20
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CCL20 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736
|
|
G
|
Ccl5
|
C-C motif chemokine ligand 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL5 mRNA
|
CTD |
PMID:37021957 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,738,651...68,824,884
|
|
G
|
Ccl9
|
C-C motif chemokine ligand 9
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of CCL6 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,863,995...68,868,877
|
|
G
|
Ccn4
|
cellular communication network factor 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CCN4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:100,534,505...100,563,094
|
|
G
|
Ccnd1
|
cyclin D1
|
multiple interactions decreases methylation increases expression
|
ISO
|
MIR19A mRNA affects the reaction [butylbenzyl phthalate results in increased expression of CCND1 protein]; MIR19B1 mRNA affects the reaction [butylbenzyl phthalate results in increased expression of CCND1 protein]; MIR34A mRNA inhibits the reaction [butylbenzyl phthalate results in increased expression of CCND1 protein] butylbenzyl phthalate results in decreased methylation of CCND1 promoter butylbenzyl phthalate results in increased expression of CCND1 mRNA; butylbenzyl phthalate results in increased expression of CCND1 protein
|
CTD |
PMID:29864457 PMID:30243731 PMID:31016752 PMID:35487445 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
G
|
Ccnd2
|
cyclin D2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CCND2 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CCND2 mRNA
|
CTD |
PMID:28013214 PMID:39947446 |
|
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301 Ensembl chr 4:161,653,048...161,680,301
|
|
G
|
Ccr3
|
C-C motif chemokine receptor 3
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of CCR3 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 8:132,463,533...132,511,601
Ensembl chr 8:132,463,788...132,511,593
|
|
G
|
Cct2
|
chaperonin containing TCP1 subunit 2
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CCT2 mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977
|
|
G
|
Cd36
|
CD36 molecule
|
multiple interactions
|
ISO EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CD36 mRNA [Dietary Fats co-treated with diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CD36 mRNA
|
CTD |
PMID:30599393 PMID:39150890 |
|
NCBI chr 4:18,209,088...18,302,142
|
|
G
|
Cd93
|
CD93 molecule
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of CD93 protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CD93 mRNA
|
CTD |
PMID:38954831 PMID:39150890 |
|
NCBI chr 3:135,891,859...135,898,378
Ensembl chr 3:156,345,019...156,351,537
|
|
G
|
Cdc6
|
cell division cycle 6
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of CDC6 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241
|
|
G
|
Cdh1
|
cadherin 1
|
decreases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in decreased expression of CDH1 protein [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of CDH1 protein
|
CTD |
PMID:22552774 PMID:37364641 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
G
|
Cdhr1
|
cadherin-related family member 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDHR1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:12,843,436...12,863,321
Ensembl chr16:12,863,696...12,883,579
|
|
G
|
Cdk4
|
cyclin-dependent kinase 4
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDK4 mRNA
|
CTD |
PMID:35762964 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
G
|
Cdk5r1
|
cyclin-dependent kinase 5 regulatory subunit 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDK5R1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,978,911...65,989,272
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
decreases expression multiple interactions
|
ISO EXP
|
butylbenzyl phthalate results in decreased expression of CDKN1A mRNA; butylbenzyl phthalate results in decreased expression of CDKN1A protein [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CDKN1A mRNA [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CDKN1A mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of CDKN1A mRNA] MIR19A mRNA affects the reaction [butylbenzyl phthalate results in decreased expression of CDKN1A protein]; MIR19B1 mRNA affects the reaction [butylbenzyl phthalate results in decreased expression of CDKN1A protein]; MIR34A mRNA inhibits the reaction [butylbenzyl phthalate results in decreased expression of CDKN1A protein]
|
CTD |
PMID:29864457 PMID:30243731 PMID:33316053 PMID:35762964 PMID:39947446 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CDKN1B mRNA
|
CTD |
PMID:37839492 |
|
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
G
|
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDKN1C mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:208,084,787...208,087,498
|
|
G
|
Cdkn2a
|
cyclin-dependent kinase inhibitor 2A
|
multiple interactions increases methylation decreases expression
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CDKN2A mRNA butylbenzyl phthalate results in increased methylation of CDKN2A promoter butylbenzyl phthalate results in decreased expression of CDKN2A mRNA
|
CTD |
PMID:28013214 PMID:35487445 |
|
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248
|
|
G
|
Cdo1
|
cysteine dioxygenase type 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDO1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:41,619,070...41,633,891
|
|
G
|
Cebpa
|
CCAAT/enhancer binding protein alpha
|
multiple interactions
|
ISO
|
[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of CEBPA mRNA; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of CEBPA protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA; butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]; Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]]
|
CTD |
PMID:26820058 PMID:28595985 PMID:37021957 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:96,896,171...96,899,309
|
|
G
|
Celsr3
|
cadherin, EGF LAG seven-pass G-type receptor 3
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CELSR3 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 8:109,530,597...109,558,360
Ensembl chr 8:118,409,136...118,436,847
|
|
G
|
Cenpm
|
centromere protein M
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CENPM mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:113,748,026...113,759,296
Ensembl chr 7:115,628,129...115,643,866
|
|
G
|
Cerk
|
ceramide kinase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:117,225,855...117,269,436
Ensembl chr 7:119,105,674...119,148,570
|
|
G
|
Cfap299
|
cilia and flagella associated protein 299
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CFAP299 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr14:10,787,191...11,272,894
Ensembl chr14:11,090,449...11,577,999
|
|
G
|
Cfd
|
complement factor D
|
multiple interactions
|
ISO
|
[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of CFD mRNA
|
CTD |
PMID:26820058 |
|
NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572
|
|
G
|
Cga
|
glycoprotein hormones, alpha polypeptide
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein affects the expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CXCR4 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CYP11A1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of HSD3B2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PTX3 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PGR mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of RGS2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of STAR mRNA]; butylbenzyl phthalate inhibits the reaction [CGA protein results in increased secretion of Dinoprostone]; butylbenzyl phthalate inhibits the reaction [CGA protein results in increased secretion of Progesterone]; Cyclic AMP inhibits the reaction [[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PGR mRNA]] [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of EDN2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of MMP9 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PGR mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PLAT mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of CDKN1A mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of IL6 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PTGS2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINB2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINE1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of TIMP1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP14 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP16 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of SLCO2A1 mRNA]
|
CTD |
PMID:25016925 PMID:33316053 PMID:37552060 |
|
NCBI chr 5:54,283,109...54,295,464
Ensembl chr 5:54,235,019...54,295,464
|
|
G
|
Chchd1
|
coiled-coil-helix-coiled-coil-helix domain containing 1
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of CHCHD1 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr15:3,592,719...3,593,901
Ensembl chr15:3,641,981...3,643,155
|
|
G
|
Chga
|
chromogranin A
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CHGA mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:127,460,854...127,472,237
|
|
G
|
Chgb
|
chromogranin B
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CHGB mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:140,495,951...140,510,054
|
|
G
|
Chrna3
|
cholinergic receptor nicotinic alpha 3 subunit
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of CHRNA3 mRNA
|
CTD |
PMID:36746855 |
|
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:64,297,755...64,311,412
|
|
G
|
Cited1
|
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CITED1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr X:67,350,376...67,355,072
Ensembl chr X:71,390,331...71,393,649
|
|
G
|
Clip3
|
CAP-GLY domain containing linker protein 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CLIP3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:94,674,492...94,690,643
Ensembl chr 1:94,674,661...94,690,642
|
|
G
|
Clstn3
|
calsyntenin 3
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CLSTN3 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 4:159,017,795...159,051,069
Ensembl chr 4:159,017,795...159,051,069
|
|
G
|
Cmah
|
cytidine monophospho-N-acetylneuraminic acid hydroxylase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CMAH mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr17:40,985,129...41,070,317
Ensembl chr17:41,011,641...41,070,252
|
|
G
|
Cmbl
|
carboxymethylenebutenolidase homolog
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CMBL mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:84,242,512...84,301,880
|
|
G
|
Cndp2
|
carnosine dipeptidase 2
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:80,314,801...80,331,900
|
|
G
|
Cntn2
|
contactin 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CNTN2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr13:46,497,269...46,528,112
Ensembl chr13:46,499,396...46,528,027
|
|
G
|
Cntnap1
|
contactin associated protein 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CNTNAP1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr10:86,109,850...86,125,612
Ensembl chr10:86,611,890...86,631,730
|
|
G
|
Cntnap2
|
contactin associated protein 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CNTNAP2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:75,109,358...77,366,258
Ensembl chr 4:75,109,858...77,366,258
|
|
G
|
Col10a1
|
collagen type X alpha 1 chain
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL10A1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr20:38,183,103...38,189,488
Ensembl chr20:39,716,822...39,751,440
|
|
G
|
Col18a1
|
collagen type XVIII alpha 1 chain
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of COL18A1 protein
|
CTD |
PMID:38954831 |
|
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,473,645...11,582,112
|
|
G
|
Col1a1
|
collagen type I alpha 1 chain
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL1A1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
G
|
Col2a1
|
collagen type II alpha 1 chain
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate co-treated with COL2A1 protein] results in increased expression of IL1B protein; [butylbenzyl phthalate co-treated with COL2A1 protein] results in increased expression of IL6 protein
|
CTD |
PMID:32308655 |
|
NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:130,977,561...131,006,627
|
|
G
|
Col3a1
|
collagen type III alpha 1 chain
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL3A1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
|
|
G
|
Col6a1
|
collagen type VI alpha 1 chain
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,457...11,924,107
|
|
G
|
Col6a2
|
collagen type VI alpha 2 chain
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,265...12,057,042
|
|
G
|
Col8a1
|
collagen type VIII alpha 1 chain
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL8A1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr11:42,776,851...42,906,432
Ensembl chr11:56,369,868...56,376,229
|
|
G
|
Comt
|
catechol-O-methyltransferase
|
decreases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in decreased expression of COMT mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COMT mRNA fulvestrant inhibits the reaction [butylbenzyl phthalate results in decreased expression of COMT mRNA]
|
CTD |
PMID:24040167 PMID:39150890 |
|
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533
|
|
G
|
Cox5b
|
cytochrome c oxidase subunit 5B
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of COX5B mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:46,417,838...46,420,403
|
|
G
|
Cp
|
ceruloplasmin
|
decreases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in decreased expression of CP mRNA; butylbenzyl phthalate results in decreased expression of CP protein CP protein inhibits the reaction [butylbenzyl phthalate results in decreased expression of GPX4 protein]; CP protein inhibits the reaction [butylbenzyl phthalate results in decreased expression of OCLN protein]; CP protein inhibits the reaction [butylbenzyl phthalate results in decreased expression of TJP1 protein]; CP protein inhibits the reaction [butylbenzyl phthalate results in increased expression of PTGS2 protein]
|
CTD |
PMID:39921026 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:104,368,456...104,427,087
|
|
G
|
Cpne8
|
copine 8
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CPNE8 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:121,615,293...121,789,507
Ensembl chr 7:123,494,865...123,669,060
|
|
G
|
Cpox
|
coproporphyrinogen oxidase
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of CPOX mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr11:41,936,585...41,946,568
Ensembl chr11:55,405,784...55,415,761
|
|
G
|
Cps1
|
carbamoyl-phosphate synthase 1
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CPS1 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:76,000,754...76,186,734
|
|
G
|
Cpt1a
|
carnitine palmitoyltransferase 1A
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CPT1A mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:209,993,875...210,056,326
|
|
G
|
Cpt1b
|
carnitine palmitoyltransferase 1B
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CPT1B mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:122,370,444...122,380,036
|
|
G
|
Cpt2
|
carnitine palmitoyltransferase 2
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CPT2 mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:127,893,207...127,910,818
|
|
G
|
Cpz
|
carboxypeptidase Z
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CPZ mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr14:75,223,692...75,246,946
Ensembl chr14:79,448,139...79,471,556
|
|
G
|
Creg1
|
cellular repressor of E1A-stimulated genes 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CREG1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr13:78,019,814...78,032,310
Ensembl chr13:80,549,933...80,565,272
|
|
G
|
Crh
|
corticotropin releasing hormone
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CRH mRNA
|
CTD |
PMID:32518293 |
|
NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386
|
|
G
|
Crhr1
|
corticotropin releasing hormone receptor 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CRHR1 mRNA
|
CTD |
PMID:32518293 |
|
NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,540,192...89,583,466
|
|
G
|
Crisp1
|
cysteine-rich secretory protein 1
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of CRISP1 mRNA
|
CTD |
PMID:36756972 |
|
NCBI chr 9:20,741,775...20,768,796
Ensembl chr 9:28,238,328...28,265,344
|
|
G
|
Crmp1
|
collapsin response mediator protein 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CRMP1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr14:73,509,933...73,556,192
Ensembl chr14:77,734,675...77,780,916
|
|
G
|
Crp
|
C-reactive protein
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CRP protein [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CRP mRNA
|
CTD |
PMID:32949613 PMID:38954831 |
|
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
G
|
Csf1
|
colony stimulating factor 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of CSF1 protein
|
CTD |
PMID:38954831 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:198,065,405...198,084,468
|
|
G
|
Csrnp1
|
cysteine and serine rich nuclear protein 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CSRNP1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:128,582,365...128,588,469
|
|
G
|
Ctnnb1
|
catenin beta 1
|
affects localization increases acetylation multiple interactions
|
ISO
|
butylbenzyl phthalate affects the localization of CTNNB1 protein butylbenzyl phthalate results in increased acetylation of CTNNB1 protein HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate affects the localization of CTNNB1 protein]; trichostatin A inhibits the reaction [butylbenzyl phthalate affects the localization of CTNNB1 protein]
|
CTD |
PMID:22552774 PMID:27923775 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of CXCL12 protein
|
CTD |
PMID:38954831 |
|
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
G
|
Cxcl13
|
C-X-C motif chemokine ligand 13
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of CXCL13 protein [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CXCL13 mRNA
|
CTD |
PMID:32949613 PMID:38954831 |
|
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,912,858...13,917,920
|
|
G
|
Cxcl3
|
C-X-C motif chemokine ligand 3
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CXCL1 mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
|
|
G
|
Cxcl6
|
C-X-C motif chemokine ligand 6
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CXCL5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,594,959...17,596,417
|
|
G
|
Cxcl9
|
C-X-C motif chemokine ligand 9
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of CXCL9 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299
|
|
G
|
Cxcr4
|
C-X-C motif chemokine receptor 4
|
multiple interactions increases expression
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CXCR4 mRNA] butylbenzyl phthalate results in increased expression of CXCR4 mRNA
|
CTD |
PMID:32308655 PMID:37552060 |
|
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
|
|
G
|
Cyb5a
|
cytochrome b5 type A
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CYB5A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:14,453,966...14,455,094 Ensembl chr18:14,453,966...14,455,094
|
|
G
|
Cyba
|
cytochrome b-245 alpha chain
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CYBA mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
G
|
Cybb
|
cytochrome b-245 beta chain
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CYBB mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
|
|
G
|
Cycs
|
cytochrome c, somatic
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CYCS protein
|
CTD |
PMID:35739755 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
G
|
Cyp11a1
|
cytochrome P450, family 11, subfamily a, polypeptide 1
|
increases expression multiple interactions
|
EXP ISO
|
butylbenzyl phthalate results in increased expression of CYP11A1 mRNA; butylbenzyl phthalate results in increased expression of CYP11A1 protein [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CYP11A1 mRNA] [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP11A1 mRNA [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP11A1 mRNA; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP11A1 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP11A1 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP11A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP11A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP11A1 mRNA; [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP11A1 mRNA; [dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in decreased expression of CYP11A1 mRNA
|
CTD |
PMID:26472102 PMID:28013214 PMID:29029336 PMID:30802670 PMID:31319113 PMID:32518293 PMID:34597818 PMID:35739735 PMID:37552060 PMID:37788136 PMID:39150890 PMID:39947446 More...
|
|
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196
|
|
G
|
Cyp11b2
|
cytochrome P450, family 11, subfamily b, polypeptide 2
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of CYP11B1 mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:108,719,349...108,725,763
|
|
G
|
Cyp11b3
|
cytochrome P450, family 11, subfamily b, polypeptide 3
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of CYP11B2 mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:108,689,165...108,694,921
|
|
G
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1
|
decreases expression multiple interactions
|
EXP ISO
|
butylbenzyl phthalate results in decreased expression of CYP17A1 mRNA [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CYP17A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA
|
CTD |
PMID:26472102 PMID:29029336 PMID:30802670 PMID:33983380 PMID:37788136 |
|
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974
|
|
G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
multiple interactions increases expression decreases expression decreases activity
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP19A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 protein; [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP19A1 mRNA; schizandrin B inhibits the reaction [butylbenzyl phthalate results in increased expression of CYP19A1 mRNA]; schizandrin B inhibits the reaction [butylbenzyl phthalate results in increased expression of CYP19A1 protein] butylbenzyl phthalate results in increased expression of CYP19A1 mRNA; butylbenzyl phthalate results in increased expression of CYP19A1 protein butylbenzyl phthalate results in increased expression of and results in increased activity of CYP19A1 protein; Fulvestrant inhibits the reaction [butylbenzyl phthalate results in increased activity of CYP19A1 protein] butylbenzyl phthalate results in decreased expression of CYP19A1 mRNA; butylbenzyl phthalate results in decreased expression of CYP19A1 protein butylbenzyl phthalate results in decreased activity of CYP19A1 protein
|
CTD |
PMID:27825933 PMID:28013214 PMID:29029336 PMID:31016752 PMID:34597818 PMID:38227285 More...
|
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
increases expression decreases activity
|
ISO EXP
|
butylbenzyl phthalate results in increased expression of CYP1A1 protein butylbenzyl phthalate results in decreased activity of CYP1A1 protein
|
CTD |
PMID:22138065 PMID:27432241 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
decreases activity
|
EXP
|
butylbenzyl phthalate results in decreased activity of CYP1A2 protein
|
CTD |
PMID:27432241 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
multiple interactions increases expression
|
ISO
|
3',4'-dimethoxyflavone inhibits the reaction [butylbenzyl phthalate results in increased expression of CYP1B1 mRNA]; 3',4'-dimethoxyflavone inhibits the reaction [butylbenzyl phthalate results in increased expression of CYP1B1 protein]; AHR mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of CYP1B1 mRNA]; AHR mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of CYP1B1 protein]; butylbenzyl phthalate promotes the reaction [AHR protein binds to CYP1B1 promoter] schizandrin B inhibits the reaction [butylbenzyl phthalate results in increased expression of CYP1B1 mRNA] butylbenzyl phthalate results in increased expression of CYP1B1 mRNA; butylbenzyl phthalate results in increased expression of CYP1B1 protein
|
CTD |
PMID:22138065 PMID:38227285 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
G
|
Cyp26b1
|
cytochrome P450, family 26, subfamily b, polypeptide 1
|
multiple interactions
|
EXP ISO
|
[diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in increased expression of CYP26B1 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CYP26B1 mRNA
|
CTD |
PMID:37788136 PMID:39150890 |
|
NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176
|
|
G
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1
|
increases expression
|
EXP
|
butylbenzyl phthalate results in increased expression of CYP27A1 mRNA
|
CTD |
PMID:26472102 |
|
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
|
|
G
|
Cyp2b1
|
cytochrome P450, family 2, subfamily b, polypeptide 1
|
decreases activity
|
EXP
|
butylbenzyl phthalate results in decreased activity of CYP2B1 protein
|
CTD |
PMID:27432241 |
|
NCBI chr 1:81,518,387...81,544,999
|
|
G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of CYP2B10 mRNA
|
CTD |
PMID:26519955 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
G
|
Cyp2c11
|
cytochrome P450, subfamily 2, polypeptide 11
|
decreases activity
|
EXP
|
butylbenzyl phthalate results in decreased activity of CYP2C11 protein
|
CTD |
PMID:27432241 |
|
NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853
|
|
G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
decreases activity
|
EXP
|
butylbenzyl phthalate results in decreased activity of CYP2E1 protein
|
CTD |
PMID:27432241 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
G
|
Cyp2f4
|
cytochrome P450, family 2, subfamily f, polypeptide 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CYP2F2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:91,543,768...91,557,553
|
|
G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of CYP3A4 protein
|
CTD |
PMID:33965509 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
G
|
Cyp3a62
|
cytochrome P450, family 3, subfamily a, polypeptide 62
|
decreases activity
|
EXP
|
butylbenzyl phthalate results in decreased activity of CYP3A62 protein
|
CTD |
PMID:27432241 |
|
NCBI chr12:16,397,998...16,433,833
Ensembl chr12:21,471,542...21,547,598
|
|
G
|
Cyp4f18
|
cytochrome P450, family 4, subfamily f, polypeptide 18
|
multiple interactions
|
ISO
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of CYP4F18 protein
|
CTD |
PMID:38995844 |
|
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,740,001...17,838,958
|
|
G
|
Cyp51
|
cytochrome P450, family 51
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of CYP51 mRNA
|
CTD |
PMID:26472102 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,991,613...31,010,450
|
|
G
|
Dancr
|
differentiation antagonizing non-protein coding RNA
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DANCR mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr14:34,126,956...34,127,936
|
|
G
|
Dcaf12l1
|
DDB1 and CUL4 associated factor 12-like 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DCAF12L1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr X:123,695,286...123,698,905
Ensembl chr X:128,572,811...128,577,222
|
|
G
|
Dclk3
|
doublecortin-like kinase 3
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DCLK3 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 8:111,401,544...111,453,999
Ensembl chr 8:120,279,757...120,332,432
|
|
G
|
Ddc
|
dopa decarboxylase
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DDC mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of DDIT3 mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
G
|
Ddit4
|
DNA-damage-inducible transcript 4
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of DDIT4 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:28,434,944...28,437,037
|
|
G
|
Ddit4l
|
DNA-damage-inducible transcript 4-like
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DDIT4L mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:228,801,705...228,806,225
|
|
G
|
Dgkb
|
diacylglycerol kinase, beta
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DGKB mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:54,640,948...55,397,210
Ensembl chr 6:60,368,519...61,124,420
|
|
G
|
Dglucy
|
D-glutamate cyclase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DGLUCY mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:120,055,480...120,130,910
Ensembl chr 6:125,785,087...125,860,496
|
|
G
|
Dhcr7
|
7-dehydrocholesterol reductase
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of DHCR7 mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382
|
|
G
|
Dhrs3
|
dehydrogenase/reductase 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:162,031,386...162,065,653
|
|
G
|
Dhx8
|
DEAH-box helicase 8
|
multiple interactions
|
ISO
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of DHX8 protein
|
CTD |
PMID:38995844 |
|
NCBI chr10:86,667,641...86,704,198
Ensembl chr10:87,168,062...87,205,875
|
|
G
|
Diablo
|
diablo, IAP-binding mitochondrial protein
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of DIABLO mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:38,716,668...38,731,265
|
|
G
|
Dicer1
|
dicer 1 ribonuclease III
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in increased expression of DICER1 mRNA
|
CTD |
PMID:33086190 |
|
NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:129,396,014...129,457,252
|
|
G
|
Dkk1
|
dickkopf WNT signaling pathway inhibitor 1
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of DKK1 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650
|
|
G
|
Dkk2
|
dickkopf WNT signaling pathway inhibitor 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DKK2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:220,568,338...220,660,225
Ensembl chr 2:223,242,377...223,334,724
|
|
G
|
Dnaaf10
|
dynein axonemal assembly factor 10
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of WDR92 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr14:91,618,649...91,639,828
Ensembl chr14:95,820,234...95,841,442
|
|
G
|
Dner
|
delta/notch-like EGF repeat containing
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DNER mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:85,586,985...85,902,461
Ensembl chr 9:93,035,108...93,350,568
|
|
G
|
Dock3
|
dedicator of cyto-kinesis 3
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DOCK3 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 8:107,552,462...107,903,527
Ensembl chr 8:116,431,159...116,782,195
|
|
G
|
Dpf1
|
double PHD fingers 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DPF1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:84,602,212...84,615,954
Ensembl chr 1:93,726,970...93,743,425
|
|
G
|
Dpt
|
dermatopontin
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of DPT mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr13:77,123,224...77,151,646
Ensembl chr13:79,655,985...79,684,758
|
|
G
|
Dpysl3
|
dihydropyrimidinase-like 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DPYSL3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr18:35,374,427...35,480,228
Ensembl chr18:35,625,357...35,731,152
|
|
G
|
Drd4
|
dopamine receptor D4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DRD4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:205,826,049...205,830,458
|
|
G
|
Drosha
|
drosha ribonuclease III
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in increased expression of DROSHA mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in increased expression of DROSHA protein
|
CTD |
PMID:33086190 |
|
NCBI chr 2:61,864,886...61,976,688
Ensembl chr 2:63,591,968...63,703,687
|
|
G
|
Dusp4
|
dual specificity phosphatase 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DUSP4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:64,079,893...64,093,700
|
|
G
|
Dync1i1
|
dynein cytoplasmic 1 intermediate chain 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DYNC1I1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 4:33,852,597...34,166,159
Ensembl chr 4:34,819,430...35,142,319
|
|
G
|
Ebp
|
EBP, cholestenol delta-isomerase
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of EBP mRNA
|
CTD |
PMID:26472102 |
|
NCBI chr X:16,971,372...16,977,782
Ensembl chr X:16,971,405...16,977,781
|
|
G
|
Ece2
|
endothelin-converting enzyme 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ECE2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr11:80,259,130...80,278,446
Ensembl chr11:93,767,559...93,793,292
|
|
G
|
Edn1
|
endothelin 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EDN1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
G
|
Edn2
|
endothelin 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of EDN2 mRNA]
|
CTD |
PMID:33316053 |
|
NCBI chr 5:133,751,316...133,756,814
Ensembl chr 5:139,036,492...139,043,070
|
|
G
|
Egfr
|
epidermal growth factor receptor
|
multiple interactions increases phosphorylation
|
ISO
|
fulvestrant inhibits the reaction [butylbenzyl phthalate results in increased phosphorylation of EGFR protein]
|
CTD |
PMID:22552774 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
G
|
Egr1
|
early growth response 1
|
multiple interactions increases expression
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EGR1 mRNA butylbenzyl phthalate results in increased expression of EGR1 mRNA
|
CTD |
PMID:32308655 PMID:39150890 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
G
|
Eif4e
|
eukaryotic translation initiation factor 4E
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of EIF4E mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105
|
|
G
|
Elavl2
|
ELAV like RNA binding protein 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ELAVL2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:105,960,872...106,086,463
Ensembl chr 5:111,076,705...111,224,918
|
|
G
|
Elmod1
|
ELMO domain containing 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ELMOD1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 8:54,298,363...54,355,348
Ensembl chr 8:63,137,295...63,251,322
|
|
G
|
Emb
|
embigin
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EMB mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:50,801,973...50,862,920
|
|
G
|
Emp2
|
epithelial membrane protein 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EMP2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:5,866,869...5,901,533
Ensembl chr10:5,866,922...5,901,532
|
|
G
|
Emx2
|
empty spiracles homeobox 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EMX2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:268,612,663...268,619,671
Ensembl chr 1:268,612,663...268,619,671
|
|
G
|
Enc1
|
ectodermal-neural cortex 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ENC1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:30,283,736...30,315,721
|
|
G
|
Epdr1
|
ependymin related 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EPDR1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr17:45,333,932...45,358,597
Ensembl chr17:50,029,256...50,054,250
|
|
G
|
Epha4
|
Eph receptor A4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EPHA4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:86,263,982...86,406,755
|
|
G
|
Ermp1
|
endoplasmic reticulum metallopeptidase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ERMP1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:227,383,992...227,422,120
Ensembl chr 1:236,801,466...236,839,197
|
|
G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ERN1 mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ERN1 protein
|
CTD |
PMID:37364641 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,830,428...91,920,791
|
|
G
|
Errfi1
|
ERBB receptor feedback inhibitor 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ERRFI1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:166,606,834...166,620,432
|
|
G
|
Espn
|
espin
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ESPN mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 5:167,909,271...167,943,168
Ensembl chr 5:167,909,271...167,942,984
|
|
G
|
Esr1
|
estrogen receptor 1
|
multiple interactions decreases expression increases activity affects binding decreases methylation
|
ISO EXP
|
butylbenzyl phthalate binds to and results in increased activity of ESR1 protein; butylbenzyl phthalate inhibits the reaction [Estradiol results in increased activity of ESR1 protein]; Oxygen deficiency promotes the reaction [butylbenzyl phthalate results in decreased expression of ESR1 mRNA]; Oxygen deficiency promotes the reaction [butylbenzyl phthalate results in decreased expression of ESR1 protein]; Tamoxifen inhibits the reaction [butylbenzyl phthalate binds to and results in increased activity of ESR1 protein] [Zeranol co-treated with butylbenzyl phthalate] affects the expression of ESR1 protein butylbenzyl phthalate results in decreased expression of ESR1 mRNA; butylbenzyl phthalate results in decreased expression of ESR1 protein butylbenzyl phthalate results in increased activity of ESR1 protein [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ESR1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ESR1 protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ESR1 mRNA butylbenzyl phthalate binds to ESR1 protein butylbenzyl phthalate results in decreased methylation of ESR1 gene; butylbenzyl phthalate results in decreased methylation of ESR1 promoter
|
CTD |
PMID:15840436 PMID:16326419 PMID:19913605 PMID:20822795 PMID:22467034 PMID:22949852 PMID:28013214 PMID:28571686 PMID:29162470 PMID:30851587 PMID:33049310 PMID:35163327 PMID:35739755 PMID:37364641 More...
|
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
G
|
Esr2
|
estrogen receptor 2
|
multiple interactions increases expression increases activity affects binding
|
ISO
|
butylbenzyl phthalate binds to and results in decreased activity of ESR2 protein; butylbenzyl phthalate binds to and results in increased activity of ESR2 protein; butylbenzyl phthalate inhibits the reaction [Estradiol results in increased activity of ESR2 protein] butylbenzyl phthalate results in increased expression of ESR2 mRNA [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ESR2 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ESR2 protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ESR2 mRNA butylbenzyl phthalate results in increased activity of ESR2 protein butylbenzyl phthalate binds to ESR2 protein
|
CTD |
PMID:15840436 PMID:19913605 PMID:28571686 PMID:31016752 PMID:32518293 PMID:35739755 PMID:37364641 More...
|
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
G
|
Esyt1
|
extended synaptotagmin 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ESYT1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:928,848...946,199
Ensembl chr 7:1,513,381...1,530,732
|
|
G
|
Etfdh
|
electron transfer flavoprotein dehydrogenase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ETFDH mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:167,025,823...167,060,770
|
|
G
|
Ets1
|
ETS proto-oncogene 1, transcription factor
|
multiple interactions
|
ISO
|
butylbenzyl phthalate promotes the reaction [ETS1 protein binds to MMP3 promoter]; butylbenzyl phthalate promotes the reaction [NR1I2 protein binds to ETS1 protein]; butylbenzyl phthalate results in increased localization of and results in increased activity of ETS1 protein
|
CTD |
PMID:33965509 |
|
NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021
|
|
G
|
Etv5
|
ETS variant transcription factor 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ETV5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr11:78,608,618...78,666,221
Ensembl chr11:92,113,224...92,170,767
|
|
G
|
Eva1a
|
eva-1 homolog A, regulator of programmed cell death
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EVA1A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:114,593,773...114,643,011
Ensembl chr 4:116,151,173...116,200,827
|
|
G
|
Eya2
|
EYA transcriptional coactivator and phosphatase 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EYA2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:154,335,598...154,519,006
Ensembl chr 3:174,818,554...174,938,034
|
|
G
|
Fabp4
|
fatty acid binding protein 4
|
increases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in increased expression of FABP4 mRNA [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of FABP4 mRNA
|
CTD |
PMID:24155963 PMID:26820058 PMID:27923775 PMID:34520170 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:93,488,271...93,492,972
|
|
G
|
Fabp5
|
fatty acid binding protein 5
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:93,672,458...93,676,127
|
|
G
|
Fads3
|
fatty acid desaturase 3
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of FADS3 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 1:216,110,547...216,127,431
Ensembl chr 1:216,110,201...216,141,758
|
|
G
|
Fah
|
fumarylacetoacetate hydrolase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FAH mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:147,957,935...147,981,046
|
|
G
|
Fam163a
|
family with sequence similarity 163, member A
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FAM163A mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr13:70,813,129...70,891,410
Ensembl chr13:70,813,134...70,891,316
|
|
G
|
Fam219a
|
family with sequence similarity 219, member A
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FAM219A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:56,679,272...56,729,959
Ensembl chr 5:61,475,185...61,525,749
|
|
G
|
Fam222a
|
family with sequence similarity 222, member A
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FAM222A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr12:41,982,064...42,033,085
Ensembl chr12:47,647,405...47,693,703
|
|
G
|
Far1
|
fatty acyl CoA reductase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FAR1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:167,644,622...167,705,868
Ensembl chr 1:177,079,150...177,161,696
|
|
G
|
Fas
|
Fas cell surface death receptor
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate co-treated with Dietary Fats] results in increased expression of FAS mRNA; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of FAS mRNA
|
CTD |
PMID:32905190 PMID:39947446 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
G
|
Fasn
|
fatty acid synthase
|
multiple interactions
|
ISO EXP
|
[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of FASN mRNA; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of FASN protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of FASN mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FASN mRNA
|
CTD |
PMID:26820058 PMID:31240115 PMID:35739755 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
G
|
Fbxl7
|
F-box and leucine-rich repeat protein 7
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:77,139,775...77,509,223
Ensembl chr 2:78,871,287...79,239,697
|
|
G
|
Fcgr2a
|
Fc gamma receptor 2A
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FCGR3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394 Ensembl chr13:85,855,437...85,864,394
|
|
G
|
Fez1
|
fasciculation and elongation protein zeta 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FEZ1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 8:44,733,288...44,778,519
Ensembl chr 8:44,733,300...44,784,097
|
|
G
|
Fgf11
|
fibroblast growth factor 11
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FGF11 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:54,516,508...54,522,067
Ensembl chr10:55,016,411...55,020,454
|
|
G
|
Fgf2
|
fibroblast growth factor 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of FGF2 mRNA
|
CTD |
PMID:37021957 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
G
|
Fgf5
|
fibroblast growth factor 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FGF5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr14:11,323,827...11,346,164
Ensembl chr14:11,627,906...11,650,243
|
|
G
|
Fgfr2
|
fibroblast growth factor receptor 2
|
decreases expression multiple interactions
|
EXP ISO
|
butylbenzyl phthalate results in decreased expression of FGFR2 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FGFR2 mRNA
|
CTD |
PMID:26472102 PMID:39150890 |
|
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914
|
|
G
|
Fhl2
|
four and a half LIM domains 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FHL2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:52,880,998...52,923,326
|
|
G
|
Fkbp1b
|
FKBP prolyl isomerase 1B
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FKBP1B mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 6:33,551,583...33,570,055
Ensembl chr 6:33,558,517...33,568,129
|
|
G
|
Fkbp4
|
FKBP prolyl isomerase 4
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of FKBP4 mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr 4:163,389,464...163,397,918
Ensembl chr 4:163,389,464...163,397,918
|
|
G
|
Fkbp5
|
FKBP prolyl isomerase 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FKBP5 mRNA
|
CTD |
PMID:32518293 |
|
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118
|
|
G
|
Flcn
|
folliculin
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FLCN mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:45,088,164...45,107,581
Ensembl chr10:45,088,167...45,107,309
|
|
G
|
Flg
|
filaggrin
|
multiple interactions
|
ISO
|
[FLG gene polymorphism affects the susceptibility to butylbenzyl phthalate] which affects the abundance of mono-benzyl phthalate
|
CTD |
PMID:24380925 |
|
NCBI chr 2:181,583,801...181,596,464
Ensembl chr 2:181,583,808...181,595,968
|
|
G
|
Fosb
|
FosB proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FOSB mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:88,082,127...88,089,477
|
|
G
|
Foxo1
|
forkhead box O1
|
multiple interactions
|
ISO
|
butylbenzyl phthalate results in increased expression of and results in increased acetylation of FOXO1 protein
|
CTD |
PMID:27923775 |
|
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
|
|
G
|
Fsd2
|
fibronectin type III and SPRY domain containing 2
|
increases expression decreases expression
|
EXP
|
butylbenzyl phthalate results in increased expression of FSD2 mRNA butylbenzyl phthalate results in decreased expression of FSD2 mRNA
|
CTD |
PMID:26472102 |
|
NCBI chr 1:135,484,002...135,522,517
Ensembl chr 1:144,898,502...144,931,704
|
|
G
|
Fshb
|
follicle stimulating hormone subunit beta
|
multiple interactions increases expression
|
EXP ISO
|
butylbenzyl phthalate promotes the reaction [Dibutyl Phthalate results in increased expression of FSHB protein] [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of FSHB protein butylbenzyl phthalate results in increased expression of FSHB protein
|
CTD |
PMID:29969652 PMID:34597818 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:114,003,262...114,007,072
|
|
G
|
Fshr
|
follicle stimulating hormone receptor
|
multiple interactions increases expression
|
ISO EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FSHR mRNA butylbenzyl phthalate results in increased expression of FSHR mRNA; butylbenzyl phthalate results in increased expression of FSHR protein
|
CTD |
PMID:28013214 PMID:31319113 |
|
NCBI chr 6:10,952,329...11,160,288
Ensembl chr 6:10,952,329...11,160,288
|
|
G
|
Fxyd7
|
FXYD domain-containing ion transport regulator 7
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FXYD7 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:86,277,678...86,286,954
Ensembl chr 1:95,405,225...95,414,345
|
|
G
|
Fzd1
|
frizzled class receptor 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of FZD1 mRNA; Dietary Fats inhibits the reaction [[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of FZD1 mRNA]
|
CTD |
PMID:30599393 |
|
NCBI chr 4:30,265,074...30,269,472
Ensembl chr 4:30,247,228...30,833,176
|
|
G
|
Fzd2
|
frizzled class receptor 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FZD2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:88,061,988...88,063,898
Ensembl chr10:88,061,667...88,065,396
|
|
G
|
Fzd8
|
frizzled class receptor 8
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FZD8 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr17:62,007,849...62,015,485
Ensembl chr17:62,007,627...62,015,961
|
|
G
|
Gabpb1
|
GA binding protein transcription factor subunit beta 1
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of GABPB1 mRNA
|
CTD |
PMID:26520405 |
|
NCBI chr 3:113,879,972...113,924,742
Ensembl chr 3:134,333,339...134,361,344
|
|
G
|
Gadd45a
|
growth arrest and DNA-damage-inducible, alpha
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GADD45A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
|
|
G
|
Galnt4
|
polypeptide N-acetylgalactosaminyltransferase 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GALNT4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:33,925,229...33,927,770
|
|
G
|
Ganab
|
glucosidase II alpha subunit
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GANAB mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:215,222,918...215,242,808
Ensembl chr 1:215,222,995...215,243,036
|
|
G
|
Gata4
|
GATA binding protein 4
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GATA4 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GATA4 mRNA
|
CTD |
PMID:37364641 PMID:39150890 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:41,635,572...41,681,609
|
|
G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GCLC mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
G
|
Gdf15
|
growth differentiation factor 15
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GDF15 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
|
|
G
|
Gfi1b
|
growth factor independent 1B transcriptional repressor
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of GFI1B mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 3:11,940,232...11,952,989
Ensembl chr 3:32,338,214...32,350,916
|
|
G
|
Gfra3
|
GDNF family receptor alpha 3
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GFRA3 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr18:26,571,952...26,600,225
Ensembl chr18:26,571,921...26,600,225
|
|
G
|
Gfra4
|
GDNF family receptor alpha 4
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GFRA4 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 3:138,707,970...138,715,279
Ensembl chr 3:138,703,114...138,711,561
|
|
G
|
Ggt1
|
gamma-glutamyltransferase 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GGT1 protein
|
CTD |
PMID:35739755 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,141...13,088,050
|
|
G
|
Ggta1
|
glycoprotein alpha-galactosyltransferase 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GGTA1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 3:18,732,985...18,824,916
Ensembl chr 3:39,130,467...39,206,870
|
|
G
|
Gk
|
glycerol kinase
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GK mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:54,112,214...54,196,701
|
|
G
|
Glipr2
|
GLI pathogenesis-related 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GLIPR2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:58,170,417...58,202,258
Ensembl chr 5:62,966,195...62,998,716
|
|
G
|
Gls
|
glutaminase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GLS mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:56,836,584...56,908,861
|
|
G
|
Gls2
|
glutaminase 2
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GLS2 mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr 7:617,252...633,424
Ensembl chr 7:1,201,838...1,218,013
|
|
G
|
Gmeb1
|
glucocorticoid modulatory element binding protein 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GMEB1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:144,421,151...144,462,448
Ensembl chr 5:149,705,825...149,737,259
|
|
G
|
Gng2
|
G protein subunit gamma 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GNG2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr15:4,316,038...4,416,918
Ensembl chr15:4,365,135...4,466,059
|
|
G
|
Got1
|
glutamic-oxaloacetic transaminase 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GOT1 protein
|
CTD |
PMID:35739755 |
|
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
|
|
G
|
Gpam
|
glycerol-3-phosphate acyltransferase, mitochondrial
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GPAM mRNA
|
CTD |
PMID:31240115 |
|
NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:264,113,813...264,175,911
|
|
G
|
Gpcpd1
|
glycerophosphocholine phosphodiesterase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GPCPD1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:119,787,681...119,832,550
Ensembl chr 3:140,240,575...140,285,372
|
|
G
|
Gpd1
|
glycerol-3-phosphate dehydrogenase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GPD1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368
|
|
G
|
Gper1
|
G protein-coupled estrogen receptor 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GPER1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of GPER1 mRNA
|
CTD |
PMID:35739755 PMID:37364641 |
|
NCBI chr12:20,331,073...20,336,527
Ensembl chr12:20,327,679...20,337,144
|
|
G
|
Gpi
|
glucose-6-phosphate isomerase
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GPI1 mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:95,965,396...95,993,261
|
|
G
|
Gpr3
|
G protein-coupled receptor 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GPR3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:150,695,406...150,698,526
Ensembl chr 5:150,695,251...150,706,529
|
|
G
|
Gprin2
|
G protein regulated inducer of neurite outgrowth 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GPRIN2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:9,496,452...9,512,672
Ensembl chr16:9,502,711...9,513,259
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GPT protein
|
CTD |
PMID:35739755 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of GPX1 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GPX1 mRNA
|
CTD |
PMID:28013214 PMID:37021957 PMID:39947446 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
G
|
Gpx4
|
glutathione peroxidase 4
|
multiple interactions decreases expression
|
ISO
|
CP protein inhibits the reaction [butylbenzyl phthalate results in decreased expression of GPX4 protein]; Deferoxamine inhibits the reaction [butylbenzyl phthalate results in decreased expression of GPX4 protein]; ferrostatin-1 inhibits the reaction [butylbenzyl phthalate results in decreased expression of GPX4 protein]
|
CTD |
PMID:39921026 |
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
G
|
Gramd1b
|
GRAM domain containing 1B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GRAMD1B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 8:40,654,492...40,893,869
Ensembl chr 8:49,556,332...49,791,052
|
|
G
|
Grb14
|
growth factor receptor bound protein 14
|
increases expression
|
EXP
|
butylbenzyl phthalate results in increased expression of GRB14 mRNA
|
CTD |
PMID:15728792 |
|
NCBI chr 3:69,976,331...70,091,921
Ensembl chr 3:69,976,339...70,091,921
|
|
G
|
Greb1
|
growth regulating estrogen receptor binding 1
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of GREB1 mRNA
|
CTD |
PMID:35307500 |
|
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:45,169,289...45,291,126
|
|
G
|
Grem2
|
gremlin 2, DAN family BMP antagonist
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GREM2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr13:86,778,543...86,871,509
Ensembl chr13:89,310,662...89,404,312
|
|
G
|
Grin2b
|
glutamate ionotropic receptor NMDA type subunit 2B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIN2B mRNA
|
CTD |
PMID:32518293 |
|
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570
|
|
G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions increases phosphorylation
|
ISO
|
HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate results in increased phosphorylation of GSK3B protein]
|
CTD |
PMID:22552774 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of GSR mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GSR mRNA
|
CTD |
PMID:28013214 PMID:39947446 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:65,185,574...65,228,394
|
|
G
|
Gsta2
|
glutathione S-transferase alpha 2
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of GSTA2 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:88,064,616...88,077,092
|
|
G
|
Gsta3
|
glutathione S-transferase alpha 3
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GSTA3 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:31,154,989...31,180,654
|
|
G
|
Gstm2
|
glutathione S-transferase mu 2
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of GSTM2 mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr 2:198,312,179...198,316,962
|
|
G
|
Gzma
|
granzyme A
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of GZMA mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:46,473,763...46,485,696
|
|
G
|
H19
|
H19 imprinted maternally expressed transcript
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of H19 mRNA
|
CTD |
PMID:33395283 |
|
NCBI chr 1:207,160,175...207,162,851
|
|
G
|
H2ax
|
H2A.X variant histone
|
multiple interactions increases phosphorylation
|
ISO
|
Nicotinamide Mononucleotide inhibits the reaction [butylbenzyl phthalate results in increased phosphorylation of H2AX protein]
|
CTD |
PMID:36756972 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
G
|
H3f3b
|
H3.3 histone B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of H3F3B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:101,755,404...101,764,616
Ensembl chr10:101,755,404...101,757,636
|
|
G
|
Hadha
|
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HADHA mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:31,907,291...31,947,698
|
|
G
|
Hadhb
|
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HADHB mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:31,873,404...31,907,557
Ensembl chr 6:31,873,404...31,907,835
|
|
G
|
Has2
|
hyaluronan synthase 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HAS2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:90,002,929...90,018,535
|
|
G
|
Hck
|
HCK proto-oncogene, Src family tyrosine kinase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HCK mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:162,031,833...162,074,933
Ensembl chr 3:162,031,817...162,074,935
|
|
G
|
Hdac6
|
histone deacetylase 6
|
multiple interactions increases response to substance increases expression
|
ISO
|
[butylbenzyl phthalate promotes the reaction [TFAP2A protein binds to HDAC6 promoter]] which results in increased expression of HDAC6 mRNA; butylbenzyl phthalate promotes the reaction [TFAP2A protein binds to HDAC6 promoter]; HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate affects the localization of CTNNB1 protein]; HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]]; HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate results in decreased expression of KRT7 protein]; HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of VIM protein]; HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate results in increased phosphorylation of AKT1 protein]; HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate results in increased phosphorylation of GSK3B protein]; TFAP2A mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of HDAC6 protein] HDAC6 results in increased susceptibility to butylbenzyl phthalate butylbenzyl phthalate results in increased expression of HDAC6 mRNA; butylbenzyl phthalate results in increased expression of HDAC6 protein
|
CTD |
PMID:22552774 |
|
NCBI chr X:17,222,538...17,244,373
Ensembl chr X:17,222,856...17,244,370
|
|
G
|
Hebp1
|
heme binding protein 1
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of HEBP1 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 4:167,974,316...168,003,854
Ensembl chr 4:169,705,668...169,735,199
|
|
G
|
Hey1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of HEY1 mRNA
|
CTD |
PMID:26472102 |
|
NCBI chr 2:95,003,935...95,006,457
Ensembl chr 2:95,002,943...95,007,624
|
|
G
|
Hgs
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of HGS mRNA
|
CTD |
PMID:39921026 |
|
NCBI chr10:105,739,617...105,757,838
Ensembl chr10:106,237,824...106,256,174
|
|
G
|
Hint1
|
histidine triad nucleotide binding protein 1
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of HINT1 mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr10:38,989,516...38,993,259
Ensembl chr 4:93,430,926...93,431,642 Ensembl chr10:93,430,926...93,431,642
|
|
G
|
Hk1
|
hexokinase 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of HK1 mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,773,220...30,874,814
|
|
G
|
Hmgb2
|
high mobility group box 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HMGB2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:37,721,379...37,723,860
|
|
G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of HMGCR mRNA; [butylbenzyl phthalate co-treated with Dietary Fats] results in increased expression of HMGCR mRNA
|
CTD |
PMID:32905190 PMID:35739755 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
G
|
Hmgcs1
|
3-hydroxy-3-methylglutaryl-CoA synthase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HMGCS1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:53,382,643...53,399,802
|
|
G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of HMOX1 mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Hnf1a
|
HNF1 homeobox A
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of HNF1A mRNA
|
CTD |
PMID:15728792 |
|
NCBI chr12:47,299,171...47,333,457
Ensembl chr12:47,306,245...47,332,755
|
|
G
|
Hoxb8
|
homeo box B8
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HOXB8 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr10:81,248,313...81,251,261
Ensembl chr10:81,739,704...81,747,802
|
|
G
|
Hoxd3
|
homeo box D3
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HOXD3 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 3:80,041,598...80,057,700
Ensembl chr 3:80,046,126...80,057,700
|
|
G
|
Hp
|
haptoglobin
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of HP mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:54,446,217...54,467,518
|
|
G
|
Hpgd
|
15-hydroxyprostaglandin dehydrogenase
|
multiple interactions
|
ISO
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] results in increased expression of HPGD mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] results in increased expression of HPGD protein
|
CTD |
PMID:38995844 |
|
NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831
|
|
G
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1
|
increases expression
|
EXP
|
butylbenzyl phthalate results in increased expression of HSD11B1 protein
|
CTD |
PMID:31319113 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:107,257,239...107,327,432
|
|
G
|
Hsd17b11
|
hydroxysteroid (17-beta) dehydrogenase 11
|
increases expression multiple interactions
|
EXP ISO
|
butylbenzyl phthalate results in increased expression of HSD17B11 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD17B11 mRNA
|
CTD |
PMID:26472102 PMID:39150890 |
|
NCBI chr14:5,693,304...5,743,157
Ensembl chr14:5,997,906...6,047,811
|
|
G
|
Hsd17b8
|
hydroxysteroid (17-beta) dehydrogenase 8
|
increases expression
|
EXP
|
butylbenzyl phthalate results in increased expression of HSD17B8 mRNA
|
CTD |
PMID:19560483 PMID:26472102 |
|
NCBI chr20:4,826,725...4,828,742
Ensembl chr20:4,828,608...4,830,634
|
|
G
|
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
multiple interactions increases expression
|
ISO EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD3B1 mRNA; [dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of HSD3B1 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of HSD3B1 mRNA butylbenzyl phthalate results in increased expression of HSD3B1 mRNA; butylbenzyl phthalate results in increased expression of HSD3B1 protein
|
CTD |
PMID:28013214 PMID:31319113 PMID:35739735 PMID:35762964 |
|
NCBI chr 2:188,858,574...188,864,694
|
|
G
|
Hsd3b2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of HSD3B2 mRNA]
|
CTD |
PMID:37552060 |
|
NCBI chr 2:188,784,614...188,812,535
Ensembl chr 2:188,784,614...188,790,569
|
|
G
|
Hsd3b3
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of HSD3B3 mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr 2:186,138,044...186,144,024
Ensembl chr 2:188,826,110...188,904,981
|
|
G
|
Hsdl2
|
hydroxysteroid dehydrogenase like 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSDL2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:79,212,525...79,274,798
|
|
G
|
Hsp90b1
|
heat shock protein 90 beta family member 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSP90B1 mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:22,997,962...23,012,293
|
|
G
|
Hspa12a
|
heat shock protein family A (Hsp70) member 12A
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:257,935,642...258,096,602
Ensembl chr 1:267,921,782...268,082,794
|
|
G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 protein
|
CTD |
PMID:37364641 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
G
|
Hspa8
|
heat shock protein family A (Hsp70) member 8
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of HSPA8 mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
|
|
G
|
Hspb8
|
heat shock protein family B (small) member 8
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSPB8 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:45,837,066...45,851,937
|
|
G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSPD1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
G
|
Htr1a
|
5-hydroxytryptamine receptor 1A
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of HTR1A mRNA
|
CTD |
PMID:32518293 |
|
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:38,427,083...38,540,760
|
|
G
|
Htr2a
|
5-hydroxytryptamine receptor 2A
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of HTR2A mRNA
|
CTD |
PMID:32518293 |
|
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619
|
|
G
|
Htr2c
|
5-hydroxytryptamine receptor 2C
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of HTR2C mRNA
|
CTD |
PMID:36746855 |
|
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:115,452,842...115,682,324
|
|
G
|
Htra1
|
HtrA serine peptidase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HTRA1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:194,927,687...194,977,620
|
|
G
|
Id1
|
inhibitor of DNA binding 1
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of ID1 mRNA
|
CTD |
PMID:26472102 |
|
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685
|
|
G
|
Idh3a
|
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IDH3A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:63,867,820...63,887,223
|
|
G
|
Ido2
|
indoleamine 2,3-dioxygenase 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of IDO2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr16:67,459,158...67,498,052
Ensembl chr16:74,161,774...74,200,650
|
|
G
|
Ier2
|
immediate early response 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IER2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr19:23,494,551...23,496,075
Ensembl chr19:40,398,160...40,402,708
|
|
G
|
Ifi27l2a
|
interferon, alpha-inducible protein 27 like 2A
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of IFI27L2A mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:128,363,658...128,365,146
|
|
G
|
Ifng
|
interferon gamma
|
multiple interactions increases expression
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of IFNG protein butylbenzyl phthalate results in increased expression of IFNG protein
|
CTD |
PMID:32308655 PMID:38954831 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
G
|
Igf1
|
insulin-like growth factor 1
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of IGF1 mRNA
|
CTD |
PMID:26472102 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
G
|
Igfbp1
|
insulin-like growth factor binding protein 1
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of IGFBP1 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344
|
|
G
|
Igfbp2
|
insulin-like growth factor binding protein 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of IGFBP2 protein
|
CTD |
PMID:38954831 |
|
NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171
|
|
G
|
Igfbp5
|
insulin-like growth factor binding protein 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IGFBP5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390
|
|
G
|
Igfbp6
|
insulin-like growth factor binding protein 6
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of IGFBP6 protein
|
CTD |
PMID:38954831 |
|
NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:135,154,685...135,159,795
|
|
G
|
Igfbp7
|
insulin-like growth factor binding protein 7
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of IGFBP7 mRNA
|
CTD |
PMID:19560483 |
|
NCBI chr14:30,737,414...30,797,317
Ensembl chr14:31,091,347...31,151,620
|
|
G
|
Il10
|
interleukin 10
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of IL10 mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
G
|
Il11
|
interleukin 11
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of IL11 mRNA
|
CTD |
PMID:36746855 |
|
NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:78,096,930...78,104,915
|
|
G
|
Il12a
|
interleukin 12A
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of IL12A mRNA
|
CTD |
PMID:36746855 |
|
NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:155,275,625...155,282,997
|
|
G
|
Il13
|
interleukin 13
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of IL13 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of IL13 protein
|
CTD |
PMID:35739755 PMID:38954831 |
|
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
|
|
G
|
Il17a
|
interleukin 17A
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of IL17A protein
|
CTD |
PMID:32308655 |
|
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
|
|
G
|
Il17ra
|
interleukin 17 receptor A
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of IL17R mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:155,339,400...155,362,382
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate co-treated with COL2A1 protein] results in increased expression of IL1B protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of IL1B mRNA
|
CTD |
PMID:32308655 PMID:37021957 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il4
|
interleukin 4
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of IL4 mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of IL6 mRNA; [butylbenzyl phthalate co-treated with COL2A1 protein] results in increased expression of IL6 protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of IL6 mRNA]
|
CTD |
PMID:32308655 PMID:33316053 PMID:35739755 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Inha
|
inhibin subunit alpha
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of INHA mRNA
|
CTD |
PMID:26472102 PMID:33983380 |
|
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:84,443,109...84,446,009
|
|
G
|
Inpp5j
|
inositol polyphosphate-5-phosphatase J
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of INPP5J mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr14:82,597,789...82,608,930
Ensembl chr14:82,597,790...82,609,678
|
|
G
|
Ins1
|
insulin 1
|
multiple interactions
|
ISO
|
butylbenzyl phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]
|
CTD |
PMID:32407875 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
G
|
Ins2
|
insulin 2
|
multiple interactions
|
ISO
|
[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] affects the abundance of diphosphoric acid analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of carbamic acid analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of Cholesterol analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of Cystathionine analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of Desmosterol analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of ethylamine analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of Glycine analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of Inositol analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of methylphosphate analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of monoethyl phosphate analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of n-butylamine analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of Palmitic Acid analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of phosphoric acid analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of Pyrrolidonecarboxylic Acid analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of sebacic acid analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of stearic acid analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of undecane analog; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of ACACA protein; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of ADIPOQ mRNA; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of ADIPOQ protein; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of CEBPA mRNA; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of CEBPA protein; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of CFD mRNA; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of FABP4 mRNA; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of FASN mRNA; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of FASN protein; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of LPL mRNA; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PLIN1 protein; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG mRNA; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG protein; butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased abundance of Triglycerides]; butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]; butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]; butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]; butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of TNF mRNA]; Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased abundance of Triglycerides]]; Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]]; Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]]; Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]; Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of TNF mRNA]] butylbenzyl phthalate promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased secretion of TNFRSF11B protein]; butylbenzyl phthalate promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; butylbenzyl phthalate promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]
|
CTD |
PMID:26820058 PMID:28595985 PMID:31016361 PMID:34864131 |
|
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
|
|
G
|
Insig1
|
insulin induced gene 1
|
decreases expression multiple interactions
|
EXP
|
butylbenzyl phthalate results in decreased expression of INSIG1 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of INSIG1 mRNA
|
CTD |
PMID:15728792 PMID:31240115 |
|
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778
|
|
G
|
Insl3
|
insulin-like 3
|
decreases expression multiple interactions
|
EXP
|
butylbenzyl phthalate results in decreased expression of INSL3 mRNA [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of INSL3 mRNA
|
CTD |
PMID:14687758 PMID:16102138 PMID:18411233 PMID:33983380 PMID:37788136 |
|
NCBI chr16:18,432,668...18,434,539
|
|
G
|
Ints13
|
integrator complex subunit 13
|
multiple interactions
|
ISO
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of INTS13 protein
|
CTD |
PMID:38995844 |
|
NCBI chr 4:181,190,438...181,222,235
Ensembl chr 4:181,189,765...181,222,235
|
|
G
|
Irf2bp2
|
interferon regulatory factor 2 binding protein 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRF2BP2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:71,456,689...71,462,368
|
|
G
|
Irgm
|
immunity-related GTPase M
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRGM1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:33,734,640...33,742,720
Ensembl chr10:33,732,961...33,743,228
|
|
G
|
Irgq
|
immunity-related GTPase Q
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRGQ mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:80,123,925...80,131,881
Ensembl chr 1:89,239,205...89,259,799
|
|
G
|
Irs1
|
insulin receptor substrate 1
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of IRS1 mRNA
|
CTD |
PMID:33395283 |
|
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538
|
|
G
|
Isg15
|
ISG15 ubiquitin-like modifier
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ISG15 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:172,066,369...172,067,656
|
|
G
|
Itga11
|
integrin subunit alpha 11
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITGA11 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 8:63,145,998...63,254,714
Ensembl chr 8:72,016,652...72,150,137
|
|
G
|
Itga2
|
integrin subunit alpha 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITGA2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:48,253,412...48,354,509
|
|
G
|
Itga7
|
integrin subunit alpha 7
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITGA7 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:1,360,125...1,388,886
Ensembl chr 7:1,944,460...1,973,339
|
|
G
|
Itgb3
|
integrin subunit beta 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITGB3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800
|
|
G
|
Itih5
|
inter-alpha-trypsin inhibitor heavy chain 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITIH5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr17:68,248,115...68,352,216
Ensembl chr17:73,161,611...73,262,496
|
|
G
|
Itprip
|
inositol 1,4,5-trisphosphate receptor interacting protein
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITPRIP mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:246,762,804...246,786,379
Ensembl chr 1:256,699,832...256,727,644
|
|
G
|
Ivd
|
isovaleryl-CoA dehydrogenase
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of IVD mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr 3:105,851,710...105,872,144
Ensembl chr 3:126,305,364...126,328,160
|
|
G
|
Jag1
|
jagged canonical Notch ligand 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of JAG1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:144,859,453...144,894,872
|
|
G
|
Junb
|
JunB proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of JUNB mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:40,073,541...40,085,218
|
|
G
|
Kank4
|
KN motif and ankyrin repeat domains 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KANK4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:118,516,994...118,581,024
Ensembl chr 5:118,517,971...118,581,002
|
|
G
|
Kbtbd11
|
kelch repeat and BTB domain containing 11
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KBTBD11 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:74,618,291...74,638,010
Ensembl chr16:81,313,093...81,340,390
|
|
G
|
Kctd10
|
potassium channel tetramerization domain containing 10
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KCTD10 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr12:42,230,159...42,248,792
Ensembl chr12:47,890,819...47,909,390
|
|
G
|
Kctd11
|
potassium channel tetramerization domain containing 11
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KCTD11 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:54,602,575...54,604,738
Ensembl chr10:55,100,801...55,103,583
|
|
G
|
Kdelr3
|
KDEL endoplasmic reticulum protein retention receptor 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KDELR3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:111,079,236...111,089,463
Ensembl chr 7:112,959,718...112,969,858
|
|
G
|
Kif18b
|
kinesin family member 18B
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of KIF18B mRNA
|
CTD |
PMID:36756972 |
|
NCBI chr10:87,870,424...87,889,895
Ensembl chr10:88,370,524...88,389,691
|
|
G
|
Kif5a
|
kinesin family member 5A
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KIF5A protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5A mRNA
|
CTD |
PMID:37690569 |
|
NCBI chr 7:64,937,210...64,974,339
Ensembl chr 7:64,934,740...64,978,272
|
|
G
|
Kif5c
|
kinesin family member 5C
|
multiple interactions
|
EXP ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5C mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KIF5C mRNA
|
CTD |
PMID:31199487 PMID:39150890 |
|
NCBI chr 3:34,032,082...34,185,597
Ensembl chr 3:54,441,310...54,594,813
|
|
G
|
Klf1
|
KLF transcription factor 1
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of KLF1 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr19:23,250,627...23,253,802
Ensembl chr19:40,155,480...40,158,607
|
|
G
|
Klf11
|
KLF transcription factor 11
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KLF11 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:41,285,699...41,297,548
Ensembl chr 6:47,014,326...47,037,044
|
|
G
|
Kmt5a
|
lysine methyltransferase 5A
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KMT5A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr12:32,139,353...32,167,777
Ensembl chr12:37,800,344...37,823,783
|
|
G
|
Krt18
|
keratin 18
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KRT18 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848 Ensembl chr10:135,035,982...135,039,848
|
|
G
|
Krt7
|
keratin 7
|
decreases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in decreased expression of KRT7 protein HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate results in decreased expression of KRT7 protein]
|
CTD |
PMID:22552774 |
|
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:134,407,584...134,423,786
|
|
G
|
L1cam
|
L1 cell adhesion molecule
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of L1CAM mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of L1CAM protein
|
CTD |
PMID:31199487 PMID:37690569 |
|
NCBI chr X:156,748,597...156,775,116
Ensembl chr X:156,748,597...156,775,077
|
|
G
|
Lamp3
|
lysosomal-associated membrane protein 3
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of LAMP3 mRNA
|
CTD |
PMID:20678512 |
|
NCBI chr11:81,153,491...81,224,643
Ensembl chr11:94,661,399...94,726,195
|
|
G
|
Laptm5
|
lysosomal protein transmembrane 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LAPTM5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:143,087,759...143,109,807
Ensembl chr 5:148,339,435...148,393,927
|
|
G
|
Lats2
|
large tumor suppressor kinase 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LATS2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr15:31,825,068...31,877,193
Ensembl chr15:35,940,632...35,980,842
|
|
G
|
Lcn2
|
lipocalin 2
|
multiple interactions
|
EXP ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of LCN2 protein
|
CTD |
PMID:31199487 PMID:38954831 |
|
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
|
|
G
|
Ldlr
|
low density lipoprotein receptor
|
decreases expression multiple interactions
|
EXP ISO
|
butylbenzyl phthalate results in decreased expression of LDLR mRNA [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of LDLR mRNA
|
CTD |
PMID:15728792 PMID:35739755 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
G
|
Lef1
|
lymphoid enhancer binding factor 1
|
multiple interactions
|
ISO
|
butylbenzyl phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]; HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]]; trichostatin A inhibits the reaction [butylbenzyl phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]]
|
CTD |
PMID:22552774 |
|
NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929
|
|
G
|
Lep
|
leptin
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of LEP protein
|
CTD |
PMID:38954831 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
G
|
Lgr4
|
leucine-rich repeat-containing G protein-coupled receptor 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LGR4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:96,447,385...96,550,006
Ensembl chr 3:116,901,968...117,004,153
|
|
G
|
Lgr6
|
leucine-rich repeat-containing G protein-coupled receptor 6
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LGR6 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr13:46,424,382...46,544,074
Ensembl chr13:48,976,193...49,095,857
|
|
G
|
Lhb
|
luteinizing hormone subunit beta
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased secretion of LHB protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased secretion of LHB protein
|
CTD |
PMID:37364641 PMID:37839492 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:105,037,457...105,038,445
|
|
G
|
Lhcgr
|
luteinizing hormone/choriogonadotropin receptor
|
decreases expression increases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of LHCGR mRNA butylbenzyl phthalate results in increased expression of LHCGR mRNA; butylbenzyl phthalate results in increased expression of LHCGR protein
|
CTD |
PMID:15728792 PMID:31319113 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:11,415,415...11,478,061
|
|
G
|
Lipe
|
lipase E, hormone sensitive type
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LIPE mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:90,093,433...90,112,117
|
|
G
|
LOC120098360
|
small nucleolar RNA SNORA13
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNORA13 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr18:25,404,452...25,404,585
Ensembl chr18:25,678,566...25,678,699
|
|
G
|
Lonrf2
|
LON peptidase N-terminal domain and ring finger 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LONRF2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 9:41,033,125...41,070,551
Ensembl chr 9:48,530,549...48,570,807
|
|
G
|
Lpcat1
|
lysophosphatidylcholine acyltransferase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LPCAT1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:29,766,070...29,816,401
Ensembl chr 1:31,594,622...31,644,946
|
|
G
|
Lpin1
|
lipin 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LPIN1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:45,041,522...45,145,991
|
|
G
|
Lpl
|
lipoprotein lipase
|
multiple interactions
|
ISO
|
[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of LPL mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of LPL mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LPL mRNA
|
CTD |
PMID:26820058 PMID:30768133 PMID:39150890 |
|
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107
|
|
G
|
Lratd1
|
LRAT domain containing 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRATD1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:36,916,969...36,922,143
Ensembl chr 6:42,640,190...42,651,204
|
|
G
|
Lrg1
|
leucine-rich alpha-2-glycoprotein 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRG1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:947,516...949,773
Ensembl chr 9:1,034,679...1,037,337
|
|
G
|
Lrrc4b
|
leucine rich repeat containing 4B
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LRRC4B mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:104,058,558...104,092,831
Ensembl chr 1:104,072,128...104,093,298
|
|
G
|
Lrtm2
|
leucine-rich repeats and transmembrane domains 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRTM2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:152,485,863...152,508,248
Ensembl chr 4:154,158,168...154,167,641
|
|
G
|
Lss
|
lanosterol synthase
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of LSS mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,073,543...12,118,253
|
|
G
|
Lum
|
lumican
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of LUM mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:34,245,360...34,252,508
|
|
G
|
Lynx1
|
Ly6/neurotoxin 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LYNX1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 7:106,632,800...106,638,003
Ensembl chr 7:108,521,780...108,527,130
|
|
G
|
Lyset
|
lysosomal enzyme trafficking factor
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TMEM251 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:121,884,577...121,886,319
Ensembl chr 6:127,649,450...127,652,661
|
|
G
|
Mafk
|
MAF bZIP transcription factor K
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MAFK mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr12:14,834,628...14,856,414
Ensembl chr12:19,948,476...19,959,192
|
|
G
|
Magee1
|
MAGE family member E1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MAGEE1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr X:70,189,242...70,192,789
Ensembl chr X:74,254,958...74,258,371
|
|
G
|
Map2
|
microtubule-associated protein 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MAP2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
G
|
Map6
|
microtubule-associated protein 6
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MAP6 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:162,980,339...163,046,548
Ensembl chr 1:162,980,181...163,046,548
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases phosphorylation multiple interactions
|
EXP ISO
|
butylbenzyl phthalate results in increased phosphorylation of MAPK1 protein [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of MAPK1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased phosphorylation of MAPK1 protein
|
CTD |
PMID:31319113 PMID:35739755 PMID:37364641 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk14
|
mitogen activated protein kinase 14
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of MAPK14 protein
|
CTD |
PMID:37364641 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
increases phosphorylation multiple interactions
|
EXP ISO
|
butylbenzyl phthalate results in increased phosphorylation of MAPK3 protein [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of MAPK3 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased phosphorylation of MAPK3 protein
|
CTD |
PMID:31319113 PMID:35739755 PMID:37364641 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mapre3
|
microtubule-associated protein, RP/EB family, member 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MAPRE3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:31,233,736...31,278,626
Ensembl chr 6:31,233,736...31,278,775
|
|
G
|
Mapt
|
microtubule-associated protein tau
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MAPT mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
G
|
Mark4
|
microtubule affinity regulating kinase 4
|
multiple interactions
|
ISO
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of MARK4 protein
|
CTD |
PMID:38995844 |
|
NCBI chr 1:88,203,352...88,239,858
Ensembl chr 1:88,203,393...88,236,553
|
|
G
|
Mboat1
|
membrane bound O-acyltransferase domain containing 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MBOAT1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr17:34,331,413...34,445,088
Ensembl chr17:34,540,041...34,653,698
|
|
G
|
Mboat7
|
membrane bound O-acyltransferase domain containing 7
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MBOAT7 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:74,440,618...74,454,896
Ensembl chr 1:74,439,660...74,454,894
|
|
G
|
Mc2r
|
melanocortin 2 receptor
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of MC2R mRNA
|
CTD |
PMID:32518293 |
|
NCBI chr18:64,279,878...64,291,775
Ensembl chr18:64,277,360...64,291,881
|
|
G
|
Mccc1
|
methylcrotonyl-CoA carboxylase subunit 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MCCC1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:118,799,147...118,851,181
Ensembl chr 2:120,727,316...120,779,554
|
|
G
|
Mcm2
|
minichromosome maintenance complex component 2
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of MCM2 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:122,903,682...122,918,094
|
|
G
|
Mcm5
|
minichromosome maintenance complex component 5
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of MCM5 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,488,813...13,517,758
|
|
G
|
Mcm6
|
minichromosome maintenance complex component 6
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of MCM6 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467
|
|
G
|
Me3
|
malic enzyme 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ME3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:143,534,024...143,735,551
Ensembl chr 1:152,946,628...153,148,026
|
|
G
|
Mex3b
|
mex-3 RNA binding family member B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MEX3B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:136,855,130...136,859,365
Ensembl chr 1:146,264,318...146,268,543
|
|
G
|
Mfsd4a
|
major facilitator superfamily domain containing 4A
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MFSD4A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr13:43,469,488...43,510,467
Ensembl chr13:46,021,659...46,062,633
|
|
G
|
Mgll
|
monoglyceride lipase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MGLL mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:122,749,436...122,851,440
|
|
G
|
Mgp
|
matrix Gla protein
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of MGP mRNA
|
CTD |
PMID:39921026 |
|
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:171,497,471...171,500,859
|
|
G
|
Mgst1
|
microsomal glutathione S-transferase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MGST1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:172,760,886...172,776,875
|
|
G
|
Mir106b
|
microRNA 106b
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR106B
|
CTD |
PMID:30698749 |
|
NCBI chr12:22,157,053...22,157,134
|
|
G
|
Mir107
|
microRNA 107
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of MIR107 mRNA
|
CTD |
PMID:33395283 |
|
NCBI chr 1:232,337,767...232,337,853
|
|
G
|
Mir126a
|
microRNA 126a
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR126
|
CTD |
PMID:33885134 |
|
NCBI chr 3:9,415,063...9,415,180
|
|
G
|
Mir127
|
microRNA 127
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR127
|
CTD |
PMID:33885134 |
|
NCBI chr 6:128,546,215...128,546,311
Ensembl chr 6:134,328,454...134,328,550
|
|
G
|
Mir141
|
microRNA 141
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR141
|
CTD |
PMID:31199487 |
|
NCBI chr 4:157,523,239...157,523,332
|
|
G
|
Mir143
|
microRNA 143
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR143
|
CTD |
PMID:33885134 |
|
NCBI chr18:57,371,349...57,371,453
|
|
G
|
Mir148b
|
microRNA 148b
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR148B
|
CTD |
PMID:30698749 |
|
NCBI chr 7:134,421,398...134,421,494
Ensembl chr 7:136,299,870...136,299,966
|
|
G
|
Mir150
|
microRNA 150
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR150
|
CTD |
PMID:33885134 |
|
NCBI chr 1:95,605,024...95,605,108
Ensembl chr 1:104,741,487...104,741,571
|
|
G
|
Mir15b
|
microRNA 15b
|
decreases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in decreased expression of MIR15B mRNA [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR15B
|
CTD |
PMID:30698749 PMID:31629899 |
|
NCBI chr 2:155,555,178...155,555,275
Ensembl chr 2:155,555,178...155,555,275
|
|
G
|
Mir184
|
microRNA 184
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR184; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR184 mRNA
|
CTD |
PMID:31199487 PMID:35762964 |
|
NCBI chr 8:90,343,134...90,343,210
|
|
G
|
Mir18a
|
microRNA 18a
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR18A
|
CTD |
PMID:30698749 |
|
NCBI chr15:92,180,765...92,180,860
Ensembl chr15:98,587,984...98,588,079
|
|
G
|
Mir193a
|
microRNA 193a
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR193A
|
CTD |
PMID:33885134 |
|
NCBI chr10:64,672,343...64,672,454
|
|
G
|
Mir19a
|
microRNA 19a
|
multiple interactions increases expression
|
ISO
|
MIR19A mRNA affects the reaction [butylbenzyl phthalate results in decreased expression of CDKN1A protein]; MIR19A mRNA affects the reaction [butylbenzyl phthalate results in decreased expression of PTEN protein]; MIR19A mRNA affects the reaction [butylbenzyl phthalate results in increased expression of CCND1 protein]; MIR19A mRNA affects the reaction [butylbenzyl phthalate results in increased expression of PCNA protein] butylbenzyl phthalate results in increased expression of MIR19A mRNA
|
CTD |
PMID:29864457 |
|
NCBI chr15:98,588,131...98,588,212
Ensembl chr15:98,588,131...98,588,212
|
|
G
|
Mir19b1
|
microRNA 19b-1
|
multiple interactions increases expression
|
ISO
|
MIR19B1 mRNA affects the reaction [butylbenzyl phthalate results in decreased expression of CDKN1A protein]; MIR19B1 mRNA affects the reaction [butylbenzyl phthalate results in decreased expression of PTEN protein]; MIR19B1 mRNA affects the reaction [butylbenzyl phthalate results in increased expression of CCND1 protein]; MIR19B1 mRNA affects the reaction [butylbenzyl phthalate results in increased expression of PCNA protein] butylbenzyl phthalate results in increased expression of MIR19B1 mRNA
|
CTD |
PMID:29864457 |
|
NCBI chr15:92,181,214...92,181,300
Ensembl chr15:98,588,433...98,588,519
|
|
G
|
Mir200b
|
microRNA 200b
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in increased expression of and results in increased cleavage of MIR200B
|
CTD |
PMID:33086190 |
|
NCBI chr 5:171,931,495...171,931,589
|
|
G
|
Mir203
|
microRNA 203
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in decreased expression of MIR203
|
CTD |
PMID:33086190 |
|
NCBI chr 6:131,199,542...131,199,656
|
|
G
|
Mir20b
|
microRNA 20b
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR20B
|
CTD |
PMID:30698749 |
|
NCBI chr X:132,422,211...132,422,282
|
|
G
|
Mir221
|
microRNA 221
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in decreased expression of MIR221 [butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR221
|
CTD |
PMID:33086190 PMID:33885134 |
|
NCBI chr X:6,023,182...6,023,290
Ensembl chr X:6,023,182...6,023,290
|
|
G
|
Mir23a
|
microRNA 23a
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR23A
|
CTD |
PMID:30698749 |
|
NCBI chr19:40,859,769...40,859,843
|
|
G
|
Mir25
|
microRNA 25
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR25
|
CTD |
PMID:33885134 |
|
NCBI chr12:17,042,932...17,043,015
|
|
G
|
Mir320a
|
microRNA 320a
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR320A [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR320
|
CTD |
PMID:30698749 PMID:33885134 |
|
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:51,926,088...51,926,169
|
|
G
|
Mir324
|
microRNA 324
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR324
|
CTD |
PMID:33885134 |
|
NCBI chr10:54,734,680...54,734,762
Ensembl chr10:55,233,361...55,233,449
|
|
G
|
Mir328
|
microRNA 328
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR328
|
CTD |
PMID:33885134 |
|
NCBI chr19:50,094,691...50,094,774
|
|
G
|
Mir339
|
microRNA 339
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR339
|
CTD |
PMID:30698749 |
|
NCBI chr12:15,277,546...15,277,641
Ensembl chr12:20,391,395...20,391,490
|
|
G
|
Mir345
|
microRNA 345
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR345
|
CTD |
PMID:33885134 |
|
NCBI chr 6:127,754,027...127,754,122
Ensembl chr 6:133,518,403...133,518,498
|
|
G
|
Mir34a
|
microRNA 34a
|
multiple interactions increases expression decreases expression
|
ISO
|
MIR34A mRNA inhibits the reaction [butylbenzyl phthalate results in decreased expression of CDKN1A protein]; MIR34A mRNA inhibits the reaction [butylbenzyl phthalate results in increased expression of CCND1 protein]; MIR34A mRNA inhibits the reaction [butylbenzyl phthalate results in increased expression of MYC protein]; MIR34A mRNA inhibits the reaction [butylbenzyl phthalate results in increased expression of PCNA protein] MIR34A mRNA affects the reaction [butylbenzyl phthalate results in decreased expression of NAMPT protein] butylbenzyl phthalate results in increased expression of MIR34A mRNA butylbenzyl phthalate results in decreased expression of MIR34A mRNA
|
CTD |
PMID:30243731 PMID:34520170 |
|
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:165,815,952...165,816,053
|
|
G
|
Mir451a
|
microRNA 451a
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR451A
|
CTD |
PMID:33885134 |
|
NCBI chr10:62,961,520...62,961,591
Ensembl chr10:63,459,569...63,459,640
|
|
G
|
Mir500
|
microRNA 500
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR500
|
CTD |
PMID:30698749 |
|
NCBI chr X:17,930,647...17,930,726
Ensembl chr X:17,930,637...17,930,728
|
|
G
|
Mir503
|
microRNA 503
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in increased expression of and results in increased cleavage of MIR503
|
CTD |
PMID:33086190 |
|
NCBI chr X:132,806,303...132,806,373
|
|
G
|
Mir532
|
microRNA 532
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR532
|
CTD |
PMID:33885134 |
|
NCBI chr X:17,919,185...17,919,263
Ensembl chr X:17,919,185...17,919,263
|
|
G
|
Mir675
|
microRNA 675
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of MIR675 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr 1:197,732,275...197,732,358
|
|
G
|
Mir96
|
microRNA 96
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in increased expression of and results in increased cleavage of MIR96
|
CTD |
PMID:33086190 |
|
NCBI chr 4:58,788,411...58,788,516
|
|
G
|
Mir99b
|
microRNA 99b
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR99B
|
CTD |
PMID:33885134 |
|
NCBI chr 1:67,350,064...67,350,133
Ensembl chr 1:67,350,060...67,350,139
|
|
G
|
Mirlet7a1
|
microRNA let-7a-1
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of MIRLET7A-1 mRNA
|
CTD |
PMID:33395283 |
|
NCBI chr17:16,113,766...16,113,859
Ensembl chr17:16,320,135...16,320,234
|
|
G
|
Mirlet7b
|
microRNA let-7b
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of MIRLET7B mRNA
|
CTD |
PMID:33395283 |
|
NCBI chr 7:116,804,186...116,804,270
Ensembl chr 7:118,684,038...118,684,122
|
|
G
|
Mirlet7c1
|
microRNA let-7c-1
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of MIRLET7C-1 mRNA
|
CTD |
PMID:33395283 |
|
NCBI chr11:16,201,163...16,201,256
Ensembl chr11:29,688,107...29,688,214
|
|
G
|
Mirlet7d
|
microRNA let-7d
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of MIRLET7D mRNA
|
CTD |
PMID:33395283 |
|
NCBI chr17:16,115,893...16,115,990
Ensembl chr17:16,322,260...16,322,357
|
|
G
|
Mirlet7f-1
|
microRNA let7f-1
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of MIRLET7F-1 mRNA
|
CTD |
PMID:33395283 |
|
NCBI chr17:16,114,130...16,114,226
|
|
G
|
Mllt11
|
MLLT11, transcription factor 7 cofactor
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MLLT11 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 2:185,484,791...185,493,961
Ensembl chr 2:185,484,793...185,493,961
|
|
G
|
Mlxipl
|
MLX interacting protein-like
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MLXIPL mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr12:27,178,158...27,213,675
Ensembl chr12:27,178,158...27,213,660
|
|
G
|
Mme
|
membrane metallo-endopeptidase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MME mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:149,806,826...149,957,381
Ensembl chr 2:149,872,291...149,953,463
|
|
G
|
Mmp14
|
matrix metallopeptidase 14
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP14 mRNA]
|
CTD |
PMID:33316053 |
|
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893
|
|
G
|
Mmp16
|
matrix metallopeptidase 16
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP16 mRNA]
|
CTD |
PMID:33316053 |
|
NCBI chr 5:31,312,280...31,556,276
Ensembl chr 5:36,109,265...36,353,252
|
|
G
|
Mmp2
|
matrix metallopeptidase 2
|
multiple interactions increases expression
|
ISO
|
ZEB1 protein affects the reaction [butylbenzyl phthalate results in increased expression of MMP2 protein]
|
CTD |
PMID:31212022 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
G
|
Mmp3
|
matrix metallopeptidase 3
|
increases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in increased expression of MMP3 protein butylbenzyl phthalate promotes the reaction [ETS1 protein binds to MMP3 promoter]; butylbenzyl phthalate promotes the reaction [NR1I2 protein binds to MMP3 promoter]
|
CTD |
PMID:33965509 |
|
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
G
|
Mmp9
|
matrix metallopeptidase 9
|
increases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in increased expression of MMP9 protein [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of MMP9 mRNA]
|
CTD |
PMID:31212022 PMID:33316053 PMID:33965509 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
G
|
Mpi
|
mannose phosphate isomerase
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of MPI mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr 8:57,947,883...57,956,205
Ensembl chr 8:66,844,116...66,852,016
|
|
G
|
Mpp2
|
MAGUK p55 scaffold protein 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MPP2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:87,011,434...87,043,883
Ensembl chr10:87,511,638...87,544,029
|
|
G
|
Mpzl2
|
myelin protein zero-like 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MPZL2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 8:45,348,285...45,359,298
Ensembl chr 8:54,243,556...54,256,074
|
|
G
|
Mrgbp
|
MRG domain binding protein
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MRGBP mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:167,697,129...167,700,592
Ensembl chr 3:188,074,709...188,078,153
|
|
G
|
Mrpl1
|
mitochondrial ribosomal protein L1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MRPL1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr14:13,300,522...13,359,654
Ensembl chr14:13,604,499...13,663,602
|
|
G
|
Mrpl42
|
mitochondrial ribosomal protein L42
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of MRPL42 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 7:30,117,977...30,141,757
Ensembl chr 7:32,004,777...32,035,104
|
|
G
|
Msh2
|
mutS homolog 2
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of MSH2 mRNA
|
CTD |
PMID:26472102 |
|
NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503
|
|
G
|
Mt2
|
metallothionein 2
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of MT2 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,837,927...10,838,709
|
|
G
|
Mtss2
|
MTSS I-BAR domain containing 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MTSS2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr19:38,692,793...38,714,575
Ensembl chr19:55,602,498...55,623,950
|
|
G
|
Mtus1
|
microtubule associated scaffold protein 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MTUS1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:51,202,497...51,347,794
Ensembl chr16:57,906,128...58,051,474
|
|
G
|
Mvd
|
mevalonate diphosphate decarboxylase
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of MVD mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr19:67,404,911...67,414,974
Ensembl chr19:67,404,911...67,422,366
|
|
G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
multiple interactions increases expression
|
ISO
|
MIR34A mRNA inhibits the reaction [butylbenzyl phthalate results in increased expression of MYC protein] butylbenzyl phthalate results in increased expression of MYC mRNA; butylbenzyl phthalate results in increased expression of MYC protein
|
CTD |
PMID:30243731 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
G
|
Myo10
|
myosin X
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MYO10 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:76,100,989...76,305,619
Ensembl chr 2:77,831,532...78,036,137
|
|
G
|
Myocd
|
myocardin
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of MYOCD mRNA
|
CTD |
PMID:26472102 |
|
NCBI chr10:49,833,219...49,928,806
Ensembl chr10:50,332,356...50,426,819
|
|
G
|
Nab2
|
Ngfi-A binding protein 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NAB2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:63,497,589...63,504,105
Ensembl chr 7:65,382,863...65,389,255
|
|
G
|
Nacad
|
NAC alpha domain containing
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NACAD mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr14:81,465,299...81,473,866
Ensembl chr14:85,679,215...85,688,147
|
|
G
|
Nampt
|
nicotinamide phosphoribosyltransferase
|
decreases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in decreased expression of NAMPT mRNA; butylbenzyl phthalate results in decreased expression of NAMPT protein MIR34A mRNA affects the reaction [butylbenzyl phthalate results in decreased expression of NAMPT protein]
|
CTD |
PMID:34520170 |
|
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544
|
|
G
|
Ncald
|
neurocalcin delta
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NCALD mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:68,532,671...68,964,740
Ensembl chr 7:70,419,433...70,849,482
|
|
G
|
Nceh1
|
neutral cholesterol ester hydrolase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NCEH1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:110,074,985...110,135,592
Ensembl chr 2:112,003,502...112,064,272
|
|
G
|
Ncf1
|
neutrophil cytosolic factor 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of NCF1 mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079
|
|
G
|
Ncs1
|
neuronal calcium sensor 1
|
multiple interactions
|
EXP ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NCS1 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NCS1 mRNA
|
CTD |
PMID:31199487 PMID:39150890 |
|
NCBI chr 3:14,523,220...14,568,829
Ensembl chr 3:34,920,971...34,968,711
|
|
G
|
Ndn
|
necdin, MAGE family member
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NDN mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:115,849,168...115,850,767
Ensembl chr 1:125,260,997...125,262,785
|
|
G
|
Ndrg4
|
NDRG family member 4
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NDRG4 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr19:9,357,470...9,393,465
Ensembl chr19:9,357,470...9,392,972
|
|
G
|
Ndufa4
|
Ndufa4, mitochondrial complex associated
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of NDUFA4 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 4:40,002,216...40,009,384
Ensembl chr 4:40,968,391...40,975,559
|
|
G
|
Ndufs1
|
NADH:ubiquinone oxidoreductase core subunit S1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NDUFS1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:64,546,430...64,579,751
Ensembl chr 9:72,040,090...72,073,605
|
|
G
|
Nefh
|
neurofilament heavy chain
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFH mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:84,044,023...84,054,417
|
|
G
|
Nefl
|
neurofilament light chain
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFL mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr15:46,477,330...46,481,203
Ensembl chr15:46,458,204...46,482,515
|
|
G
|
Nell1
|
neural EGFL like 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NELL1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:99,709,305...100,573,872
Ensembl chr 1:108,845,462...109,709,858
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
decreases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in decreased expression of NFE2L2 mRNA [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of NFE2L2 mRNA; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of NFE2L2 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NFE2L2 mRNA
|
CTD |
PMID:27923775 PMID:37021957 PMID:37364641 PMID:39150890 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
G
|
Nfe2l3
|
NFE2 like bZIP transcription factor 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NFE2L3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:80,506,756...80,534,629
Ensembl chr 4:81,837,404...81,865,532
|
|
G
|
Nfil3
|
nuclear factor, interleukin 3 regulated
|
increases expression
|
EXP
|
butylbenzyl phthalate results in increased expression of NFIL3 mRNA
|
CTD |
PMID:15728792 |
|
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,432,198...12,450,826
|
|
G
|
Ngfr
|
nerve growth factor receptor
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NGFR mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
|
|
G
|
Nherf1
|
NHERF family PDZ scaffold protein 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC9A3R1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:100,403,189...100,420,290
Ensembl chr10:100,901,227...100,919,579
|
|
G
|
Nme1
|
NME/NM23 nucleoside diphosphate kinase 1
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of NME1 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr10:79,403,939...79,426,620
Ensembl chr10:79,403,940...79,413,310
|
|
G
|
Nme2
|
NME/NM23 nucleoside diphosphate kinase 2
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of NME2 mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr10:78,898,097...78,903,514
Ensembl chr20:11,179,066...11,179,497 Ensembl chr10:11,179,066...11,179,497
|
|
G
|
Nmrk1
|
nicotinamide riboside kinase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NMRK1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:225,475,975...225,503,414
Ensembl chr 1:225,475,830...225,503,602
|
|
G
|
Nnat
|
neuronatin
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NNAT mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:166,646,373...166,648,845
Ensembl chr 3:166,646,384...166,649,086
|
|
G
|
Nol4
|
nucleolar protein 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NOL4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr18:13,932,499...14,294,873
Ensembl chr18:14,207,303...14,569,677
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NOS2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
G
|
Notch4
|
notch receptor 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NOTCH4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr20:4,160,362...4,184,466
Ensembl chr20:4,161,730...4,189,072
|
|
G
|
Npc1
|
NPC intracellular cholesterol transporter 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NPC1 mRNA
|
CTD |
PMID:31240115 |
|
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,654,237...3,699,800
|
|
G
|
Npl
|
N-acetylneuraminate pyruvate lyase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NPL mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr13:68,205,602...68,247,940
Ensembl chr13:68,205,603...68,247,999
|
|
G
|
Nr0b1
|
nuclear receptor subfamily 0, group B, member 1
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of NR0B1 mRNA
|
CTD |
PMID:15728792 PMID:33983380 |
|
NCBI chr X:50,756,886...50,761,014
Ensembl chr X:54,707,639...54,712,083
|
|
G
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NR1H4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:25,733,471...25,829,389
|
|
G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
increases activity multiple interactions
|
ISO
|
butylbenzyl phthalate results in increased activity of NR1I2 protein butylbenzyl phthalate binds to and results in increased activity of NR1I2 protein butylbenzyl phthalate binds to and results in increased activity of NR1I2 protein; butylbenzyl phthalate promotes the reaction [NR1I2 protein binds to ETS1 protein]; butylbenzyl phthalate promotes the reaction [NR1I2 protein binds to MMP3 promoter]; butylbenzyl phthalate results in increased localization of and results in increased activity of NR1I2 protein
|
CTD |
PMID:27551952 PMID:33049310 PMID:33965509 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:75,965,632...76,002,380
|
|
G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
affects binding increases activity
|
ISO
|
butylbenzyl phthalate binds to NR1I3 protein butylbenzyl phthalate results in increased activity of NR1I3 protein; butylbenzyl phthalate results in increased activity of NR1I3 protein alternative form
|
CTD |
PMID:25938866 PMID:27551952 PMID:28927721 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:86,165,349...86,170,370
|
|
G
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of NR3C1 mRNA
|
CTD |
PMID:32518293 |
|
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
|
|
G
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NR3C2 mRNA
|
CTD |
PMID:32518293 |
|
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078
|
|
G
|
Nr4a1
|
nuclear receptor subfamily 4, group A, member 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NR4A1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:134,247,192...134,268,041
|
|
G
|
Nr4a2
|
nuclear receptor subfamily 4, group A, member 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NR4A2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:62,098,743...62,106,769
|
|
G
|
Nr4a3
|
nuclear receptor subfamily 4, group A, member 3
|
decreases expression multiple interactions
|
EXP ISO
|
butylbenzyl phthalate results in decreased expression of NR4A3 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NR4A3 mRNA
|
CTD |
PMID:19560483 PMID:39150890 |
|
NCBI chr 5:67,157,141...67,198,287
Ensembl chr 5:67,157,375...67,198,285
|
|
G
|
Nrbp2
|
nuclear receptor binding protein 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NRBP2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:107,798,642...107,805,225
Ensembl chr 7:109,679,330...109,685,588
|
|
G
|
Nrf1
|
nuclear respiratory factor 1
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of NRF1 mRNA
|
CTD |
PMID:26520405 PMID:27923775 |
|
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:59,632,372...59,738,353
|
|
G
|
Nrxn2
|
neurexin 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NRXN2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:213,155,673...213,271,526
Ensembl chr 1:213,155,673...213,271,526
|
|
G
|
Nsdhl
|
NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of NSDHL mRNA
|
CTD |
PMID:19560483 |
|
NCBI chr X:150,775,034...150,807,161
Ensembl chr X:155,817,340...155,848,220
|
|
G
|
Nsg1
|
neuronal vesicle trafficking associated 1
|
multiple interactions
|
EXP ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NSG1 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NSG1 mRNA
|
CTD |
PMID:31199487 PMID:39150890 |
|
NCBI chr14:72,648,771...72,670,521
Ensembl chr14:76,860,746...76,883,390
|
|
G
|
Nsg2
|
neuronal vesicle trafficking associated 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NSG2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr10:15,601,594...15,661,441
Ensembl chr10:16,147,325...16,165,915
|
|
G
|
Nt5dc2
|
5'-nucleotidase domain containing 2
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of NT5DC2 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr16:6,322,485...6,330,538
Ensembl chr16:6,328,523...6,336,980
|
|
G
|
Ntn4
|
netrin 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NTN4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:28,186,611...28,300,390
Ensembl chr 7:30,073,333...30,188,309
|
|
G
|
Nup210
|
nucleoporin 210
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NUP210 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:123,511,558...123,609,874
Ensembl chr 4:125,068,736...125,167,047
|
|
G
|
Nxf3
|
nuclear RNA export factor 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NXF3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr X:99,025,901...99,050,409
Ensembl chr X:103,818,542...103,830,872
|
|
G
|
Ocln
|
occludin
|
multiple interactions decreases expression
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of OCLN protein; CP protein inhibits the reaction [butylbenzyl phthalate results in decreased expression of OCLN protein]; Deferoxamine inhibits the reaction [butylbenzyl phthalate results in decreased expression of OCLN protein]; ferrostatin-1 inhibits the reaction [butylbenzyl phthalate results in decreased expression of OCLN protein] butylbenzyl phthalate results in decreased expression of OCLN mRNA; butylbenzyl phthalate results in decreased expression of OCLN protein
|
CTD |
PMID:37364641 PMID:39921026 |
|
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411
|
|
G
|
Olfm1
|
olfactomedin 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of OLFM1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 3:11,520,522...11,558,240
Ensembl chr 3:31,918,573...31,956,260
|
|
G
|
Olfml3
|
olfactomedin-like 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OLFML3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:193,932,665...193,935,494
|
|
G
|
Omd
|
osteomodulin
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of OMD mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr17:15,060,217...15,068,441
Ensembl chr17:15,266,646...15,274,870
|
|
G
|
Oprl1
|
opioid related nociceptin receptor 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OPRL1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:189,212,175...189,217,426
|
|
G
|
Osgin2
|
oxidative stress induced growth inhibitor family member 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OSGIN2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:29,500,406...29,519,340
Ensembl chr 5:34,297,417...34,316,931
|
|
G
|
Oxt
|
oxytocin/neurophysin I prepropeptide
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of OXT mRNA
|
CTD |
PMID:32518293 |
|
NCBI chr 3:138,235,754...138,236,594
Ensembl chr 3:138,235,754...138,236,594
|
|
G
|
Oxtr
|
oxytocin receptor
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of OXTR mRNA
|
CTD |
PMID:32518293 |
|
NCBI chr 4:147,154,374...147,171,723
Ensembl chr 4:147,154,374...147,170,750
|
|
G
|
P4ha2
|
prolyl 4-hydroxylase subunit alpha 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of P4HA2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:38,243,136...38,271,983
Ensembl chr10:38,743,894...38,772,993
|
|
G
|
Palmd
|
palmdelphin
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:207,574,249...207,626,239
|
|
G
|
Papss2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PAPSS2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:239,867,597...239,952,614
Ensembl chr 1:239,867,574...239,952,616
|
|
G
|
Pcca
|
propionyl-CoA carboxylase subunit alpha
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PCCA mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr15:99,627,955...99,969,555
Ensembl chr15:106,034,610...106,374,908
|
|
G
|
Pcdhga11
|
protocadherin gamma subfamily A, 11
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PCDHGA11 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr18:29,583,373...29,667,865
|
|
G
|
Pck1
|
phosphoenolpyruvate carboxykinase 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of PCK1 mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561
|
|
G
|
Pcna
|
proliferating cell nuclear antigen
|
multiple interactions increases expression
|
ISO
|
MIR19A mRNA affects the reaction [butylbenzyl phthalate results in increased expression of PCNA protein]; MIR19B1 mRNA affects the reaction [butylbenzyl phthalate results in increased expression of PCNA protein]; MIR34A mRNA inhibits the reaction [butylbenzyl phthalate results in increased expression of PCNA protein] butylbenzyl phthalate results in increased expression of PCNA mRNA; butylbenzyl phthalate results in increased expression of PCNA protein
|
CTD |
PMID:29864457 PMID:30243731 PMID:31016752 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
G
|
Pcp4
|
Purkinje cell protein 4
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PCP4 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr11:35,759,711...35,861,725
Ensembl chr11:49,270,186...49,331,186
|
|
G
|
Pcsk1n
|
proprotein convertase subtilisin/kexin type 1 inhibitor
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PCSK1N mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr X:17,251,963...17,255,405
Ensembl chr X:17,251,965...17,257,360
|
|
G
|
Pcsk2
|
proprotein convertase subtilisin/kexin type 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PCSK2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:151,333,938...151,636,628
Ensembl chr 3:151,333,234...151,638,849
|
|
G
|
Pcsk5
|
proprotein convertase subtilisin/kexin type 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PCSK5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:214,837,847...215,267,626
Ensembl chr 1:224,264,678...224,694,347
|
|
G
|
Pcsk9
|
proprotein convertase subtilisin/kexin type 9
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of PCSK9 protein
|
CTD |
PMID:38954831 |
|
NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507
|
|
G
|
Pcyt1a
|
phosphate cytidylyltransferase 1A, choline
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PCYT1A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr11:68,313,860...68,357,828
Ensembl chr11:81,819,285...81,862,395
|
|
G
|
Pde1b
|
phosphodiesterase 1B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDE1B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:134,627,378...134,654,581
Ensembl chr 7:136,505,689...136,533,033
|
|
G
|
Pde3a
|
phosphodiesterase 3A
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDE3A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:175,904,276...176,170,531
Ensembl chr 4:175,904,077...176,169,270
|
|
G
|
Pde3b
|
phosphodiesterase 3B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDE3B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:168,606,762...168,770,078
Ensembl chr 1:178,041,207...178,204,503
|
|
G
|
Pde4b
|
phosphodiesterase 4B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDE4B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:122,135,174...122,598,267
|
|
G
|
Pde4d
|
phosphodiesterase 4D
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDE4D mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:42,110,838...43,262,569
|
|
G
|
Pdgfb
|
platelet derived growth factor subunit B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in increased secretion of PDGFB protein
|
CTD |
PMID:38954831 |
|
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343
|
|
G
|
Pdgfc
|
platelet derived growth factor C
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDGFC mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:166,316,870...166,493,449
Ensembl chr 2:168,614,353...168,791,573
|
|
G
|
Pdia3
|
protein disulfide isomerase family A, member 3
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of PDIA3 mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:128,841,917...128,867,327
|
|
G
|
Pdk3
|
pyruvate dehydrogenase kinase 3
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of PDK3 mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr X:58,486,699...58,553,533
Ensembl chr X:62,480,535...62,547,371
|
|
G
|
Pdk4
|
pyruvate dehydrogenase kinase 4
|
increases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in increased expression of PDK4 protein [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of PDK4 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of PDK4 mRNA butylbenzyl phthalate results in increased expression of and results in increased stability of PDK4 mRNA
|
CTD |
PMID:31629899 PMID:37364641 PMID:39150890 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:34,556,330...34,568,381
|
|
G
|
Pdp2
|
pyruvate dehydrogenase phosphatase catalytic subunit 2
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of PDP2 mRNA
|
CTD |
PMID:31629899 |
|
NCBI chr19:386,408...394,068
Ensembl chr19:392,183...400,902
|
|
G
|
Pdzrn3
|
PDZ domain containing RING finger 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:133,770,736...133,996,959
Ensembl chr 4:135,327,082...135,553,294
|
|
G
|
Per1
|
period circadian regulator 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PER1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:54,302,641...54,314,211
|
|
G
|
Pex5l
|
peroxisomal biogenesis factor 5-like
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PEX5L mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:117,623,199...117,836,772
Ensembl chr 2:117,623,199...117,836,685
|
|
G
|
Pfkp
|
phosphofructokinase, platelet
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of PFKP mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:68,639,481...68,705,752
|
|
G
|
Pfn2
|
profilin 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PFN2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:144,217,100...144,222,936
Ensembl chr 2:144,205,636...144,222,936
|
|
G
|
Pgam1
|
phosphoglycerate mutase 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of PGAM1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of PGAM1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of PGAM1 protein
|
CTD |
PMID:30698749 PMID:37364641 |
|
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:250,673,049...250,690,203
|
|
G
|
Pgp
|
phosphoglycolate phosphatase
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of PGP mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr10:13,495,232...13,497,858
Ensembl chr10:13,999,331...14,002,408
|
|
G
|
Pgr
|
progesterone receptor
|
increases expression multiple interactions
|
EXP ISO
|
butylbenzyl phthalate results in increased expression of PGR mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PGR mRNA]; Cyclic AMP inhibits the reaction [[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PGR mRNA]] [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PGR mRNA]
|
CTD |
PMID:11474214 PMID:33316053 PMID:35307500 PMID:37552060 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:14,354,398...14,413,271
|
|
G
|
Phc3
|
polyhomeotic homolog 3
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of PHC3 mRNA
|
CTD |
PMID:39921026 |
|
NCBI chr 2:112,408,709...112,483,719
Ensembl chr 2:114,337,227...114,405,816
|
|
G
|
Phospho1
|
phosphoethanolamine/phosphocholine phosphatase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PHOSPHO1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:80,762,062...80,769,596
Ensembl chr10:81,257,427...81,268,481
|
|
G
|
Phtf1
|
putative homeodomain transcription factor 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PHTF1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:191,470,849...191,537,399
Ensembl chr 2:194,161,000...194,219,530
|
|
G
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of PIK3R1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of PIK3R1 protein
|
CTD |
PMID:35739755 PMID:37364641 |
|
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
|
|
G
|
Pkhd1l1
|
PKHD1 like 1
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of PKHD1L1 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 7:75,620,384...75,795,335
Ensembl chr 7:77,505,152...77,679,994
|
|
G
|
Pklr
|
pyruvate kinase L/R
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of PKLR mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:176,840,764...176,849,644
|
|
G
|
Plac8
|
placenta associated 8
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of PLAC8 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr14:9,052,601...9,074,264
Ensembl chr14:9,356,972...9,378,572
|
|
G
|
Plat
|
plasminogen activator, tissue type
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PLAT mRNA]
|
CTD |
PMID:33316053 |
|
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
G
|
Plau
|
plasminogen activator, urokinase
|
increases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in increased expression of PLAU protein [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLAU mRNA
|
CTD |
PMID:33965509 PMID:39150890 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
G
|
Plcl2
|
phospholipase C-like 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLCL2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:3,292,564...3,477,009
Ensembl chr 9:3,529,841...3,713,712
|
|
G
|
Plin1
|
perilipin 1
|
multiple interactions increases expression
|
ISO
|
[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PLIN1 protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of PLIN1 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of PLIN1 mRNA butylbenzyl phthalate results in increased expression of PLIN1 protein
|
CTD |
PMID:26820058 PMID:34520170 PMID:37021957 PMID:39150890 |
|
NCBI chr 1:133,664,294...133,676,854
Ensembl chr 1:143,074,214...143,086,206
|
|
G
|
Plin2
|
perilipin 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLIN2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:106,202,634...106,258,878
|
|
G
|
Plin5
|
perilipin 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLIN5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:939,745...946,188
Ensembl chr 9:1,026,307...1,033,284
|
|
G
|
Plpp3
|
phospholipid phosphatase 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:125,155,945...125,235,667
|
|
G
|
Plpp7
|
phospholipid phosphatase 7 (inactive)
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP7 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:15,384,461...15,398,820
Ensembl chr 3:35,782,204...35,796,575
|
|
G
|
Plppr3
|
phospholipid phosphatase related 3
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PLPPR3 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 7:10,481,624...10,493,059
Ensembl chr 7:10,481,636...10,495,921
|
|
G
|
Pls1
|
plastin 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PLS1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 8:96,316,703...96,426,592
Ensembl chr 8:105,197,455...105,292,447
|
|
G
|
Pltp
|
phospholipid transfer protein
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of PLTP mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:173,994,162...174,012,505
|
|
G
|
Plxnc1
|
plexin C1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLXNC1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:29,390,038...29,543,985
Ensembl chr 7:31,276,978...31,431,092
|
|
G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
affects binding multiple interactions
|
ISO
|
butylbenzyl phthalate binds to PPARA protein [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PPARA mRNA
|
CTD |
PMID:23843199 PMID:28013214 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
G
|
Ppard
|
peroxisome proliferator-activated receptor delta
|
affects binding
|
ISO
|
butylbenzyl phthalate binds to PPARB protein
|
CTD |
PMID:23843199 |
|
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,352,183...6,365,707
|
|
G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
affects binding multiple interactions increases activity increases expression
|
ISO EXP
|
butylbenzyl phthalate binds to PPARG protein [Dietary Fats co-treated with diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PPARG mRNA butylbenzyl phthalate results in increased activity of PPARG protein butylbenzyl phthalate results in increased expression of PPARG mRNA [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG mRNA; [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG protein; butylbenzyl phthalate binds to and results in increased activity of PPARG protein; butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]; Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]; PPARG protein promotes the reaction [butylbenzyl phthalate binds to and results in increased activity of PPARG protein] butylbenzyl phthalate binds to and results in increased activity of PPARG protein; butylbenzyl phthalate inhibits the reaction [GW 1929 binds to PPARG protein]
|
CTD |
PMID:23843199 PMID:24155963 PMID:26172262 PMID:26820058 PMID:27923775 PMID:28595985 PMID:30599393 PMID:31016361 PMID:32407875 PMID:33049310 PMID:34520170 More...
|
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
decreases expression multiple interactions affects expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of PPARGC1A mRNA [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of PPARGC1A mRNA butylbenzyl phthalate affects the expression of PPARGC1A mRNA
|
CTD |
PMID:26520405 PMID:27923775 PMID:37021957 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
G
|
Ppp2r2b
|
protein phosphatase 2, regulatory subunit B, beta
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PPP2R2B mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr18:34,653,716...35,080,889
Ensembl chr18:34,904,686...35,356,977
|
|
G
|
Prdm1
|
PR/SET domain 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PRDM1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr20:49,542,465...49,564,088
Ensembl chr20:49,542,465...49,564,088
|
|
G
|
Prg4
|
proteoglycan 4
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of PRG4 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr13:62,487,257...62,504,657
Ensembl chr13:65,037,363...65,054,508
|
|
G
|
Prima1
|
proline rich membrane anchor 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PRIMA1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 6:122,338,365...122,390,955
Ensembl chr 6:128,103,175...128,154,865
|
|
G
|
Prkar2b
|
protein kinase cAMP-dependent type II regulatory subunit beta
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PRKAR2B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:48,563,659...48,653,933
Ensembl chr 6:54,291,151...54,381,411
|
|
G
|
Prkd1
|
protein kinase D1
|
multiple interactions
|
ISO
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of PRKD1 protein
|
CTD |
PMID:38995844 |
|
NCBI chr 6:73,460,640...73,774,433
Ensembl chr 6:73,460,640...73,836,509
|
|
G
|
Procr
|
protein C receptor
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PROCR mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:164,711,636...164,718,989
|
|
G
|
Prpf8
|
pre-mRNA processing factor 8
|
multiple interactions
|
ISO
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of PRPF8 protein
|
CTD |
PMID:38995844 |
|
NCBI chr10:60,331,494...60,354,606
Ensembl chr10:60,829,778...60,852,887
|
|
G
|
Prph
|
peripherin
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PRPH mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 7:130,218,149...130,222,136
Ensembl chr 7:132,097,285...132,101,068
|
|
G
|
Prss23
|
serine protease 23
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PRSS23 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:143,402,725...143,422,182
Ensembl chr 1:152,813,670...152,947,871
|
|
G
|
Prxl2a
|
peroxiredoxin like 2A
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PRXL2A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:16,866,601...16,886,378
Ensembl chr16:16,900,699...16,920,561
|
|
G
|
Psmb4
|
proteasome 20S subunit beta 4
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of PSMB4 mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr 2:185,131,787...185,134,561
Ensembl chr 2:185,131,786...185,135,287
|
|
G
|
Pten
|
phosphatase and tensin homolog
|
decreases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in decreased expression of PTEN mRNA; butylbenzyl phthalate results in decreased expression of PTEN protein MIR19A mRNA affects the reaction [butylbenzyl phthalate results in decreased expression of PTEN protein]; MIR19B1 mRNA affects the reaction [butylbenzyl phthalate results in decreased expression of PTEN protein]
|
CTD |
PMID:29864457 |
|
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
|
|
G
|
Ptger1
|
prostaglandin E receptor 1
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of PTGER1 mRNA
|
CTD |
PMID:36746855 |
|
NCBI chr19:24,470,258...24,473,687
Ensembl chr19:41,374,471...41,378,284
|
|
G
|
Ptger2
|
prostaglandin E receptor 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PTGER2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:20,696,013...20,708,950
|
|
G
|
Ptges
|
prostaglandin E synthase
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PTGES mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 3:14,177,892...14,189,236
Ensembl chr 3:34,575,639...34,586,995
|
|
G
|
Ptgr1
|
prostaglandin reductase 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PTGR1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:78,579,057...78,597,811
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions increases expression
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PTGS2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PTGS2 mRNA; CP protein inhibits the reaction [butylbenzyl phthalate results in increased expression of PTGS2 protein]; Deferoxamine inhibits the reaction [butylbenzyl phthalate results in increased expression of PTGS2 protein]; ferrostatin-1 inhibits the reaction [butylbenzyl phthalate results in increased expression of PTGS2 protein] butylbenzyl phthalate results in increased expression of PTGS2 mRNA; butylbenzyl phthalate results in increased expression of PTGS2 protein
|
CTD |
PMID:33316053 PMID:39150890 PMID:39921026 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Ptk2
|
protein tyrosine kinase 2
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of PTK2 protein
|
CTD |
PMID:37364641 |
|
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:107,015,733...107,172,091
|
|
G
|
Ptpn5
|
protein tyrosine phosphatase, non-receptor type 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PTPN5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:106,756,896...106,816,828
|
|
G
|
Ptprn
|
protein tyrosine phosphatase, receptor type, N
|
multiple interactions
|
EXP ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PTPRN mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PTPRN mRNA
|
CTD |
PMID:31199487 PMID:39150890 |
|
NCBI chr 9:76,741,010...76,756,704
Ensembl chr 9:84,189,676...84,204,850
|
|
G
|
Ptx3
|
pentraxin 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PTX3 mRNA] [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of PTX3 protein
|
CTD |
PMID:37552060 PMID:38954831 |
|
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:152,781,955...152,803,372
|
|
G
|
Pygm
|
glycogen phosphorylase, muscle associated
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of PYGM mRNA
|
CTD |
PMID:39921026 |
|
NCBI chr 1:213,119,805...213,134,622
Ensembl chr 1:213,119,791...213,134,612
|
|
G
|
Qsox1
|
quiescin sulfhydryl oxidase 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of QSOX1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr13:70,500,060...70,537,711
Ensembl chr13:70,500,060...70,537,733
|
|
G
|
Rab3b
|
RAB3B, member RAS oncogene family
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB3B mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB3B protein
|
CTD |
PMID:31199487 PMID:37690569 |
|
NCBI chr 5:123,629,562...123,697,410
Ensembl chr 5:128,841,716...128,926,086
|
|
G
|
Rab6b
|
RAB6B, member RAS oncogene family
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB6B mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB6B protein
|
CTD |
PMID:31199487 PMID:37690569 |
|
NCBI chr 8:112,574,223...112,642,911
Ensembl chr 8:112,574,167...112,642,907
|
|
G
|
Ralgds
|
ral guanine nucleotide dissociation stimulator
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RALGDS mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:32,237,644...32,278,045
Ensembl chr 3:32,237,786...32,278,045
|
|
G
|
Ramp1
|
receptor activity modifying protein 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RAMP1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:91,765,481...91,816,152
|
|
G
|
Rarg
|
retinoic acid receptor, gamma
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RARG mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:135,246,427...135,268,889
Ensembl chr 7:135,246,427...135,268,889
|
|
G
|
Rarres2
|
retinoic acid receptor responder 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of RARRES2 protein
|
CTD |
PMID:38954831 |
|
NCBI chr 4:78,853,450...78,856,652
Ensembl chr 4:78,853,453...78,856,457
|
|
G
|
Rasgef1b
|
RasGEF domain family, member 1B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RASGEF1B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr14:9,859,512...10,380,044
Ensembl chr14:10,644,521...10,697,296
|
|
G
|
Rasl11b
|
RAS-like family 11 member B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RASL11B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr14:34,014,924...34,019,146
Ensembl chr14:34,368,726...34,373,250
|
|
G
|
Rassf4
|
Ras association domain family member 4
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RASSF4 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 4:149,897,525...149,932,658
Ensembl chr 4:151,569,984...151,604,883
|
|
G
|
Rbp4
|
retinol binding protein 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of RBP4 protein
|
CTD |
PMID:38954831 |
|
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:245,306,349...245,313,898
|
|
G
|
Rbpms
|
RNA binding protein, mRNA processing factor
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RBPMS mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:58,239,370...58,395,424
Ensembl chr16:64,942,530...65,098,503
|
|
G
|
Rcan2
|
regulator of calcineurin 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RCAN2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:24,456,861...24,674,234
Ensembl chr 9:24,456,861...24,672,189
|
|
G
|
Resp18
|
regulated endocrine-specific protein 18
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RESP18 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 9:76,765,179...76,771,824
Ensembl chr 9:84,213,467...84,221,299
|
|
G
|
Retsat
|
retinol saturase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RETSAT mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:106,211,459...106,220,222
Ensembl chr 4:106,211,436...106,229,552
|
|
G
|
Rgs1
|
regulator of G-protein signaling 1
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of RGS1 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:58,568,844...58,573,187
|
|
G
|
Rgs16
|
regulator of G-protein signaling 16
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of RGS16 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr13:68,421,480...68,443,312
Ensembl chr13:68,438,120...68,443,313
|
|
G
|
Rgs2
|
regulator of G-protein signaling 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of RGS2 mRNA] [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RGS2 mRNA
|
CTD |
PMID:37552060 PMID:39150890 |
|
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:58,349,163...58,352,697
|
|
G
|
Rgs4
|
regulator of G-protein signaling 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RGS4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr13:84,469,593...84,475,884
Ensembl chr13:84,469,593...84,475,884
|
|
G
|
Rnf125
|
ring finger protein 125
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RNF125 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr18:12,528,995...12,550,646
Ensembl chr18:12,528,838...12,554,430
|
|
G
|
Rnf145
|
ring finger protein 145
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RNF145 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:29,006,391...29,050,788
Ensembl chr10:29,507,772...29,552,151
|
|
G
|
Rnf183
|
ring finger protein 183
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of RNF183 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 5:75,877,111...75,886,253
Ensembl chr 5:80,892,190...80,902,196
|
|
G
|
Rnps1
|
RNA binding protein with serine rich domain 1
|
multiple interactions
|
ISO
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of RNPS1 protein
|
CTD |
PMID:38995844 |
|
NCBI chr10:13,445,516...13,455,858
Ensembl chr10:13,950,184...13,960,393
|
|
G
|
Rps2
|
ribosomal protein S2
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of RPS2 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr10:13,747,316...13,749,165
Ensembl chr10:14,251,380...14,253,695
|
|
G
|
Rras2
|
RAS related 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RRAS2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:177,668,144...177,737,551
|
|
G
|
Rrm2
|
ribonucleotide reductase regulatory subunit M2
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of RRM2 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:47,067,690...47,075,370
|
|
G
|
Rtn1
|
reticulon 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RTN1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 6:96,499,137...96,719,340
Ensembl chr 6:96,499,134...96,719,340
|
|
G
|
Rtn4r
|
reticulon 4 receptor
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RTN4R mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr11:96,348,613...96,373,554
Ensembl chr11:96,348,502...96,373,554
|
|
G
|
Rtraf
|
RNA transcription, translation and transport factor
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of RTRAF mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr15:4,447,243...4,457,973
Ensembl chr15:4,480,966...4,507,115
|
|
G
|
Rxra
|
retinoid X receptor alpha
|
affects binding
|
ISO
|
butylbenzyl phthalate binds to RXRA protein
|
CTD |
PMID:23843199 |
|
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:31,388,223...31,474,417
|
|
G
|
Rxrb
|
retinoid X receptor beta
|
affects binding
|
ISO
|
butylbenzyl phthalate binds to RXRB protein
|
CTD |
PMID:23843199 |
|
NCBI chr20:4,818,707...4,824,968
Ensembl chr20:4,818,709...4,825,359
|
|
G
|
Rxrg
|
retinoid X receptor gamma
|
affects binding
|
ISO
|
butylbenzyl phthalate binds to RXRG protein
|
CTD |
PMID:23843199 |
|
NCBI chr13:82,276,330...82,318,097
Ensembl chr13:82,276,291...82,318,095
|
|
G
|
S100a6
|
S100 calcium binding protein A6
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of S100A6 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 2:178,398,189...178,399,763
Ensembl chr 2:178,398,481...178,399,762
|
|
G
|
Samd4b
|
sterile alpha motif domain containing 4B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SAMD4B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:83,689,413...83,728,652
Ensembl chr 1:92,809,800...92,841,393
|
|
G
|
Scara5
|
scavenger receptor class A, member 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SCARA5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr15:39,880,017...39,985,007
Ensembl chr15:44,055,630...44,160,585
|
|
G
|
Scarb1
|
scavenger receptor class B, member 1
|
decreases expression multiple interactions
|
EXP ISO
|
butylbenzyl phthalate results in decreased expression of SCARB1 mRNA; butylbenzyl phthalate results in decreased expression of SCARB1 protein [dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of SCARB1 mRNA
|
CTD |
PMID:26472102 PMID:31319113 PMID:33983380 PMID:35739735 |
|
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980
|
|
G
|
Scd
|
stearoyl-CoA desaturase
|
multiple interactions
|
ISO EXP
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of SCD1 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of SCD mRNA
|
CTD |
PMID:31240115 PMID:35739755 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:253,218,970...253,231,785
|
|
G
|
Scd3
|
stearoyl-coenzyme A desaturase 3
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of SCD3 mRNA
|
CTD |
PMID:36756972 |
|
NCBI chr 1:243,093,057...243,114,451
Ensembl chr 1:253,023,722...253,062,382
|
|
G
|
Scd4
|
stearoyl-coenzyme A desaturase 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SCD4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:243,203,433...243,216,007
Ensembl chr 1:253,139,826...253,165,235
|
|
G
|
Scg3
|
secretogranin III
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SCG3 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 8:76,399,777...76,442,015
Ensembl chr 8:85,280,253...85,361,874
|
|
G
|
Scg5
|
secretogranin V
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SCG5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:100,544,101...100,588,558
Ensembl chr 3:120,998,420...121,042,795
|
|
G
|
Scgn
|
secretagogin, EF-hand calcium binding protein
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SCGN mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr17:41,106,681...41,148,656
Ensembl chr17:41,534,497...41,576,522
|
|
G
|
Scn3b
|
sodium voltage-gated channel beta subunit 3
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SCN3B mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 8:40,630,372...40,652,869
Ensembl chr 8:49,527,577...49,550,018
|
|
G
|
Scrn1
|
secernin 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SCRN1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 4:83,632,125...83,694,225
Ensembl chr 4:84,965,751...85,031,205
|
|
G
|
Selenop
|
selenoprotein P
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SELENOP mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:54,225,152...54,236,019
|
|
G
|
Sema7a
|
semaphorin 7A (John Milton Hagen blood group)
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SEMA7A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 8:67,244,318...67,267,060
Ensembl chr 8:67,243,824...67,267,058
|
|
G
|
Serpinb1a
|
serpin family B member 1A
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SERPINB1A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,799,415...31,808,166
|
|
G
|
Serpinb2
|
serpin family B member 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINB2 mRNA]
|
CTD |
PMID:33316053 |
|
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:24,056,021...24,065,031
|
|
G
|
Serpine1
|
serpin family E member 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINE1 mRNA]
|
CTD |
PMID:33316053 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:25,237,952...25,248,357
|
|
G
|
Serpinf1
|
serpin family F member 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of SERPINF1 protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SERPINF1 mRNA
|
CTD |
PMID:38954831 PMID:39150890 |
|
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,748,506...60,760,898
|
|
G
|
Sf3b1
|
splicing factor 3b, subunit 1
|
multiple interactions
|
ISO
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of SF3B1 protein
|
CTD |
PMID:38995844 |
|
NCBI chr 9:63,986,829...64,026,723
Ensembl chr 9:63,986,829...64,026,719
|
|
G
|
Sfrp1
|
secreted frizzled-related protein 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SFRP1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:75,278,325...75,316,736
Ensembl chr16:75,278,325...75,316,736
|
|
G
|
Sfrp2
|
secreted frizzled-related protein 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SFRP2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:171,387,385...171,395,079
|
|
G
|
Sh3bp4
|
SH3-domain binding protein 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SH3BP4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 9:89,660,156...89,739,163
Ensembl chr 9:97,107,877...97,186,878
|
|
G
|
Sh3bp5
|
SH3-domain binding protein 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SH3BP5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:6,583,462...6,678,344
Ensembl chr16:6,589,877...6,655,211
|
|
G
|
Sh3bp5l
|
SH3 binding domain protein 5 like
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SH3BP5L mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:42,512,437...42,529,564
Ensembl chr10:43,012,969...43,027,320
|
|
G
|
Sh3gl3
|
SH3 domain containing GRB2 like 3, endophilin A3
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SH3GL3 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:136,124,500...136,255,669
Ensembl chr 1:145,533,728...145,664,881
|
|
G
|
Sh3tc2
|
SH3 domain and tetratricopeptide repeats 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SH3TC2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr18:55,416,383...55,477,419
Ensembl chr18:57,686,735...57,800,541
|
|
G
|
Shbg
|
sex hormone binding globulin
|
affects binding
|
ISO
|
butylbenzyl phthalate binds to SHBG protein
|
CTD |
PMID:25349334 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,831,718...54,838,760
|
|
G
|
Shc2
|
SHC adaptor protein 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SHC2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 7:10,066,705...10,088,926
Ensembl chr 7:10,717,320...10,739,539
|
|
G
|
Sik1
|
salt-inducible kinase 1
|
multiple interactions increases expression
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SIK1 mRNA butylbenzyl phthalate results in increased expression of SIK1 mRNA
|
CTD |
PMID:32308655 PMID:39150890 |
|
NCBI chr20:9,947,104...9,958,729
Ensembl chr20:9,947,105...9,958,698
|
|
G
|
Sirt1
|
sirtuin 1
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of SIRT1 mRNA; butylbenzyl phthalate results in decreased expression of SIRT1 protein
|
CTD |
PMID:26520405 PMID:27923775 PMID:34520170 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
G
|
Sirt3
|
sirtuin 3
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of SIRT3 mRNA; butylbenzyl phthalate results in decreased expression of SIRT3 protein
|
CTD |
PMID:26520405 PMID:27923775 PMID:34520170 |
|
NCBI chr 1:205,371,703...205,394,145
Ensembl chr 1:205,371,710...205,394,076
|
|
G
|
Sirt7
|
sirtuin 7
|
decreases expression affects expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of SIRT7 mRNA butylbenzyl phthalate affects the expression of SIRT7 mRNA
|
CTD |
PMID:27923775 PMID:31016965 |
|
NCBI chr10:106,394,802...106,401,627
Ensembl chr10:106,394,802...106,401,498
|
|
G
|
Six4
|
SIX homeobox 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SIX4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:91,802,328...91,816,002
Ensembl chr 6:97,538,202...97,551,872
|
|
G
|
Slain1
|
SLAIN motif family, member 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLAIN1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr15:86,897,476...86,957,113
Ensembl chr15:86,897,476...86,957,113
|
|
G
|
Slc12a2
|
solute carrier family 12 member 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC12A2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470
|
|
G
|
Slc12a7
|
solute carrier family 12 member 7
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC12A7 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:29,472,692...29,554,246
Ensembl chr 1:31,301,243...31,382,957
|
|
G
|
Slc13a2
|
solute carrier family 13 member 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SLC13A2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr10:63,291,813...63,319,127
Ensembl chr10:63,789,876...63,817,184
|
|
G
|
Slc13a5
|
solute carrier family 13 member 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC13A5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:57,364,806...57,389,500
Ensembl chr10:57,364,806...57,389,516
|
|
G
|
Slc16a3
|
solute carrier family 16 member 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC16A3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:106,712,328...106,756,168
Ensembl chr10:106,714,466...106,720,903
|
|
G
|
Slc16a6
|
solute carrier family 16, member 6
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC16A6 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:94,923,888...94,946,990
Ensembl chr10:94,923,888...94,947,965
|
|
G
|
Slc1a5
|
solute carrier family 1 member 5
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC1A5 mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:86,584,949...86,599,054
|
|
G
|
Slc1a6
|
solute carrier family 1 member 6
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC1A6 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:10,841,836...10,870,424
Ensembl chr 7:11,492,422...11,553,997
|
|
G
|
Slc20a1
|
solute carrier family 20 member 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC20A1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:136,880,290...136,894,249
|
|
G
|
Slc24a3
|
solute carrier family 24 member 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC24A3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:132,552,119...133,051,192
Ensembl chr 3:153,004,987...153,504,497
|
|
G
|
Slc25a15
|
solute carrier family 25 member 15
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A15 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:69,631,581...69,654,869
Ensembl chr16:76,324,288...76,357,321
|
|
G
|
Slc25a51
|
solute carrier family 25, member 51
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A51 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:59,649,980...59,663,454
Ensembl chr 5:64,443,616...64,459,462
|
|
G
|
Slc27a1
|
solute carrier family 27 member 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC27A1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:18,278,984...18,300,173
Ensembl chr16:18,313,015...18,330,045
|
|
G
|
Slc27a4
|
solute carrier family 27 member 4
|
multiple interactions
|
EXP
|
[Dietary Fats co-treated with diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of SLC27A4 mRNA
|
CTD |
PMID:30599393 |
|
NCBI chr 3:33,472,903...33,485,824
Ensembl chr 3:33,472,903...33,485,824
|
|
G
|
Slc27a6
|
solute carrier family 27 member 6
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC27A6 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr18:52,040,241...52,099,622
Ensembl chr18:54,238,729...54,312,632
|
|
G
|
Slc29a4
|
solute carrier family 29 member 4
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SLC29A4 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr12:16,967,047...16,998,276
Ensembl chr12:16,967,047...16,988,338
|
|
G
|
Slc2a1
|
solute carrier family 2 member 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A1 mRNA
|
CTD |
PMID:37364641 |
|
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742
|
|
G
|
Slc2a2
|
solute carrier family 2 member 2
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of SLC2A2 mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467
|
|
G
|
Slc2a3
|
solute carrier family 2 member 3
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A3 protein
|
CTD |
PMID:37364641 |
|
NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:157,632,887...157,646,186
|
|
G
|
Slc36a2
|
solute carrier family 36 member 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC36A2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:39,278,002...39,306,082
Ensembl chr10:39,778,693...39,806,773
|
|
G
|
Slc38a3
|
solute carrier family 38, member 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC38A3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 8:117,202,534...117,220,310
Ensembl chr 8:117,202,536...117,218,630
|
|
G
|
Slc38a5
|
solute carrier family 38, member 5
|
multiple interactions decreases expression
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC38A5 mRNA butylbenzyl phthalate results in decreased expression of SLC38A5 mRNA
|
CTD |
PMID:32308655 PMID:39150890 |
|
NCBI chr X:16,885,701...16,894,470
Ensembl chr X:16,885,701...16,894,470
|
|
G
|
Slc5a5
|
solute carrier family 5 member 5
|
increases expression
|
ISO EXP
|
butylbenzyl phthalate results in increased expression of SLC5A5 mRNA
|
CTD |
PMID:16257484 |
|
NCBI chr16:18,580,705...18,590,692
Ensembl chr16:18,580,705...18,590,691
|
|
G
|
Slc5a7
|
solute carrier family 5 member 7
|
multiple interactions
|
EXP ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SLC5A7 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC5A7 mRNA
|
CTD |
PMID:31199487 PMID:39150890 |
|
NCBI chr 9:7,595,440...7,626,258
Ensembl chr 9:7,922,697...7,953,509
|
|
G
|
Slc6a7
|
solute carrier family 6 member 7
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC6A7 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr18:54,448,464...54,467,319
Ensembl chr18:56,718,849...56,737,702
|
|
G
|
Slc7a7
|
solute carrier family 7 member 7
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC7A7 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr15:31,792,122...31,852,732
Ensembl chr15:31,792,125...31,835,683
|
|
G
|
Slc7a8
|
solute carrier family 7 member 8
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC7A8 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr15:32,153,016...32,212,715
Ensembl chr15:32,153,018...32,212,715
|
|
G
|
Slc8a1
|
solute carrier family 8 member A1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC8A1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:18,946,798...19,287,964
|
|
G
|
Slco2a1
|
solute carrier organic anion transporter family, member 2a1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of SLCO2A1 mRNA]
|
CTD |
PMID:33316053 |
|
NCBI chr 8:112,467,739...112,551,923
Ensembl chr 8:112,467,160...112,551,921
|
|
G
|
Slfn2
|
schlafen family member 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLFN2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:67,953,322...67,959,659
Ensembl chr10:68,455,363...68,457,329
|
|
G
|
Slirp
|
SRA stem-loop interacting RNA binding protein
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of SLIRP mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 6:107,088,760...107,097,791
Ensembl chr 6:112,819,448...112,828,715
|
|
G
|
Slit3
|
slit guidance ligand 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLIT3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:20,075,929...20,660,704
Ensembl chr10:20,076,021...20,660,704
|
|
G
|
Smad7
|
SMAD family member 7
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SMAD7 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr18:71,263,508...71,291,849
Ensembl chr18:71,263,508...71,291,849
|
|
G
|
Smim24
|
small integral membrane protein 24
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SMIM24 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 7:8,313,369...8,316,498
Ensembl chr 7:8,964,107...8,967,234
|
|
G
|
Smpd3
|
sphingomyelin phosphodiesterase 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SMPD3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr19:51,072,209...51,155,639
Ensembl chr19:51,072,209...51,085,936
|
|
G
|
Snhg11
|
small nucleolar RNA host gene 11
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SNHG11 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 3:147,031,367...147,037,043
|
|
G
|
Snn
|
stannin
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SNN mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:4,572,933...4,581,606
Ensembl chr 1:82,440,586...82,441,390 Ensembl chr10:82,440,586...82,441,390
|
|
G
|
Snora50c
|
small nucleolar RNA, H/ACA box 50C
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNORA50C mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr10:91,435,570...91,435,702
Ensembl chr10:91,935,331...91,935,463
|
|
G
|
Snora64
|
small nucleolar RNA, H/ACA box 64
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNORA64 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr10:13,748,139...13,748,272
Ensembl chr10:14,252,671...14,252,804
|
|
G
|
Snora65
|
small nucleolar RNA, H/ACA box 65
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNORA65 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr 3:16,265,801...16,265,930
Ensembl chr 3:36,663,472...36,663,601
|
|
G
|
Snora72
|
small nucleolar RNA, H/ACA box 72
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNORA72 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr X:66,278,209...66,278,328
Ensembl chr X:70,318,225...70,318,344
|
|
G
|
Sntb1
|
syntrophin, beta 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SNTB1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:87,060,926...87,329,315
Ensembl chr 7:88,950,642...89,219,017
|
|
G
|
Soat1
|
sterol O-acyltransferase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SOAT1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr13:71,105,178...71,147,776
Ensembl chr13:71,105,178...71,147,672
|
|
G
|
Socs3
|
suppressor of cytokine signaling 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SOCS3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,690,976...103,704,825
|
|
G
|
Sod1
|
superoxide dismutase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of SOD1 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SOD1 mRNA
|
CTD |
PMID:28013214 PMID:39947446 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
G
|
Sohlh2
|
spermatogenesis and oogenesis specific basic helix-loop-helix 2
|
increases expression decreases expression multiple interactions
|
EXP
|
butylbenzyl phthalate results in increased expression of SOHLH2 mRNA butylbenzyl phthalate results in decreased expression of SOHLH2 protein 4-vinyl-1-cyclohexene dioxide inhibits the reaction [butylbenzyl phthalate results in increased expression of SOHLH2 mRNA]; [4-vinyl-1-cyclohexene dioxide co-treated with butylbenzyl phthalate] results in decreased expression of SOHLH2 protein
|
CTD |
PMID:29969652 |
|
NCBI chr 2:139,362,246...139,384,700
Ensembl chr 2:141,512,293...141,534,863
|
|
G
|
Sord
|
sorbitol dehydrogenase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SORD mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:129,638,302...129,686,100
|
|
G
|
Sox9
|
SRY-box transcription factor 9
|
decreases expression multiple interactions increases expression
|
EXP ISO
|
butylbenzyl phthalate results in decreased expression of SOX9 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SOX9 mRNA butylbenzyl phthalate results in increased expression of SOX9 mRNA; butylbenzyl phthalate results in increased expression of SOX9 protein
|
CTD |
PMID:26472102 PMID:31319113 PMID:39150890 |
|
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250
|
|
G
|
Sp1
|
Sp1 transcription factor
|
decreases expression multiple interactions
|
ISO
|
butylbenzyl phthalate results in decreased expression of SP1 mRNA [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of SP1 mRNA
|
CTD |
PMID:29029336 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:135,420,050...135,450,513
|
|
G
|
Spata13
|
spermatogenesis associated 13
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SPATA13 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr15:34,778,479...34,907,645
Ensembl chr15:38,810,386...39,083,755
|
|
G
|
Specc1
|
sperm antigen with calponin homology and coiled-coil domains 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SPECC1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:46,638,947...46,912,989
Ensembl chr10:47,138,398...47,412,319
|
|
G
|
Spp2
|
secreted phosphoprotein 2
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of SPP2 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr 9:89,006,858...89,026,676
Ensembl chr 9:96,454,957...96,474,452
|
|
G
|
Sqle
|
squalene epoxidase
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of SQLE mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SQLE mRNA
|
CTD |
PMID:35739755 PMID:39150890 |
|
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050
|
|
G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
multiple interactions increases phosphorylation
|
ISO
|
fulvestrant inhibits the reaction [butylbenzyl phthalate results in increased phosphorylation of SRC protein]
|
CTD |
PMID:22552774 |
|
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
G
|
Srd5a1
|
steroid 5 alpha-reductase 1
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of SRD5A1 mRNA
|
CTD |
PMID:19560483 |
|
NCBI chr 1:35,514,914...35,548,898
Ensembl chr 1:35,514,846...35,548,903
|
|
G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
multiple interactions
|
EXP ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of and affects the methylation of SREBF1 mRNA [butylbenzyl phthalate co-treated with Dietary Fats] results in increased activity of and results in increased localization of SREBF1 protein
|
CTD |
PMID:31240115 PMID:32905190 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
G
|
Srebf2
|
sterol regulatory element binding transcription factor 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of and results in increased methylation of SREBF2 mRNA
|
CTD |
PMID:31240115 |
|
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943
|
|
G
|
Srpx2
|
sushi-repeat-containing protein, X-linked 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SRPX2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr X:101,399,748...101,425,486
Ensembl chr X:101,399,853...101,425,484
|
|
G
|
Star
|
steroidogenic acute regulatory protein
|
decreases expression multiple interactions increases expression
|
EXP ISO
|
butylbenzyl phthalate results in decreased expression of STAR mRNA; butylbenzyl phthalate results in decreased expression of STAR protein [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of STAR mRNA] butylbenzyl phthalate results in increased expression of STAR mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of STAR mRNA; [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of STAR mRNA [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in increased expression of STAR mRNA; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] affects the expression of STAR mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STAR mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of STAR mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of STAR mRNA; [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of STAR mRNA; [dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in decreased expression of STAR mRNA
|
CTD |
PMID:19560483 PMID:26472102 PMID:28013214 PMID:29029336 PMID:30802670 PMID:31319113 PMID:33983380 PMID:34597818 PMID:35739735 PMID:35762964 PMID:37552060 PMID:37788136 PMID:37839492 PMID:38227285 PMID:39947446 More...
|
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
G
|
Stk32c
|
serine/threonine kinase 32C
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:193,900,718...193,981,723
Ensembl chr 1:203,330,325...203,411,325
|
|
G
|
Stmn4
|
stathmin 4
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STMN4 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr15:44,716,825...44,734,776
Ensembl chr15:44,716,880...44,742,086
|
|
G
|
Ston2
|
stonin 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of STON2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:110,567,485...110,676,376
Ensembl chr 6:116,298,198...116,407,092
|
|
G
|
Suclg2
|
succinate-CoA ligase GDP-forming subunit beta
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SUCLG2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:128,067,031...128,337,146
Ensembl chr 4:129,623,834...129,937,296
|
|
G
|
Sulf1
|
sulfatase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SULF1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:11,145,950...11,308,622
Ensembl chr 5:11,145,950...11,308,643
|
|
G
|
Susd2
|
sushi domain containing 2
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of SUSD2 mRNA
|
CTD |
PMID:32949613 |
|
NCBI chr20:13,017,516...13,024,820
Ensembl chr20:13,016,907...13,024,264
|
|
G
|
Svs5
|
seminal vesicle secretory protein 5
|
decreases expression
|
EXP
|
butylbenzyl phthalate results in decreased expression of SVS5 mRNA
|
CTD |
PMID:15728792 |
|
NCBI chr 3:152,996,146...152,997,756
Ensembl chr 3:173,415,521...173,417,131
|
|
G
|
Syt11
|
synaptotagmin 11
|
multiple interactions
|
EXP ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SYT11 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SYT11 mRNA
|
CTD |
PMID:31199487 PMID:39150890 |
|
NCBI chr 2:176,503,845...176,530,354
Ensembl chr 2:176,503,845...176,529,775
|
|
G
|
Syt5
|
synaptotagmin 5
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SYT5 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:78,320,034...78,327,750
Ensembl chr 1:78,320,034...78,327,746
|
|
G
|
Tbl1xr1
|
TBL1X/Y related 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TBL1XR1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:106,718,811...106,857,989
Ensembl chr 2:106,730,665...106,857,989
|
|
G
|
Tbx2
|
T-box transcription factor 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TBX2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr10:70,679,670...70,688,868
Ensembl chr10:71,177,082...71,186,275
|
|
G
|
Tcf21
|
transcription factor 21
|
increases expression decreases expression
|
EXP
|
butylbenzyl phthalate results in increased expression of TCF21 mRNA butylbenzyl phthalate results in decreased expression of TCF21 mRNA
|
CTD |
PMID:26472102 |
|
NCBI chr 1:22,701,353...22,704,212
Ensembl chr 1:24,520,481...24,523,348
|
|
G
|
Tcf23
|
transcription factor 23
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TCF23 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 6:31,117,839...31,126,575
Ensembl chr 6:31,120,127...31,125,878
|
|
G
|
Tcf4
|
transcription factor 4
|
multiple interactions
|
ISO
|
butylbenzyl phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]; HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]]; trichostatin A inhibits the reaction [butylbenzyl phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]]
|
CTD |
PMID:22552774 |
|
NCBI chr18:62,941,739...63,288,126
Ensembl chr18:65,216,849...65,558,401
|
|
G
|
Tchhl1
|
trichohyalin-like 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TCHHL1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:181,818,424...181,821,666
Ensembl chr 2:181,818,448...181,821,678
|
|
G
|
Tcp11x2
|
t-complex 11 family, X-linked 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TCP11X2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr X:98,591,191...98,640,800
Ensembl chr X:102,884,209...103,432,453
|
|
G
|
Tcte1
|
t-complex-associated testis expressed 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TCTE1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 9:15,463,573...15,482,258
Ensembl chr 9:22,961,176...22,970,391
|
|
G
|
Tdrp
|
testis development related protein
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TDRP mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:75,624,047...75,652,635
Ensembl chr16:82,314,220...82,354,861
|
|
G
|
Tfam
|
transcription factor A, mitochondrial
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of TFAM mRNA
|
CTD |
PMID:27923775 |
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,355,363...17,369,877
|
|
G
|
Tfap2a
|
transcription factor AP-2 alpha
|
affects localization multiple interactions
|
ISO
|
butylbenzyl phthalate affects the localization of TFAP2A protein [butylbenzyl phthalate promotes the reaction [TFAP2A protein binds to HDAC6 promoter]] which results in increased expression of HDAC6 mRNA; butylbenzyl phthalate promotes the reaction [TFAP2A protein binds to HDAC6 promoter]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [butylbenzyl phthalate affects the localization of TFAP2A protein]; RTKI cpd inhibits the reaction [butylbenzyl phthalate affects the localization of TFAP2A protein]; TFAP2A mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of HDAC6 protein]
|
CTD |
PMID:22552774 |
|
NCBI chr17:24,230,064...24,253,219
Ensembl chr17:24,229,910...24,253,219
|
|
G
|
Tff1
|
trefoil factor 1
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of TFF1 mRNA
|
CTD |
PMID:35307500 |
|
NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,237,095...9,240,956
|
|
G
|
Tfrc
|
transferrin receptor
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TFRC mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318
|
|
G
|
Tgfa
|
transforming growth factor alpha
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TGFA mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:120,175,593...120,258,339
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TGFB1 mRNA
|
CTD |
PMID:35739755 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Tgm2
|
transglutaminase 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TGM2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240
|
|
G
|
Thbs3
|
thrombospondin 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of THBS3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:176,919,549...176,931,357
Ensembl chr 2:176,919,230...176,931,357
|
|
G
|
Thbs4
|
thrombospondin 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of THBS4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:25,718,219...25,760,345
Ensembl chr 2:25,718,219...25,761,369
|
|
G
|
Thsd4
|
thrombospondin type 1 domain containing 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of THSD4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 8:60,384,636...60,984,419
Ensembl chr 8:69,284,646...69,917,342
|
|
G
|
Thsd7b
|
thrombospondin type 1 domain containing 7B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of THSD7B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr13:40,768,567...41,667,262
Ensembl chr13:43,320,891...44,218,785
|
|
G
|
Thy1
|
Thy-1 cell surface antigen
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of THY1 protein
|
CTD |
PMID:22552774 |
|
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:53,286,148...53,291,540
|
|
G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of TIMP1 mRNA]
|
CTD |
PMID:33316053 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
G
|
Tjp1
|
tight junction protein 1
|
multiple interactions decreases expression
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of TJP1 protein; CP protein inhibits the reaction [butylbenzyl phthalate results in decreased expression of TJP1 protein]; Deferoxamine inhibits the reaction [butylbenzyl phthalate results in decreased expression of TJP1 protein]; ferrostatin-1 inhibits the reaction [butylbenzyl phthalate results in decreased expression of TJP1 protein] butylbenzyl phthalate results in decreased expression of TJP1 mRNA; butylbenzyl phthalate results in decreased expression of TJP1 protein
|
CTD |
PMID:37364641 PMID:39921026 |
|
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158
|
|
G
|
Tlnrd1
|
talin rod domain containing 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TLNRD1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:137,864,340...137,866,359
Ensembl chr 1:147,178,456...147,283,303
|
|
G
|
Tmeff2
|
transmembrane protein with EGF-like and two follistatin-like domains 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEFF2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 9:57,937,873...58,225,372
Ensembl chr 9:57,937,873...58,225,372
|
|
G
|
Tmem130
|
transmembrane protein 130
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM130 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr12:9,837,055...9,862,843
Ensembl chr12:14,950,784...14,976,568
|
|
G
|
Tmem35a
|
transmembrane protein 35A
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM35A mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr X:101,796,623...101,807,471
Ensembl chr X:101,796,623...101,807,470
|
|
G
|
Tmem50b
|
transmembrane protein 50B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TMEM50B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr11:30,804,835...30,837,675
Ensembl chr11:44,290,807...44,323,607
|
|
G
|
Tmem63c
|
transmembrane protein 63c
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM63C mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 6:106,667,389...106,738,778
Ensembl chr 6:112,399,118...112,469,729
|
|
G
|
Tmsb15b2
|
thymosin beta 15B2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TMSB15B2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr X:105,090,980...105,093,094
Ensembl chr X:105,090,980...105,093,094
|
|
G
|
Tmx1
|
thioredoxin-related transmembrane protein 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TMX1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:88,960,691...88,971,744
Ensembl chr 6:94,696,358...94,708,618
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression
|
ISO
|
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of TNF mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of TNF protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of TNF protein; butylbenzyl phthalate inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of TNF mRNA]; Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of TNF mRNA]] butylbenzyl phthalate results in increased expression of TNF mRNA
|
CTD |
PMID:15256756 PMID:28595985 PMID:35739755 PMID:36746855 PMID:37364641 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Tnfaip3
|
TNF alpha induced protein 3
|
increases expression
|
ISO
|
butylbenzyl phthalate results in increased expression of TNFAIP3 mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979
|
|
G
|
Tnfaip6
|
TNF alpha induced protein 6
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TNFAIP6 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:56,911,252...56,930,796
|
|
G
|
Tnfrsf11b
|
TNF receptor superfamily member 11B
|
multiple interactions
|
ISO
|
butylbenzyl phthalate promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased secretion of TNFRSF11B protein] [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of TNFRSF11B protein
|
CTD |
PMID:31016361 PMID:38954831 |
|
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:87,456,319...87,485,075
|
|
G
|
Tob2
|
transducer of ERBB2, 2
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TOB2 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:113,362,703...113,371,423
Ensembl chr 7:115,239,895...115,258,155
|
|
G
|
Tor4a
|
torsin family 4, member A
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TOR4A mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 3:8,004,292...8,007,979
Ensembl chr 3:28,399,513...28,406,473
|
|
G
|
Tp53
|
tumor protein p53
|
increases methylation multiple interactions decreases expression
|
ISO
|
butylbenzyl phthalate results in increased methylation of TP53 promoter [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of and results in increased phosphorylation of TP53 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of TP53 mRNA butylbenzyl phthalate results in decreased expression of TP53 mRNA
|
CTD |
PMID:31016752 PMID:35487445 PMID:35739755 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Tpi1
|
triosephosphate isomerase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TPI1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:159,301,562...159,305,413
|
|
G
|
Traf3
|
Tnf receptor-associated factor 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TRAF3 mRNA
|
CTD |
PMID:39947446 |
|
NCBI chr 6:130,199,696...130,307,168
Ensembl chr 6:136,027,157...136,128,363
|
|
G
|
Trap1
|
TNF receptor-associated protein 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TRAP1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:11,464,882...11,498,931
Ensembl chr10:11,970,995...12,005,355
|
|
G
|
Trarg1
|
trafficking regulator of GLUT4 (SLC2A4) 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TRARG1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr10:61,521,107...61,541,494
Ensembl chr10:62,019,189...62,039,648
|
|
G
|
Trib1
|
tribbles pseudokinase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TRIB1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:93,095,973...93,117,480
|
|
G
|
Trim6
|
tripartite motif containing 6
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TRIM6 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:158,683,746...158,696,936
Ensembl chr 1:168,095,564...168,109,719
|
|
G
|
Trpc6
|
transient receptor potential cation channel, subfamily C, member 6
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TRPC6 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:14,043,877...14,149,304
|
|
G
|
Tslp
|
thymic stromal lymphopoietin
|
multiple interactions
|
ISO
|
[Dust results in increased abundance of butylbenzyl phthalate] which results in decreased methylation of TSLP promoter
|
CTD |
PMID:33836808 |
|
NCBI chr18:24,723,990...24,728,419
Ensembl chr18:24,720,257...24,728,420
|
|
G
|
Ttyh1
|
tweety family member 1
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TTYH1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:70,053,312...70,071,872
Ensembl chr 1:79,125,574...79,144,091
|
|
G
|
Ttyh3
|
tweety family member 3
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TTYH3 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr12:13,996,831...14,025,457
Ensembl chr12:19,110,824...19,139,371
|
|
G
|
Tubb2b
|
tubulin, beta 2B class IIb
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TUBB2B protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TUBB2B mRNA
|
CTD |
PMID:31199487 PMID:37690569 |
|
NCBI chr17:30,953,086...30,956,133
Ensembl chr17:30,952,923...30,955,990
|
|
G
|
Tubb3
|
tubulin, beta 3 class III
|
multiple interactions
|
EXP ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TUBB3 protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TUBB3 mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TUBB3 mRNA
|
CTD |
PMID:31199487 PMID:37690569 PMID:39150890 |
|
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:68,365,587...68,374,740
|
|
G
|
Tubb4a
|
tubulin, beta 4A class IVa
|
multiple interactions
|
EXP ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TUBB4A protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TUBB4A mRNA [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TUBB4A mRNA
|
CTD |
PMID:31199487 PMID:37690569 PMID:39150890 |
|
NCBI chr 9:2,004,836...2,012,281
Ensembl chr 9:2,004,840...2,012,286
|
|
G
|
Tubb4b
|
tubulin, beta 4B class IVb
|
decreases expression
|
ISO
|
butylbenzyl phthalate results in decreased expression of TUBB4B mRNA
|
CTD |
PMID:32308655 |
|
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:28,435,148...28,439,719
|
|
G
|
Txnip
|
thioredoxin interacting protein
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TXNIP mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731
|
|
G
|
Txnrd1
|
thioredoxin reductase 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TXNRD1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:22,719,317...22,739,817
|
|
G
|
Ubash3b
|
ubiquitin associated and SH3 domain containing, B
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of UBASH3B mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 8:41,385,419...41,532,248
Ensembl chr 8:50,285,431...50,326,351
|
|
G
|
Ubxn11
|
UBX domain protein 11
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of UBXN11 mRNA
|
CTD |
PMID:31199487 PMID:37690569 |
|
NCBI chr 5:146,329,666...146,353,529
Ensembl chr 5:151,613,565...151,637,272
|
|
G
|
Ucp1
|
uncoupling protein 1
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of UCP1 mRNA
|
CTD |
PMID:37021957 |
|
NCBI chr19:24,808,782...24,816,853
Ensembl chr19:41,713,351...41,721,420
|
|
G
|
Unc5d
|
unc-5 netrin receptor D
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of UNC5D mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr16:62,860,119...63,406,932
Ensembl chr16:69,563,212...70,104,078
|
|
G
|
Usp18
|
ubiquitin specific peptidase 18
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of USP18 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:156,143,815...156,171,292
|
|
G
|
Vamp5
|
vesicle-associated membrane protein 5
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of VAMP5 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:104,423,813...104,435,059
Ensembl chr 4:105,982,009...105,993,247
|
|
G
|
Vdac2
|
voltage-dependent anion channel 2
|
multiple interactions
|
ISO
|
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of VDAC2 mRNA
|
CTD |
PMID:30698749 |
|
NCBI chr15:2,462,877...2,476,802
Ensembl chr15:2,512,216...2,532,229
|
|
G
|
Vegfa
|
vascular endothelial growth factor A
|
multiple interactions decreases secretion increases secretion
|
ISO
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [butylbenzyl phthalate results in increased secretion of VEGFA protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [butylbenzyl phthalate results in increased secretion of VEGFA protein]; butylbenzyl phthalate promotes the reaction [Oxygen deficiency results in increased secretion of VEGFA protein]; SB 203580 inhibits the reaction [butylbenzyl phthalate results in increased secretion of VEGFA protein]; Wortmannin inhibits the reaction [butylbenzyl phthalate results in increased secretion of VEGFA protein] butylbenzyl phthalate results in decreased secretion of VEGFA protein
|
CTD |
PMID:18252963 PMID:25016925 PMID:30851587 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
G
|
Vegfd
|
vascular endothelial growth factor D
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of VEGFD mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:33,706,055...33,740,167
|
|
G
|
Vgll4
|
vestigial-like family member 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of VGLL4 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:147,925,630...148,038,519
Ensembl chr 4:149,598,891...149,660,594
|
|
G
|
Vim
|
vimentin
|
multiple interactions increases expression
|
ISO
|
butylbenzyl phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]; HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]]; HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of VIM protein]; trichostatin A inhibits the reaction [butylbenzyl phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]]
|
CTD |
PMID:22552774 PMID:31212022 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
G
|
Vopp1
|
VOPP1 WW domain binding protein
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of VOPP1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:87,363,678...87,432,747
Ensembl chr 4:88,693,837...88,780,528
|
|
G
|
Wdr6
|
WD repeat domain 6
|
multiple interactions
|
ISO
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of WDR6 protein
|
CTD |
PMID:38995844 |
|
NCBI chr 8:109,268,079...109,274,504
Ensembl chr 8:118,146,608...118,153,092
|
|
G
|
Wfs1
|
wolframin ER transmembrane glycoprotein
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of WFS1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr14:73,810,478...73,834,993
Ensembl chr14:78,034,864...78,060,459
|
|
G
|
Wnt4
|
Wnt family member 4
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA]
|
CTD |
PMID:33316053 |
|
NCBI chr 5:154,797,245...154,818,565
Ensembl chr 5:154,797,311...154,817,128
|
|
G
|
Wnt6
|
Wnt family member 6
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 9:76,329,882...76,343,523
Ensembl chr 9:83,778,552...83,792,186
|
|
G
|
Wnt9b
|
Wnt family member 9B
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT9B mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr10:88,635,330...88,657,035
Ensembl chr10:89,135,363...89,157,065
|
|
G
|
Wt1
|
WT1 transcription factor
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:112,021,641...112,068,444
|
|
G
|
Xdh
|
xanthine dehydrogenase
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of XDH mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
G
|
Zbtb8b
|
zinc finger and BTB domain containing 8b
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ZBTB8B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 5:141,765,925...141,781,619
Ensembl chr 5:147,050,650...147,066,133
|
|
G
|
Zcchc12
|
zinc finger CCHC-type containing 12
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ZCCHC12 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr X:115,433,444...115,436,691
Ensembl chr X:120,298,652...120,302,614
|
|
G
|
Zdhhc23
|
zinc finger DHHC-type palmitoyltransferase 23
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ZDHHC23 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr11:56,718,702...56,735,063
Ensembl chr11:70,225,045...70,240,102
|
|
G
|
Zeb1
|
zinc finger E-box binding homeobox 1
|
multiple interactions increases expression increases stability
|
ISO
|
butylbenzyl phthalate results in increased expression of and results in increased stability of ZEB1 mRNA; MIR655 mRNA inhibits the reaction [butylbenzyl phthalate results in increased expression of ZEB1 mRNA]; ZEB1 protein affects the reaction [butylbenzyl phthalate results in increased expression of MMP2 protein] butylbenzyl phthalate results in increased expression of ZEB1 protein ATM protein affects the reaction [butylbenzyl phthalate results in increased expression of ZEB1 protein]; butylbenzyl phthalate results in increased expression of and affects the localization of ZEB1 protein; butylbenzyl phthalate results in increased expression of and results in increased stability of ZEB1 mRNA; MIR655 mRNA inhibits the reaction [butylbenzyl phthalate results in increased expression of ZEB1 protein]; ZEB1 protein affects the reaction [butylbenzyl phthalate results in increased expression of MMP2 protein] butylbenzyl phthalate results in increased stability of ZEB1 protein
|
CTD |
PMID:31212022 |
|
NCBI chr17:56,644,397...56,811,155
Ensembl chr17:56,644,397...56,810,745
|
|
G
|
Zfat
|
zinc finger and AT hook domain containing
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ZFAT mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 7:101,775,916...101,951,135
Ensembl chr 7:101,775,916...101,943,237
|
|
G
|
Zfp280b
|
zinc finger protein 280B
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ZFP280B mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr20:12,627,106...12,641,943
Ensembl chr20:12,626,259...12,646,139
|
|
G
|
Zfp330
|
zinc finger protein 330
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ZFP330 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr19:25,313,655...25,324,958
Ensembl chr19:42,205,549...42,229,516
|
|
G
|
Zfp467
|
zinc finger protein 467
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ZFP467 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:77,385,752...77,394,709
Ensembl chr 4:78,716,666...78,723,135
|
|
G
|
Zfp503
|
zinc finger protein 503
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ZFP503 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr15:2,313,060...2,316,848
Ensembl chr15:2,362,427...2,366,238
|
|
G
|
Zfp791
|
zinc finger protein 791
|
multiple interactions
|
ISO
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ZFP791 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr19:23,018,418...23,033,580
Ensembl chr19:39,923,678...39,938,618
|
|
G
|
Zp2
|
zona pellucida glycoprotein 2
|
multiple interactions
|
EXP
|
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ZP2 mRNA
|
CTD |
PMID:31199487 |
|
NCBI chr 1:174,513,507...174,525,288
Ensembl chr 1:183,939,880...183,963,075
|
|
|
G
|
Agt
|
angiotensinogen
|
multiple interactions
|
ISO
|
CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of CYBB mRNA]; CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of CYBB protein]; CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX1 mRNA]; CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX1 protein]; CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX4 mRNA]; CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX4 protein]; CGP 42112A inhibits the reaction [AGT protein promotes the reaction [Rotenone results in increased expression of AGTRAP mRNA]]; CGP 42112A inhibits the reaction [AGT protein promotes the reaction [Rotenone results in increased expression of AGTRAP protein]]; CGP 42112A promotes the reaction [[AGT protein co-treated with Rotenone] results in increased expression of AGTR2 protein]; CGP 42112A promotes the reaction [AGT protein promotes the reaction [Rotenone results in increased expression of AGTR2 mRNA]]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of CYBB mRNA]]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of CYBB protein]]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX1 mRNA]]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX1 protein]]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX4 mRNA]]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [AGT protein promotes the reaction [Rotenone results in increased expression of AGTRAP mRNA]]]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [AGT protein promotes the reaction [Rotenone results in increased expression of AGTRAP protein]]]; PD 123319 inhibits the reaction [CGP 42112A promotes the reaction [[AGT protein co-treated with Rotenone] results in increased expression of AGTR2 protein]]; PD 123319 inhibits the reaction [CGP 42112A promotes the reaction [AGT protein promotes the reaction [Rotenone results in increased expression of AGTR2 mRNA]]]
|
CTD |
PMID:25446015 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
G
|
Agtr2
|
angiotensin II receptor, type 2
|
multiple interactions
|
ISO EXP
|
CGP 42112A promotes the reaction [[AGT protein co-treated with Rotenone] results in increased expression of AGTR2 protein]; CGP 42112A promotes the reaction [AGT protein promotes the reaction [Rotenone results in increased expression of AGTR2 mRNA]]; PD 123319 inhibits the reaction [CGP 42112A promotes the reaction [[AGT protein co-treated with Rotenone] results in increased expression of AGTR2 protein]]; PD 123319 inhibits the reaction [CGP 42112A promotes the reaction [AGT protein promotes the reaction [Rotenone results in increased expression of AGTR2 mRNA]]] [CGP 42112A binds to and results in increased activity of AGTR2 protein] which affects the susceptibility to Phenylephrine; [CGP 42112A binds to and results in increased activity of AGTR2 protein] which results in increased abundance of and results in increased secretion of Triglycerides; [CGP 42112A binds to and results in increased activity of AGTR2 protein] which results in increased abundance of Fatty Acids, Nonesterified; CGP 42112A binds to and results in increased activity of AGTR2 protein
|
CTD |
PMID:16003179 PMID:19151255 PMID:25446015 |
|
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:116,913,656...116,918,745
|
|
G
|
Agtrap
|
angiotensin II receptor-associated protein
|
multiple interactions
|
ISO
|
CGP 42112A inhibits the reaction [AGT protein promotes the reaction [Rotenone results in increased expression of AGTRAP mRNA]]; CGP 42112A inhibits the reaction [AGT protein promotes the reaction [Rotenone results in increased expression of AGTRAP protein]]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [AGT protein promotes the reaction [Rotenone results in increased expression of AGTRAP mRNA]]]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [AGT protein promotes the reaction [Rotenone results in increased expression of AGTRAP protein]]]
|
CTD |
PMID:25446015 |
|
NCBI chr 5:158,507,427...158,519,036
Ensembl chr 5:163,791,887...163,802,174
|
|
G
|
Cybb
|
cytochrome b-245 beta chain
|
multiple interactions
|
ISO
|
CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of CYBB mRNA]; CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of CYBB protein]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of CYBB mRNA]]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of CYBB protein]]
|
CTD |
PMID:25446015 |
|
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
|
|
G
|
Nox1
|
NADPH oxidase 1
|
multiple interactions
|
ISO
|
CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX1 mRNA]; CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX1 protein]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX1 mRNA]]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX1 protein]]
|
CTD |
PMID:25446015 |
|
NCBI chr X:101,572,338...101,625,571
Ensembl chr X:101,572,340...101,595,520
|
|
G
|
Nox4
|
NADPH oxidase 4
|
multiple interactions
|
ISO
|
CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX4 mRNA]; CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX4 protein]; PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of NOX4 mRNA]]
|
CTD |
PMID:25446015 |
|
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
|
|
G
|
Ube2v2
|
ubiquitin conjugating enzyme E2 V2
|
increases expression
|
EXP
|
CGP 42112A results in increased expression of UBE2V2 mRNA; CGP 42112A results in increased expression of UBE2V2 protein
|
CTD |
PMID:17068200 |
|
NCBI chr11:85,304,528...85,338,430
Ensembl chr11:98,807,538...98,843,211
|
|
|
G
|
Ache
|
acetylcholinesterase
|
multiple interactions decreases activity
|
ISO
|
[crotoxyphos co-treated with Dichlorvos] results in decreased activity of ACHE protein crotoxyphos results in decreased activity of ACHE protein
|
CTD |
PMID:4859365 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
|
G
|
Actb
|
actin, beta
|
multiple interactions
|
ISO
|
[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate metabolite co-treated with monoethyl phthalate co-treated with monobutyl phthalate] results in increased expression of ACTB mRNA; [mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with methylparaben] results in increased expression of ACTB mRNA
|
CTD |
PMID:38992643 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:16,776,661...16,780,242
|
|
G
|
Acvr1c
|
activin A receptor type 1C
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ACVR1C mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:63,224,322...63,301,252
Ensembl chr 3:63,227,559...63,301,205
|
|
G
|
Ahr
|
aryl hydrocarbon receptor
|
affects expression multiple interactions
|
ISO
|
mono-benzyl phthalate affects the expression of AHR mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of AHR mRNA
|
CTD |
PMID:28381288 PMID:31884101 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
G
|
Ahrr
|
aryl-hydrocarbon receptor repressor
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of AHRR mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:30,810,866...30,952,866
|
|
G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of AIFM1 mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:132,528,107...132,567,237
|
|
G
|
Aldh1b1
|
aldehyde dehydrogenase 1 family, member B1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ALDH1B1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365
|
|
G
|
Angptl4
|
angiopoietin-like 4
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ANGPTL4 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:15,252,473...15,258,681
|
|
G
|
Anln
|
anillin, actin binding protein
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ANLN mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:29,134,222...29,197,513
|
|
G
|
Anxa3
|
annexin A3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ANXA3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849
|
|
G
|
Ar
|
androgen receptor
|
multiple interactions
|
ISO
|
mono-benzyl phthalate promotes the reaction [Dihydrotestosterone results in increased activity of AR protein] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of AR mRNA
|
CTD |
PMID:28571686 PMID:31884101 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
G
|
Arhgap11a
|
Rho GTPase activating protein 11A
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ARHGAP11A mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:100,590,865...100,607,146
Ensembl chr 3:121,045,187...121,061,468
|
|
G
|
Arnt
|
aryl hydrocarbon receptor nuclear translocator
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of ARNT mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546
|
|
G
|
Asf1b
|
anti-silencing function 1B histone chaperone
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ASF1B mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:41,086,114...41,100,352
|
|
G
|
Aspm
|
assembly factor for spindle microtubules
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ASPM mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489
|
|
G
|
Atf3
|
activating transcription factor 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ATF3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:105,282,440...105,295,750
|
|
G
|
Aurka
|
aurora kinase A
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of AURKA mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771
|
|
G
|
Basp1
|
brain abundant, membrane attached signal protein 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of BASP1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:77,546,092...77,597,178
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BAX mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BAX mRNA
|
CTD |
PMID:31884101 PMID:35861251 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions decreases methylation increases expression
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of BCL2 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BCL2 mRNA mono-benzyl phthalate results in decreased methylation of BCL2 promoter mono-benzyl phthalate results in increased expression of BCL2 mRNA
|
CTD |
PMID:31884101 PMID:35487445 PMID:35861251 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Bcl2l10
|
Bcl2-like 10
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of BCL2L10 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] results in increased expression of BCL2L10 mRNA
|
CTD |
PMID:31884101 PMID:33511402 |
|
NCBI chr 8:84,987,833...84,993,878
Ensembl chr 8:84,987,833...84,993,872
|
|
G
|
Bean1
|
brain expressed, associated with NEDD4, 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of BEAN1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr19:739,551...786,395
Ensembl chr19:745,993...793,039
|
|
G
|
Bex4
|
brain expressed, X-linked 4
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of BEX4 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr X:99,131,985...99,133,417
Ensembl chr X:103,923,338...103,925,496
|
|
G
|
Bicc1
|
BicC family RNA binding protein 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of BICC1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr20:17,449,639...17,686,775
Ensembl chr20:17,448,765...17,685,885
|
|
G
|
Bid
|
BH3 interacting domain death agonist
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BID mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
G
|
Blm
|
BLM RecQ like helicase
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of BLM mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:143,819,072...143,905,300
Ensembl chr 1:143,819,090...143,905,210
|
|
G
|
Bok
|
BCL2 family apoptosis regulator BOK
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of BOK mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:101,670,625...101,681,833
|
|
G
|
Bub3
|
BUB3 mitotic checkpoint protein
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of BUB3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:186,330,358...186,340,969
Ensembl chr 1:195,758,105...195,791,028
|
|
G
|
Calr
|
calreticulin
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CALR mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CASP3 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of CASP3 mRNA
|
CTD |
PMID:31884101 PMID:35861251 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp8
|
caspase 8
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CASP8 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CASP8 mRNA
|
CTD |
PMID:31884101 PMID:35861251 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:67,758,033...67,806,699
|
|
G
|
Cat
|
catalase
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CAT mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CAT mRNA
|
CTD |
PMID:31884101 PMID:35861251 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Ccbe1
|
collagen and calcium binding EGF domains 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CCBE1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr18:59,579,851...59,823,977
Ensembl chr18:61,853,149...62,094,075
|
|
G
|
Ccdc163
|
coiled-coil domain containing 163
|
multiple interactions
|
ISO
|
[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of CCDC163 mRNA
|
CTD |
PMID:37160244 |
|
NCBI chr 5:130,172,014...130,178,934
Ensembl chr 5:135,409,003...135,415,577
|
|
G
|
Cck
|
cholecystokinin
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CCK mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:130,031,013...130,037,686
|
|
G
|
Ccl2
|
C-C motif chemokine ligand 2
|
increases expression
|
ISO
|
mono-benzyl phthalate results in increased expression of CCL2 mRNA
|
CTD |
PMID:32015430 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
G
|
Ccl5
|
C-C motif chemokine ligand 5
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CCL5 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,738,651...68,824,884
|
|
G
|
Ccna2
|
cyclin A2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCNA2 mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:121,355,363...121,361,701
|
|
G
|
Ccnb1
|
cyclin B1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCNB1 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CCNB1 mRNA
|
CTD |
PMID:31884101 PMID:39752319 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
G
|
Ccnb2
|
cyclin B2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCNB2 mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682
|
|
G
|
Ccnd1
|
cyclin D1
|
increases expression decreases methylation
|
ISO
|
mono-benzyl phthalate results in increased expression of CCND1 mRNA mono-benzyl phthalate results in decreased methylation of CCND1 promoter
|
CTD |
PMID:35487445 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
G
|
Ccnd3
|
cyclin D3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCND3 mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:20,891,704...20,987,033
|
|
G
|
Ccne1
|
cyclin E1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCNE1 mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:99,918,674...99,927,822
|
|
G
|
Ccnf
|
cyclin F
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CCNF mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,758,421...13,783,837
|
|
G
|
Ccr7
|
C-C motif chemokine receptor 7
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased expression of CCR7 mRNA
|
CTD |
PMID:30398665 |
|
NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,593,594...84,604,501
|
|
G
|
Cd163
|
CD163 molecule
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in decreased expression of CD163 mRNA
|
CTD |
PMID:30398665 |
|
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:158,770,749...158,804,146
|
|
G
|
Cd24
|
CD24 molecule
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CD24A mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785
|
|
G
|
Cd36
|
CD36 molecule
|
increases expression multiple interactions
|
ISO
|
mono-benzyl phthalate results in increased expression of CD36 mRNA GW 6471 inhibits the reaction [mono-benzyl phthalate results in increased expression of CD36 mRNA]
|
CTD |
PMID:35421560 |
|
NCBI chr 4:18,209,088...18,302,142
|
|
G
|
Cd47
|
Cd47 molecule
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CD47 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr11:64,374,816...64,438,763
Ensembl chr11:64,377,926...64,438,272
|
|
G
|
Cd68
|
Cd68 molecule
|
increases expression
|
ISO
|
mono-benzyl phthalate results in increased expression of CD68 mRNA
|
CTD |
PMID:32015430 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,880,563...54,882,540
|
|
G
|
Cdca8
|
cell division cycle associated 8
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CDCA8 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:142,461,084...142,483,283
|
|
G
|
Cdk1
|
cyclin-dependent kinase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CDK1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
G
|
Cdk2
|
cyclin dependent kinase 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDK2 mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
G
|
Cdk4
|
cyclin-dependent kinase 4
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDK4 mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CDKN1A mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1B mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
G
|
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1C mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:208,084,787...208,087,498
|
|
G
|
Cdkn2a
|
cyclin-dependent kinase inhibitor 2A
|
multiple interactions increases methylation decreases expression
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CDKN2A mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN2A mRNA mono-benzyl phthalate results in increased methylation of CDKN2A promoter mono-benzyl phthalate results in decreased expression of CDKN2A mRNA
|
CTD |
PMID:31884101 PMID:35487445 PMID:35861251 |
|
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248
|
|
G
|
Cdkn2b
|
cyclin-dependent kinase inhibitor 2B
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CDKN2B mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] results in increased expression of CDKN2B mRNA
|
CTD |
PMID:31884101 PMID:33511402 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:109,114,322...109,134,855
|
|
G
|
Cdkn2c
|
cyclin-dependent kinase inhibitor 2C
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN2C mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891
|
|
G
|
Cdkn2d
|
cyclin dependent kinase inhibitor 2D
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of CDKN2D mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 8:28,108,036...28,110,809
Ensembl chr 8:28,108,044...28,110,809
|
|
G
|
Cenpa
|
centromere protein A
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CENPA mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 6:31,420,062...31,431,703
|
|
G
|
Cenpe
|
centromere protein E
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CENPE mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636
|
|
G
|
Cenpn
|
centromere protein N
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CENPN mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr19:44,971,265...44,994,019
Ensembl chr19:61,877,148...61,902,918
|
|
G
|
Cenps
|
centromere protein S
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CENPS mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:159,563,917...159,573,534
|
|
G
|
Cers5
|
ceramide synthase 5
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CERS5 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 7:130,859,993...130,897,979
Ensembl chr 7:132,738,834...132,776,786
|
|
G
|
Cfap144
|
cilia and flagella associated protein 144
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CFAP144 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:43,509,823...43,519,693
Ensembl chr10:44,009,412...44,019,281
|
|
G
|
Cga
|
glycoprotein hormones, alpha polypeptide
|
increases expression affects expression increases secretion
|
ISO
|
mono-benzyl phthalate results in increased expression of CGA mRNA mono-benzyl phthalate affects the expression of CGA mRNA mono-benzyl phthalate results in increased secretion of CGA protein
|
CTD |
PMID:28381288 PMID:29089286 |
|
NCBI chr 5:54,283,109...54,295,464
Ensembl chr 5:54,235,019...54,295,464
|
|
G
|
Chaf1a
|
chromatin assembly factor 1 subunit A
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CHAF1A mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 9:873,953...900,701
Ensembl chr 9:961,084...987,868
|
|
G
|
Chp2
|
calcineurin-like EF hand protein 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CHP2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:176,757,945...176,772,443
Ensembl chr 1:186,185,151...186,203,667
|
|
G
|
Chst15
|
carbohydrate sulfotransferase 15
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CHST15 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:187,028,860...187,107,908
Ensembl chr 1:196,460,425...196,491,444
|
|
G
|
Chtf18
|
chromosome transmission fidelity factor 18
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CHTF18 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:14,743,006...14,751,044
Ensembl chr10:15,246,362...15,255,685
|
|
G
|
Cks1b
|
CDC28 protein kinase regulatory subunit 1B
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CKS1B mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365
|
|
G
|
Cks2
|
CDC28 protein kinase regulatory subunit 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CKS2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr17:13,570,611...13,575,770
Ensembl chr17:13,722,361...13,727,519
|
|
G
|
Cpq
|
carboxypeptidase Q
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CPQ mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:66,149,377...66,716,137
|
|
G
|
Cpxm2
|
carboxypeptidase X (M14 family), member 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CPXM2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:186,836,797...186,947,222
Ensembl chr 1:196,266,930...196,377,347
|
|
G
|
Creb3l3
|
cAMP responsive element binding protein 3-like 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CREB3L3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:9,273,338...9,281,778
|
|
G
|
Crim1
|
cysteine rich transmembrane BMP regulator 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CRIM1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 6:16,695,864...16,870,264
Ensembl chr 6:22,449,948...22,622,416
|
|
G
|
Crp
|
C-reactive protein
|
increases expression
|
ISO
|
mono-benzyl phthalate results in increased expression of CRP protein
|
CTD |
PMID:21349512 |
|
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
G
|
Cryba4
|
crystallin, beta A4
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CRYBA4 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr12:44,378,734...44,393,226
Ensembl chr12:50,047,049...50,053,634
|
|
G
|
Ctsc
|
cathepsin C
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CTSC mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082
|
|
G
|
Ctsf
|
cathepsin F
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CTSF mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:202,152,777...202,158,525
Ensembl chr 1:211,582,098...211,587,916
|
|
G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased expression of CXCL10 mRNA
|
CTD |
PMID:30398665 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CXCL12 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
G
|
Cyfip2
|
cytoplasmic FMR1 interacting protein 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CYFIP2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:31,122,653...31,242,440
Ensembl chr10:31,122,653...31,242,440
|
|
G
|
Cyp11a1
|
cytochrome P450, family 11, subfamily a, polypeptide 1
|
increases expression multiple interactions affects expression
|
ISO
|
mono-benzyl phthalate results in increased expression of CYP11A1 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP11A1 mRNA mono-benzyl phthalate affects the expression of CYP11A1 mRNA
|
CTD |
PMID:28381288 PMID:29089286 PMID:31884101 |
|
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196
|
|
G
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1
|
multiple interactions
|
ISO
|
[monobutyl phthalate co-treated with mono-benzyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monoisononylphthalate] results in decreased expression of CYP17A1 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP17A1 mRNA
|
CTD |
PMID:31015488 PMID:31884101 |
|
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974
|
|
G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
affects expression multiple interactions
|
ISO
|
mono-benzyl phthalate affects the expression of CYP19A1 mRNA [monobutyl phthalate co-treated with mono-benzyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monoisononylphthalate] results in increased expression of CYP19A1 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP19A1 mRNA
|
CTD |
PMID:28381288 PMID:31015488 PMID:31884101 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CYP1A1 mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP1B1 mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
G
|
Cyp26b1
|
cytochrome P450, family 26, subfamily b, polypeptide 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CYP26B1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176
|
|
G
|
Cyp2b1
|
cytochrome P450, family 2, subfamily b, polypeptide 1
|
decreases activity
|
EXP
|
mono-benzyl phthalate results in decreased activity of CYP2B1 protein
|
CTD |
PMID:27432241 |
|
NCBI chr 1:81,518,387...81,544,999
|
|
G
|
Cyp3a62
|
cytochrome P450, family 3, subfamily a, polypeptide 62
|
decreases activity
|
EXP
|
mono-benzyl phthalate results in decreased activity of CYP3A62 protein
|
CTD |
PMID:27432241 |
|
NCBI chr12:16,397,998...16,433,833
Ensembl chr12:21,471,542...21,547,598
|
|
G
|
Dbf4
|
DBF4-CDC7 kinase regulatory subunit
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DBF4 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:26,631,514...26,656,562
|
|
G
|
Dbi
|
diazepam binding inhibitor
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DBI mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450
|
|
G
|
Dbp
|
D-box binding PAR bZIP transcription factor
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DBP mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:105,312,108...105,317,205
|
|
G
|
Dcakd
|
dephospho-CoA kinase domain containing
|
multiple interactions
|
ISO
|
[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of DCAKD mRNA
|
CTD |
PMID:37160244 |
|
NCBI chr10:87,957,738...87,989,002
Ensembl chr10:88,457,829...88,480,118
|
|
G
|
Dcc
|
DCC netrin 1 receptor
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DCC mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr18:67,144,272...68,248,159
Ensembl chr18:67,149,179...68,247,541
|
|
G
|
Ddah1
|
dimethylarginine dimethylaminohydrolase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DDAH1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:234,667,499...234,800,322
Ensembl chr 2:237,327,766...237,460,626
|
|
G
|
Ddx39a
|
DExD-box helicase 39A
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DDX39A mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr19:24,418,743...24,427,422
Ensembl chr19:41,322,836...41,332,306
|
|
G
|
Dicer1
|
dicer 1 ribonuclease III
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of DICER1 mRNA
|
CTD |
PMID:35861251 |
|
NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:129,396,014...129,457,252
|
|
G
|
Dlgap5
|
DLG associated protein 5
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DLGAP5 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr15:23,113,678...23,144,281
Ensembl chr15:23,113,678...23,144,176
|
|
G
|
Dmrt1
|
doublesex and mab-3 related transcription factor 1
|
multiple interactions
|
ISO
|
[monobutyl phthalate co-treated with mono-benzyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monoisononylphthalate] results in increased expression of DMRT1 mRNA
|
CTD |
PMID:31015488 |
|
NCBI chr 1:232,569,179...232,667,646
Ensembl chr 1:232,569,072...232,668,370
|
|
G
|
Dnajb13
|
DnaJ heat shock protein family (Hsp40) member B13
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DNAJB13 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:164,260,716...164,275,172
Ensembl chr 1:164,260,724...164,275,093
|
|
G
|
Dnmt1
|
DNA methyltransferase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of DNMT1 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of DNMT1 mRNA
|
CTD |
PMID:35861251 |
|
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119
|
|
G
|
Dock5
|
dedicator of cytokinesis 5
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DOCK5 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr15:41,979,728...42,158,733
Ensembl chr15:46,155,125...46,334,042
|
|
G
|
Dqx1
|
DEAQ box RNA-dependent ATPase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DQX1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 4:115,563,497...115,572,598
Ensembl chr 4:117,121,452...117,130,307
|
|
G
|
Drosha
|
drosha ribonuclease III
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of DROSHA mRNA
|
CTD |
PMID:35861251 |
|
NCBI chr 2:61,864,886...61,976,688
Ensembl chr 2:63,591,968...63,703,687
|
|
G
|
Dstn
|
destrin, actin depolymerizing factor
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DSTN mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:151,737,711...151,764,752
Ensembl chr 3:151,737,849...151,764,769
|
|
G
|
Eef1b2
|
eukaryotic translation elongation factor 1 beta 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of EEF1B2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 9:64,580,163...64,582,737
Ensembl chr 9:72,073,802...72,076,589
|
|
G
|
Egr3
|
early growth response 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of EGR3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:51,560,344...51,565,712
|
|
G
|
Elovl2
|
ELOVL fatty acid elongase 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ELOVL2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr17:23,544,598...23,584,855
Ensembl chr17:23,750,350...23,790,601
|
|
G
|
Ephx2
|
epoxide hydrolase 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of EPHX2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:44,465,448...44,503,160
|
|
G
|
Ereg
|
epiregulin
|
increases expression
|
ISO
|
mono-benzyl phthalate results in increased expression of EREG mRNA
|
CTD |
PMID:29089286 |
|
NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,311,485...17,325,260
|
|
G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of ESR1 mRNA; mono-benzyl phthalate promotes the reaction [Estradiol results in increased activity of ESR1 protein] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of ESR1 mRNA
|
CTD |
PMID:28571686 PMID:31884101 PMID:35861251 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
G
|
Esr2
|
estrogen receptor 2
|
multiple interactions
|
ISO
|
mono-benzyl phthalate promotes the reaction [Estradiol results in increased activity of ESR2 protein] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of ESR2 mRNA
|
CTD |
PMID:28571686 PMID:31884101 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
G
|
Etl4
|
enhancer trap locus 4
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ETL4 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr17:82,841,075...83,304,868
Ensembl chr17:87,403,819...88,213,158
|
|
G
|
Exosc1
|
exosome component 1
|
multiple interactions
|
ISO
|
[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate metabolite co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of EXOSC1 mRNA; [mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with methylparaben] results in decreased expression of EXOSC1 mRNA
|
CTD |
PMID:38992643 |
|
NCBI chr 1:240,734,777...240,745,431
Ensembl chr 1:250,684,750...250,694,748
|
|
G
|
Fabp3
|
fatty acid binding protein 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of FABP3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:147,936,119...147,942,881
|
|
G
|
Fabp4
|
fatty acid binding protein 4
|
multiple interactions increases expression
|
ISO
|
T 0070907 inhibits the reaction [mono-benzyl phthalate results in increased expression of FABP4 mRNA]
|
CTD |
PMID:35421560 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:93,488,271...93,492,972
|
|
G
|
Fetub
|
fetuin B
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of FETUB mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr11:78,082,158...78,093,022
Ensembl chr11:91,586,748...91,599,310
|
|
G
|
Filip1l
|
filamin A interacting protein 1-like
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of FILIP1L mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr11:42,937,353...43,177,085
Ensembl chr11:56,410,582...56,646,402
|
|
G
|
Fkbp6
|
FKBP prolyl isomerase family member 6
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of FKBP6 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr12:21,318,251...21,390,350
Ensembl chr12:26,947,384...27,026,913
|
|
G
|
Flg
|
filaggrin
|
multiple interactions
|
ISO
|
[FLG gene polymorphism affects the susceptibility to butylbenzyl phthalate] which affects the abundance of mono-benzyl phthalate
|
CTD |
PMID:24380925 |
|
NCBI chr 2:181,583,801...181,596,464
Ensembl chr 2:181,583,808...181,595,968
|
|
G
|
Fmn1
|
formin 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of FMN1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:120,555,445...120,939,978
Ensembl chr 3:120,555,431...120,933,124
|
|
G
|
Frzb
|
frizzled-related protein
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of FRZB mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:85,739,162...85,772,168
Ensembl chr 3:85,739,165...85,772,096
|
|
G
|
Fshr
|
follicle stimulating hormone receptor
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of FSHR mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 6:10,952,329...11,160,288
Ensembl chr 6:10,952,329...11,160,288
|
|
G
|
Gas6
|
growth arrest specific 6
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of GAS6 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr16:76,045,430...76,075,904
Ensembl chr16:82,747,345...82,778,088
|
|
G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of GCLM mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:213,031,838...213,055,003
|
|
G
|
Gcnt1
|
glucosaminyl (N-acetyl) transferase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of GCNT1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:214,718,344...214,755,735
Ensembl chr 1:224,141,108...224,185,741
|
|
G
|
Ggh
|
gamma-glutamyl hydrolase
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of GGH mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:38,326,594...38,349,647
|
|
G
|
Glul
|
glutamate-ammonia ligase
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of GLUL mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
|
|
G
|
Gmnn
|
geminin, DNA replication inhibitor
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of GMNN mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,729,824...40,738,068
|
|
G
|
Gnpda1
|
glucosamine-6-phosphate deaminase 1
|
multiple interactions
|
ISO
|
[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with methylparaben] affects the expression of GNPDA1 mRNA
|
CTD |
PMID:38992643 |
|
NCBI chr18:30,165,435...30,177,462
Ensembl chr18:30,416,607...30,428,630
|
|
G
|
Gorasp2
|
golgi reassembly stacking protein 2
|
multiple interactions
|
ISO
|
[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate metabolite co-treated with monoethyl phthalate co-treated with monobutyl phthalate] results in decreased expression of GORASP2 mRNA; [mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with methylparaben] affects the expression of GORASP2 mRNA
|
CTD |
PMID:38992643 |
|
NCBI chr 3:55,474,448...55,503,570
Ensembl chr 3:75,882,515...75,911,328
|
|
G
|
Gpam
|
glycerol-3-phosphate acyltransferase, mitochondrial
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of GPAM mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:264,113,813...264,175,911
|
|
G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of GPX1 mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
G
|
Gpx7
|
glutathione peroxidase 7
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of GPX7 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:128,372,875...128,381,725
|
|
G
|
Grem1
|
gremlin 1, DAN family BMP antagonist
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of GREM1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:120,966,623...120,979,089
|
|
G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of GSR mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:65,185,574...65,228,394
|
|
G
|
H1f4
|
H1.4 linker histone, cluster member
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of H1F4 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr17:41,914,425...41,915,206
Ensembl chr17:41,914,431...41,916,129
|
|
G
|
H2ac10
|
H2A clustered histone 10
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of H2AC10 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr17:41,570,532...41,571,020
Ensembl chr17:41,998,622...41,999,025
|
|
G
|
H2ax
|
H2A.X variant histone
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of H2AX mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
G
|
Heyl
|
hes-related family bHLH transcription factor with YRPW motif-like
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of HEYL mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:135,508,160...135,525,152
Ensembl chr 5:140,793,271...140,810,262
|
|
G
|
Hmgb2
|
high mobility group box 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of HMGB2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:37,721,379...37,723,860
|
|
G
|
Hmmr
|
hyaluronan-mediated motility receptor
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of HMMR mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,635,915...25,665,390
|
|
G
|
Hnrnpa1
|
heterogeneous nuclear ribonucleoprotein A1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of HNRNPA1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 7:136,253,633...136,260,085
Ensembl chr 7:136,253,278...136,260,085
|
|
G
|
Hp
|
haptoglobin
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] results in increased expression of HP mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:54,446,217...54,467,518
|
|
G
|
Hpgd
|
15-hydroxyprostaglandin dehydrogenase
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of HPGD mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831
|
|
G
|
Hsd17b1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of HSD17B1 mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,510,011...86,512,210
|
|
G
|
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of HSD3B1 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] results in decreased expression of HSD3B1 mRNA
|
CTD |
PMID:31884101 PMID:39150890 |
|
NCBI chr 2:188,858,574...188,864,694
|
|
G
|
Igfbp2
|
insulin-like growth factor binding protein 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of IGFBP2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171
|
|
G
|
Il25
|
interleukin 25
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of IL25 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr15:32,378,750...32,382,141
Ensembl chr15:32,378,750...32,382,141
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased expression of IL6 mRNA
|
CTD |
PMID:30398665 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Incenp
|
inner centromere protein
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of INCENP mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:215,945,558...216,017,247
Ensembl chr 1:215,948,283...215,977,084
|
|
G
|
Irf2bpl
|
interferon regulatory factor 2 binding protein-like
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of IRF2BPL mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 6:106,527,179...106,531,294
Ensembl chr 6:112,258,188...112,263,280
|
|
G
|
Itga6
|
integrin subunit alpha 6
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ITGA6 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:77,012,168...77,097,076
Ensembl chr 3:77,017,766...77,097,076
|
|
G
|
Izumo4
|
IZUMO family member 4
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of IZUMO4 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 7:9,657,975...9,661,699
Ensembl chr 7:9,657,203...9,660,794
|
|
G
|
Jam3
|
junctional adhesion molecule 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of JAM3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:33,767,606...33,828,451
Ensembl chr 8:33,767,607...33,828,623
|
|
G
|
Kat2b
|
lysine acetyltransferase 2B
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KAT2B mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 9:6,799,101...6,903,616
Ensembl chr 9:6,799,145...6,903,616
|
|
G
|
Kcnk1
|
potassium two pore domain channel subfamily K member 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KCNK1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr19:53,959,411...53,997,726
Ensembl chr19:70,856,985...70,895,051
|
|
G
|
Kctd14
|
potassium channel tetramerization domain containing 14
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KCTD14 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:151,761,688...151,766,693
Ensembl chr 1:161,171,451...161,178,413
|
|
G
|
Kdelr2
|
KDEL endoplasmic reticulum protein retention receptor 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KDELR2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr12:11,138,820...11,157,117
Ensembl chr12:16,252,424...16,270,719
|
|
G
|
Kif15
|
kinesin family member 15
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KIF15 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:131,479,340...131,550,209
Ensembl chr 8:131,479,337...131,550,202
|
|
G
|
Kif5b
|
kinesin family member 5B
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KIF5B mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr17:56,185,386...56,222,990
Ensembl chr17:56,185,380...56,223,008
|
|
G
|
Kifc1
|
kinesin family member C1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KIFC1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr20:5,000,929...5,018,967
Ensembl chr20:5,000,648...5,018,988
|
|
G
|
Kitlg
|
KIT ligand
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KITL mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793
|
|
G
|
Knstrn
|
kinetochore-localized astrin/SPAG5 binding protein
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KNSTRN mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:126,254,663...126,274,418
|
|
G
|
Kpna2
|
karyopherin subunit alpha 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KPNA2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:92,433,679...92,445,937
|
|
G
|
Krt79
|
keratin 79
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KRT79 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 7:133,056,710...133,067,750
Ensembl chr 7:134,935,396...134,947,286
|
|
G
|
Layn
|
layilin
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of LAYN mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:51,363,928...51,384,748
Ensembl chr 8:60,263,456...60,281,418
|
|
G
|
Lhcgr
|
luteinizing hormone/choriogonadotropin receptor
|
multiple interactions
|
ISO
|
[monobutyl phthalate co-treated with mono-benzyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monoisononylphthalate] results in decreased expression of LHR mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of LHCGR mRNA
|
CTD |
PMID:31015488 PMID:31884101 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:11,415,415...11,478,061
|
|
G
|
Loxl1
|
lysyl oxidase-like 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of LOXL1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:67,587,636...67,612,224
|
|
G
|
Lrrc59
|
leucine rich repeat containing 59
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of LRRC59 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:80,069,162...80,083,820
Ensembl chr10:80,069,120...80,084,079
|
|
G
|
Lrrn1
|
leucine rich repeat neuronal 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of LRRN1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 4:140,476,752...140,520,210
Ensembl chr 4:142,032,041...142,074,760
|
|
G
|
Lsm2
|
LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of LSM2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr20:3,843,467...3,847,217
Ensembl chr20:3,848,119...3,851,891
|
|
G
|
Mad2l1
|
mitotic arrest deficient 2 like 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MAD2L1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 4:97,236,419...97,247,603
Ensembl chr 4:97,236,503...97,243,222
|
|
G
|
Map2
|
microtubule-associated protein 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MAP2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
G
|
Mark1
|
microtubule affinity regulating kinase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MARK1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr13:96,450,189...96,555,304
Ensembl chr13:98,983,020...99,086,701
|
|
G
|
Mcm3
|
minichromosome maintenance complex component 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MCM3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:30,715,602...30,733,746
|
|
G
|
Meg3
|
maternally expressed 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MEG3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 6:128,491,808...128,524,010
|
|
G
|
Mfsd2a
|
MFSD2 lysolipid transporter A, lysophospholipid
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MFSD2A mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:140,510,953...140,525,916
|
|
G
|
Mgll
|
monoglyceride lipase
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] results in increased expression of MGLL mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:122,749,436...122,851,440
|
|
G
|
Mgst1
|
microsomal glutathione S-transferase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MGST1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:172,760,886...172,776,875
|
|
G
|
Mir126a
|
microRNA 126a
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR126
|
CTD |
PMID:33885134 |
|
NCBI chr 3:9,415,063...9,415,180
|
|
G
|
Mir127
|
microRNA 127
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR127
|
CTD |
PMID:33885134 |
|
NCBI chr 6:128,546,215...128,546,311
Ensembl chr 6:134,328,454...134,328,550
|
|
G
|
Mir141
|
microRNA 141
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of MIR141 mRNA
|
CTD |
PMID:35861251 |
|
NCBI chr 4:157,523,239...157,523,332
|
|
G
|
Mir143
|
microRNA 143
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR143
|
CTD |
PMID:33885134 |
|
NCBI chr18:57,371,349...57,371,453
|
|
G
|
Mir150
|
microRNA 150
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR150
|
CTD |
PMID:33885134 |
|
NCBI chr 1:95,605,024...95,605,108
Ensembl chr 1:104,741,487...104,741,571
|
|
G
|
Mir184
|
microRNA 184
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MIR184 mRNA
|
CTD |
PMID:35861251 |
|
NCBI chr 8:90,343,134...90,343,210
|
|
G
|
Mir193a
|
microRNA 193a
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR193A
|
CTD |
PMID:33885134 |
|
NCBI chr10:64,672,343...64,672,454
|
|
G
|
Mir221
|
microRNA 221
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR221
|
CTD |
PMID:33885134 |
|
NCBI chr X:6,023,182...6,023,290
Ensembl chr X:6,023,182...6,023,290
|
|
G
|
Mir25
|
microRNA 25
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR25
|
CTD |
PMID:33885134 |
|
NCBI chr12:17,042,932...17,043,015
|
|
G
|
Mir320a
|
microRNA 320a
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR320A
|
CTD |
PMID:33885134 |
|
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:51,926,088...51,926,169
|
|
G
|
Mir324
|
microRNA 324
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR324
|
CTD |
PMID:33885134 |
|
NCBI chr10:54,734,680...54,734,762
Ensembl chr10:55,233,361...55,233,449
|
|
G
|
Mir328
|
microRNA 328
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR328
|
CTD |
PMID:33885134 |
|
NCBI chr19:50,094,691...50,094,774
|
|
G
|
Mir345
|
microRNA 345
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR345
|
CTD |
PMID:33885134 |
|
NCBI chr 6:127,754,027...127,754,122
Ensembl chr 6:133,518,403...133,518,498
|
|
G
|
Mir451a
|
microRNA 451a
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR451A
|
CTD |
PMID:33885134 |
|
NCBI chr10:62,961,520...62,961,591
Ensembl chr10:63,459,569...63,459,640
|
|
G
|
Mir532
|
microRNA 532
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR532
|
CTD |
PMID:33885134 |
|
NCBI chr X:17,919,185...17,919,263
Ensembl chr X:17,919,185...17,919,263
|
|
G
|
Mir99b
|
microRNA 99b
|
multiple interactions
|
ISO
|
[butylbenzyl phthalate results in increased abundance of mono-benzyl phthalate] which affects the secretion of MIR99B
|
CTD |
PMID:33885134 |
|
NCBI chr 1:67,350,064...67,350,133
Ensembl chr 1:67,350,060...67,350,139
|
|
G
|
Mis18bp1
|
MIS18 binding protein 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MIS18BP1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 6:88,918,743...88,968,225
Ensembl chr 6:88,918,745...88,967,629
|
|
G
|
Mki67
|
marker of proliferation Ki-67
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of MKI67 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA
|
CTD |
PMID:31884101 PMID:35861251 PMID:39752319 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
G
|
Mmp3
|
matrix metallopeptidase 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MMP3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
G
|
Mmp9
|
matrix metallopeptidase 9
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased secretion of MMP9 protein
|
CTD |
PMID:30398665 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
G
|
Mns1
|
meiosis-specific nuclear structural 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MNS1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:82,029,587...82,050,276
Ensembl chr 8:82,029,587...82,050,274
|
|
G
|
Mrc1
|
mannose receptor, C type 1
|
multiple interactions
|
ISO
|
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in decreased expression of MRC1 mRNA
|
CTD |
PMID:30398665 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:82,157,705...82,239,410
|
|
G
|
Mrps21
|
mitochondrial ribosomal protein S21
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MRPS21 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:186,095,729...186,103,351
Ensembl chr 2:186,095,732...186,103,351
|
|
G
|
Ncapg
|
non-SMC condensin I complex, subunit G
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NCAPG mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr14:69,616,473...69,645,445
Ensembl chr14:69,616,473...69,645,445
|
|
G
|
Ncaph
|
non-SMC condensin I complex, subunit H
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NCAPH mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:134,825,271...134,852,502
Ensembl chr 3:134,825,271...134,852,502
|
|
G
|
Ndufs4
|
NADH:ubiquinone oxidoreductase subunit S4
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NDUFS4 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:45,951,327...46,061,829
Ensembl chr 2:47,684,406...47,794,931
|
|
G
|
Nek10
|
NIMA-related kinase 10
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NEK10 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr15:10,387,063...10,564,177
Ensembl chr15:12,813,606...13,013,567
|
|
G
|
Npepps
|
aminopeptidase puromycin sensitive
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NPEPPS mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:82,191,454...82,273,967
Ensembl chr10:82,687,871...82,770,363
|
|
G
|
Npm1
|
nucleophosmin 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NPM1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:18,245,739...18,255,913
Ensembl chr10:18,245,740...18,256,024 Ensembl chr X:18,245,740...18,256,024
|
|
G
|
Npy1r
|
neuropeptide Y receptor Y1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NPY1R mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:27,804,416...27,813,387
|
|
G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
increases activity
|
ISO
|
mono-benzyl phthalate results in increased activity of NR1I2 protein
|
CTD |
PMID:27551952 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:75,965,632...76,002,380
|
|
G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
increases activity multiple interactions
|
ISO
|
mono-benzyl phthalate results in increased activity of NR1I3 protein alternative form [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of NR1I3 mRNA
|
CTD |
PMID:27551952 PMID:31884101 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:86,165,349...86,170,370
|
|
G
|
Nup62cl
|
nucleoporin 62 C-terminal like
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NUP62CL mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr X:103,668,458...103,724,957
Ensembl chr X:108,457,043...108,512,664
|
|
G
|
Nusap1
|
nucleolar and spindle associated protein 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NUSAP1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:127,057,265...127,087,237
|
|
G
|
Odc1
|
ornithine decarboxylase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ODC1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:46,058,463...46,065,146
|
|
G
|
Pank1
|
pantothenate kinase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PANK1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:232,324,718...232,395,445
Ensembl chr 1:241,741,083...241,807,824
|
|
G
|
Pbx1
|
PBX homeobox 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PBX1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr13:82,811,664...83,121,447
Ensembl chr13:82,812,131...83,121,066
|
|
G
|
Pclaf
|
PCNA clamp associated factor
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PCLAF mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:66,420,606...66,432,994
Ensembl chr 8:75,315,707...75,328,106
|
|
G
|
Pcsk5
|
proprotein convertase subtilisin/kexin type 5
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PCSK5 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:214,837,847...215,267,626
Ensembl chr 1:224,264,678...224,694,347
|
|
G
|
Pfas
|
phosphoribosylformylglycinamidine synthase
|
multiple interactions
|
ISO
|
[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA
|
CTD |
PMID:37160244 |
|
NCBI chr10:53,690,301...53,711,811
Ensembl chr10:54,189,157...54,207,272
|
|
G
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PIK3R1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
|
|
G
|
Pla1a
|
phospholipase A1 member A
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLA1A mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr11:62,320,112...62,357,779
Ensembl chr11:75,825,585...75,878,165
|
|
G
|
Plin1
|
perilipin 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] results in increased expression of PLIN1 mRNA
|
CTD |
PMID:39150890 |
|
NCBI chr 1:133,664,294...133,676,854
Ensembl chr 1:143,074,214...143,086,206
|
|
G
|
Plin2
|
perilipin 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLIN2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:106,202,634...106,258,878
|
|
G
|
Plk1
|
polo-like kinase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLK1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:186,147,658...186,157,637
|
|
G
|
Plk4
|
polo-like kinase 4
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLK4 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:125,730,480...125,748,894
Ensembl chr 2:125,730,460...125,748,892
|
|
G
|
Pltp
|
phospholipid transfer protein
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLTP mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] results in increased expression of PLTP mRNA
|
CTD |
PMID:39150890 PMID:39752319 |
|
NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:173,994,162...174,012,505
|
|
G
|
Plxnb1
|
plexin B1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLXNB1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:118,621,961...118,647,491
Ensembl chr 8:118,623,040...118,647,489
|
|
G
|
Pnoc
|
prepronociceptin
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PNOC mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr15:43,800,240...43,827,841
Ensembl chr15:43,800,246...43,827,470
|
|
G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
affects binding multiple interactions increases activity
|
ISO
|
mono-benzyl phthalate binds to PPARA protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of PPARA mRNA mono-benzyl phthalate results in increased activity of PPARA protein
|
CTD |
PMID:23843199 PMID:27551952 PMID:31884101 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
G
|
Ppard
|
peroxisome proliferator-activated receptor delta
|
affects binding multiple interactions increases activity
|
ISO
|
mono-benzyl phthalate binds to PPARB protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARD mRNA mono-benzyl phthalate results in increased activity of PPARD protein
|
CTD |
PMID:23843199 PMID:27551952 PMID:31884101 |
|
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,352,183...6,365,707
|
|
G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
affects binding multiple interactions increases expression increases activity
|
ISO
|
mono-benzyl phthalate binds to PPARG protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA mono-benzyl phthalate results in increased expression of PPARG protein mono-benzyl phthalate results in increased activity of PPARG protein
|
CTD |
PMID:23843199 PMID:27551952 PMID:29089286 PMID:31884101 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
G
|
Ppih
|
peptidylprolyl isomerase H
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PPIH mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:132,906,324...132,924,341
Ensembl chr 5:138,191,624...138,209,580
|
|
G
|
Ppm1l
|
protein phosphatase, Mg2+/Mn2+ dependent, 1L
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PPM1L mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:153,566,653...153,839,434
Ensembl chr 2:155,876,605...156,149,371
|
|
G
|
Prc1
|
protein regulator of cytokinesis 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PRC1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:143,659,481...143,681,012
|
|
G
|
Prdm1
|
PR/SET domain 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PRDM1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr20:49,542,465...49,564,088
Ensembl chr20:49,542,465...49,564,088
|
|
G
|
Psma3
|
proteasome 20S subunit alpha 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PSMA3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 6:89,483,741...89,503,775
Ensembl chr 6:95,219,629...95,241,032
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
affects expression
|
ISO
|
mono-benzyl phthalate affects the expression of PTGS2 mRNA
|
CTD |
PMID:29089286 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Pttg1
|
PTTG1 regulator of sister chromatid separation, securin
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PTTG1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309
|
|
G
|
Rack1
|
receptor for activated C kinase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RACK1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:33,169,415...33,174,896
Ensembl chr10:33,670,270...33,675,948
|
|
G
|
Ran
|
RAN, member RAS oncogene family
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RAN mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr12:33,311,155...33,314,339
Ensembl chr12:33,311,158...33,314,317
|
|
G
|
Rasl11a
|
RAS-like family 11 member A
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RASL11A mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr12:8,258,148...8,260,909
Ensembl chr12:13,372,023...13,376,451
|
|
G
|
Rbm3
|
RNA binding motif protein 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RBM3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr X:17,020,863...17,024,341
Ensembl chr X:17,020,864...17,024,841
|
|
G
|
Rcn3
|
reticulocalbin 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RCN3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:95,564,503...95,573,762
Ensembl chr 1:104,700,545...104,710,249
|
|
G
|
Rgcc
|
regulator of cell cycle
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RGCC mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr15:61,071,574...61,084,408
Ensembl chr15:61,071,574...61,084,408
|
|
G
|
Rgs2
|
regulator of G-protein signaling 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RGS2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:58,349,163...58,352,697
|
|
G
|
Rnd2
|
Rho family GTPase 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RND2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:86,899,395...86,902,992
Ensembl chr10:86,899,395...86,902,992
|
|
G
|
Robo1
|
roundabout guidance receptor 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ROBO1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr11:24,067,869...25,108,694
Ensembl chr11:24,067,878...25,108,694
|
|
G
|
Robo2
|
roundabout guidance receptor 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ROBO2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr11:26,015,919...27,583,750
Ensembl chr11:26,015,919...26,876,185
|
|
G
|
Rpl18a
|
ribosomal protein L18A
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL18A mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr16:18,542,555...18,544,578
Ensembl chr 1:70,166,729...70,167,654 Ensembl chr16:70,166,729...70,167,654
|
|
G
|
Rpl23a
|
ribosomal protein L23A
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL23A mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:63,076,660...63,079,346
Ensembl chr10:63,574,732...63,581,606
|
|
G
|
Rpl7
|
ribosomal protein L7
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL7 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:3,217,184...3,220,192
Ensembl chr 5:7,850,630...8,003,451
|
|
G
|
Rplp0
|
ribosomal protein lateral stalk subunit P0
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPLP0 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr12:41,054,363...41,057,632
Ensembl chr12:46,715,124...46,718,422
|
|
G
|
Rps19
|
ribosomal protein S19
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPS19 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:80,480,718...80,486,511
Ensembl chr 7:104,324,520...104,325,132 Ensembl chr 1:104,324,520...104,325,132
|
|
G
|
Rps20
|
ribosomal protein S20
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPS20 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:16,819,095...16,820,476
Ensembl chr 3:42,839,965...43,095,621 Ensembl chr 9:42,839,965...43,095,621 Ensembl chr 5:42,839,965...43,095,621
|
|
G
|
S100b
|
S100 calcium binding protein B
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of S100B mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,348...12,381,081
|
|
G
|
Sass6
|
SAS-6 centriolar assembly protein
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SASS6 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:207,231,896...207,263,840
Ensembl chr 2:207,231,333...207,263,851
|
|
G
|
Sec61b
|
SEC61 translocon subunit beta
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61B mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:61,773,594...61,781,804
Ensembl chr 5:66,569,196...66,580,028
|
|
G
|
Sec61g
|
Sec61 translocon subunit gamma
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61G mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr14:90,899,766...90,906,143
Ensembl chr 9:48,798,504...48,798,710 Ensembl chr14:48,798,504...48,798,710
|
|
G
|
Sema3d
|
semaphorin 3D
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEMA3D mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 4:22,316,769...22,505,930
Ensembl chr 4:23,271,825...23,460,971
|
|
G
|
Sema3g
|
semaphorin 3G
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEMA3G mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr16:6,413,589...6,425,221
Ensembl chr16:6,420,012...6,432,553
|
|
G
|
Serpine2
|
serpin family E member 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SERPINE2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:88,573,149...88,637,202
|
|
G
|
Sesn3
|
sestrin 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SESN3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:19,415,307...19,470,943
Ensembl chr 8:19,415,347...19,466,904
|
|
G
|
Sgo1
|
shugoshin 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SGO1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 9:6,672,109...6,687,908
Ensembl chr 9:6,908,661...6,924,415
|
|
G
|
Sgo2
|
shugoshin 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SGO2A mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 9:67,032,083...67,067,439
Ensembl chr 9:67,042,833...67,068,152
|
|
G
|
Sh3bgr
|
SH3 domain binding glutamate-rich protein
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SH3BGR mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr11:35,503,663...35,527,853
Ensembl chr11:48,973,097...48,997,326
|
|
G
|
Sh3bp5
|
SH3-domain binding protein 5
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SH3BP5 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr16:6,583,462...6,678,344
Ensembl chr16:6,589,877...6,655,211
|
|
G
|
Shbg
|
sex hormone binding globulin
|
multiple interactions decreases secretion
|
ISO
|
[Phthalic Acids results in increased abundance of mono-benzyl phthalate] which results in increased expression of and results in increased secretion of SHBG protein mono-benzyl phthalate results in decreased secretion of SHBG protein
|
CTD |
PMID:24945889 PMID:28637469 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,831,718...54,838,760
|
|
G
|
Skp2
|
S-phase kinase associated protein 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of SKP2 mRNA
|
CTD |
PMID:31884101 |
|
NCBI chr 2:59,888,406...59,916,471
Ensembl chr 2:59,888,413...59,916,438
|
|
G
|
Slc12a7
|
solute carrier family 12 member 7
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SLC12A7 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:29,472,692...29,554,246
Ensembl chr 1:31,301,243...31,382,957
|
|
G
|
Slc30a4
|
solute carrier family 30 member 4
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SLC30A4 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:109,753,270...109,775,306
Ensembl chr 3:130,206,852...130,228,888
|
|
G
|
Slc38a5
|
solute carrier family 38, member 5
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SLC38A5 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr X:16,885,701...16,894,470
Ensembl chr X:16,885,701...16,894,470
|
|
G
|
Slc6a6
|
solute carrier family 6 member 6
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SLC6A6 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 4:125,752,340...125,826,033
Ensembl chr 4:125,752,372...125,826,032
|
|
G
|
Slc7a8
|
solute carrier family 7 member 8
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SLC7A8 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr15:32,153,016...32,212,715
Ensembl chr15:32,153,018...32,212,715
|
|
G
|
Smoc2
|
SPARC related modular calcium binding 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SMOC2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:55,262,472...55,391,804
Ensembl chr 1:63,935,647...64,064,955
|
|
G
|
Sobp
|
sine oculis binding protein homolog
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SOBP mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr20:46,482,265...46,661,452
Ensembl chr20:48,064,445...48,243,607
|
|
G
|
Sod1
|
superoxide dismutase 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of SOD1 mRNA
|
CTD |
PMID:35861251 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
G
|
Sox4
|
SRY-box transcription factor 4
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SOX4 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr17:35,876,298...35,881,004
Ensembl chr17:35,875,756...35,884,024
|
|
G
|
Sox9
|
SRY-box transcription factor 9
|
multiple interactions
|
ISO
|
[monobutyl phthalate co-treated with mono-benzyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monoisononylphthalate] results in increased expression of SOX9 mRNA
|
CTD |
PMID:31015488 |
|
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250
|
|
G
|
Spc25
|
SPC25 component of NDC80 kinetochore complex
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SPC25 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:74,337,872...74,396,825
Ensembl chr 3:74,383,548...74,396,718
|
|
G
|
Srgap3
|
SLIT-ROBO Rho GTPase activating protein 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SRGAP3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 4:145,839,369...146,070,556
Ensembl chr 4:147,395,880...147,625,713
|
|
G
|
Srsf5
|
serine and arginine rich splicing factor 5
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SRSF5 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:106,336,756...106,341,931
|
|
G
|
Srsf6
|
serine and arginine rich splicing factor 6
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SRSF6 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:151,589,546...151,594,869
Ensembl chr 3:172,009,061...172,014,392
|
|
G
|
Ssbp3
|
single stranded DNA binding protein 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SSBP3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:121,691,370...121,828,035
Ensembl chr 5:126,919,120...127,056,799
|
|
G
|
Star
|
steroidogenic acute regulatory protein
|
multiple interactions
|
ISO
|
[monobutyl phthalate co-treated with mono-benzyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monoisononylphthalate] results in decreased expression of STAR mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of STAR mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] results in increased expression of STAR mRNA; Colforsin inhibits the reaction [[monobutyl phthalate co-treated with mono-benzyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monoisononylphthalate] results in decreased expression of STAR mRNA]
|
CTD |
PMID:31015488 PMID:31884101 PMID:39150890 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
G
|
Stxbp6
|
syntaxin binding protein 6
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of STXBP6 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 6:67,647,721...67,884,369
Ensembl chr 6:67,650,556...67,884,725
|
|
G
|
Sulf2
|
sulfatase 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SULF2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:154,822,079...154,904,566
Ensembl chr 3:175,241,322...175,323,651
|
|
G
|
Sybu
|
syntabulin
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SYBU mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 7:77,731,662...77,833,413
Ensembl chr 7:77,731,605...77,833,686
|
|
G
|
Tac3
|
tachykinin precursor 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TAC2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 7:65,447,817...65,454,427
Ensembl chr 7:65,447,817...65,454,427
|
|
G
|
Tacc3
|
transforming, acidic coiled-coil containing protein 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TACC3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr14:81,275,755...81,289,894
Ensembl chr14:81,275,755...81,289,698
|
|
G
|
Tafa4
|
TAFA chemokine like family member 4
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TAFA4 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 4:129,437,466...129,671,320
Ensembl chr 4:130,994,167...131,227,940
|
|
G
|
Tedc1
|
tubulin epsilon and delta complex 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TEDC1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 6:132,234,764...132,245,164
Ensembl chr 6:138,056,027...138,067,274
|
|
G
|
Thrb
|
thyroid hormone receptor beta
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of THRB mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
|
|
G
|
Tmed5
|
transmembrane p24 trafficking protein 5
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TMED5 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr14:1,607,895...1,619,028
Ensembl chr14:1,752,745...1,773,389
|
|
G
|
Tmem171
|
transmembrane protein 171
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TMEM171 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:30,035,278...30,045,996
Ensembl chr 2:31,769,486...31,780,134
|
|
G
|
Tmem212
|
transmembrane protein 212
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TMEM212 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:110,775,950...110,813,313
Ensembl chr 2:112,704,189...112,741,868
|
|
G
|
Tnf
|
tumor necrosis factor
|
increases expression
|
ISO
|
mono-benzyl phthalate results in increased expression of TNF mRNA
|
CTD |
PMID:32015430 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Tnfrsf9
|
TNF receptor superfamily member 9
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TNFRSF9 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:166,664,494...166,690,831
|
|
G
|
Tnik
|
TRAF2 and NCK interacting kinase
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TNIK mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 2:111,184,352...111,587,993
Ensembl chr 2:113,112,938...113,511,339
|
|
G
|
Tns3
|
tensin 3
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TNS3 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr14:83,173,649...83,405,671
Ensembl chr14:87,387,441...87,619,712
|
|
G
|
Tp53
|
tumor protein p53
|
decreases expression increases methylation
|
ISO
|
mono-benzyl phthalate results in decreased expression of TP53 mRNA mono-benzyl phthalate results in increased methylation of TP53 promoter
|
CTD |
PMID:35487445 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Tp53i13
|
tumor protein p53 inducible protein 13
|
multiple interactions
|
ISO
|
[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate metabolite co-treated with monoethyl phthalate co-treated with monobutyl phthalate] results in decreased expression of TP53I13 mRNA; [mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with methylparaben] results in increased expression of TP53I13 mRNA
|
CTD |
PMID:38992643 |
|
NCBI chr10:62,356,722...62,363,122
Ensembl chr10:62,854,143...62,859,605
|
|
G
|
Tpst2
|
tyrosylprotein sulfotransferase 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TPST2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr12:44,321,875...44,363,892
Ensembl chr12:49,982,281...50,023,058
|
|
G
|
Tpx2
|
TPX2, microtubule nucleation factor
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TPX2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:161,778,709...161,820,941
Ensembl chr 3:161,778,742...161,820,724
|
|
G
|
Troap
|
trophinin associated protein
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TROAP mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 7:130,233,534...130,242,369
Ensembl chr 7:132,113,433...132,121,294
|
|
G
|
Tspan18
|
tetraspanin 18
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TSPAN18 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:79,160,060...79,299,907
Ensembl chr 3:99,615,466...99,755,270
|
|
G
|
Ttc39b
|
tetratricopeptide repeat domain 39B
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TTC39B mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:97,603,329...97,708,103
Ensembl chr 5:102,655,322...102,782,162
|
|
G
|
Twist2
|
twist family bHLH transcription factor 2
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TWIST2 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 9:92,374,740...92,419,222
Ensembl chr 9:99,818,962...99,920,270
|
|
G
|
Ubash3b
|
ubiquitin associated and SH3 domain containing, B
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBASH3B mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:41,385,419...41,532,248
Ensembl chr 8:50,285,431...50,326,351
|
|
G
|
Ube2c
|
ubiquitin-conjugating enzyme E2C
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2C mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:173,925,934...173,932,678
|
|
G
|
Ube2i
|
ubiquitin-conjugating enzyme E2I
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2I mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr10:14,277,749...14,294,681
Ensembl chr10:70,199,041...70,199,866 Ensembl chr10:70,199,041...70,199,866
|
|
G
|
Ube2j1
|
ubiquitin-conjugating enzyme E2, J1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2J1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:47,422,476...47,441,476
Ensembl chr 5:52,218,807...52,237,805
|
|
G
|
Vegfa
|
vascular endothelial growth factor A
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of VEGFA mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
G
|
Wnt10b
|
Wnt family member 10B
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of WNT10B mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 7:129,922,088...129,927,892
Ensembl chr 7:131,801,046...131,806,850
|
|
G
|
Wnt4
|
Wnt family member 4
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of WNT4 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:154,797,245...154,818,565
Ensembl chr 5:154,797,311...154,817,128
|
|
G
|
Wnt5a
|
Wnt family member 5A
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of WNT5A mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,703,665...3,724,860
|
|
G
|
Ybx1
|
Y box binding protein 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of YBX1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 5:138,167,444...138,188,155
Ensembl chr 5:138,167,444...138,184,188
|
|
G
|
Zc3h12c
|
zinc finger CCCH type containing 12C
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ZC3H12C mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 8:52,443,791...52,508,643
Ensembl chr 8:61,345,271...61,400,610
|
|
G
|
Zfp277
|
zinc finger protein 277
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ZFP277 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 6:57,383,454...57,512,785
Ensembl chr 6:63,110,609...63,239,831
|
|
G
|
Zfp322a
|
zinc finger protein 322a
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ZFP322A mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr17:41,773,789...41,789,654
Ensembl chr17:42,200,956...42,279,388
|
|
G
|
Zfp36
|
zinc finger protein 36
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ZFP36 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:92,796,628...92,799,108
|
|
G
|
Zpld1
|
zona pellucida-like domain containing 1
|
multiple interactions
|
ISO
|
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ZPLD1 mRNA
|
CTD |
PMID:39752319 |
|
NCBI chr11:45,482,883...45,524,555
Ensembl chr11:58,951,901...58,991,704
|
|
|
G
|
Alb
|
albumin
|
multiple interactions
|
ISO
|
ALB protein binds to and affects the transport of salicin
|
CTD |
PMID:8831264 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
G
|
Tas2r118
|
taste receptor, type 2, member 118
|
multiple interactions increases activity
|
ISO
|
4-((diethylamino)sulfonyl)benzoic acid inhibits the reaction [salicin results in increased activity of TAS2R16 protein]; Probenecid inhibits the reaction [salicin results in increased activity of TAS2R16 protein]
|
CTD |
PMID:21629661 |
|
NCBI chr 4:52,449,208...52,450,107
Ensembl chr 4:53,414,815...53,415,714
|
|
|
G
|
Alb
|
albumin
|
multiple interactions
|
ISO
|
ALB protein binds to and affects the transport of salicyl alcohol
|
CTD |
PMID:8831264 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
G
|
Bche
|
butyrylcholinesterase
|
multiple interactions
|
ISO
|
[2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide binds to and results in decreased activity of BCHE protein] which results in increased abundance of salicyl alcohol
|
CTD |
PMID:22898212 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
G
|
Sod2
|
superoxide dismutase 2
|
multiple interactions
|
EXP
|
salicyl alcohol inhibits the reaction [2,2'-azobis(2-amidinopropane) results in decreased activity of SOD2 protein]
|
CTD |
PMID:19665455 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|